<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Percutaneous vertebroplasty for osteoporotic vertebral compression fracture - Buchbinder, R - 2018 | Cochrane Library</title> <meta content="Percutaneous vertebroplasty for osteoporotic vertebral compression fracture - Buchbinder, R - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006349.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Percutaneous vertebroplasty for osteoporotic vertebral compression fracture - Buchbinder, R - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006349.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006349.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Percutaneous vertebroplasty for osteoporotic vertebral compression fracture" name="citation_title"/> <meta content="Rachelle Buchbinder" name="citation_author"/> <meta content="Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University" name="citation_author_institution"/> <meta content="rachelle.buchbinder@monash.edu" name="citation_author_email"/> <meta content="Renea V Johnston" name="citation_author"/> <meta content="Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University" name="citation_author_institution"/> <meta content="Kobi J Rischin" name="citation_author"/> <meta content="Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University" name="citation_author_institution"/> <meta content="Joanne Homik" name="citation_author"/> <meta content="University of Alberta" name="citation_author_institution"/> <meta content="C Allyson Jones" name="citation_author"/> <meta content="University of Alberta" name="citation_author_institution"/> <meta content="Kamran Golmohammadi" name="citation_author"/> <meta content="University of British Columbia" name="citation_author_institution"/> <meta content="David F Kallmes" name="citation_author"/> <meta content="Mayo Clinic" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD006349.pub4" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/11/06" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006349.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006349.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006349.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Bone Cements [therapeutic use]; Fractures, Compression [*therapy]; Glucocorticoids [therapeutic use]; Osteoporotic Fractures [*therapy]; Pain Measurement; Pain, Postoperative; Quality of Life; Randomized Controlled Trials as Topic; Spinal Fractures [*therapy]; Vertebroplasty [adverse effects, *methods]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006349.pub4&amp;doi=10.1002/14651858.CD006349.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006349.pub4&amp;doi=10.1002/14651858.CD006349.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006349.pub4&amp;doi=10.1002/14651858.CD006349.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006349.pub4&amp;doi=10.1002/14651858.CD006349.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006349.pub4&amp;doi=10.1002/14651858.CD006349.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006349.pub4&amp;doi=10.1002/14651858.CD006349.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006349.pub4&amp;doi=10.1002/14651858.CD006349.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006349.pub4&amp;doi=10.1002/14651858.CD006349.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006349.pub4&amp;doi=10.1002/14651858.CD006349.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006349.pub4&amp;doi=10.1002/14651858.CD006349.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006349.pub4&amp;doi=10.1002/14651858.CD006349.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006349.pub4&amp;doi=10.1002/14651858.CD006349.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006349.pub4&amp;doi=10.1002/14651858.CD006349.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006349.pub4&amp;doi=10.1002/14651858.CD006349.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006349.pub4&amp;doi=10.1002/14651858.CD006349.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006349.pub4&amp;doi=10.1002/14651858.CD006349.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006349.pub4&amp;doi=10.1002/14651858.CD006349.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006349.pub4&amp;doi=10.1002/14651858.CD006349.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006349.pub4&amp;doi=10.1002/14651858.CD006349.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006349.pub4&amp;doi=10.1002/14651858.CD006349.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006349.pub4&amp;doi=10.1002/14651858.CD006349.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006349.pub4&amp;doi=10.1002/14651858.CD006349.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006349.pub4&amp;doi=10.1002/14651858.CD006349.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="Xx9QLps0";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006349\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006349\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006349\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006349\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","ms","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD006349.pub4",title:"Percutaneous vertebroplasty for osteoporotic vertebral compression fracture",firstPublishedDate:"Nov 6, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Musculoskeletal Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Xx9QLps0&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006349.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006349.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006349.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006349.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006349.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006349.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006349.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006349.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006349.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006349.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>10020 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006349.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/full#CD006349-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/full#CD006349-sec-0100"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/full#CD006349-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/full#CD006349-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/full#CD006349-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/full#CD006349-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/full#CD006349-sec-0054"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/full#CD006349-sec-0092"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/appendices#CD006349-sec-0105"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/table_n/CD006349StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/table_n/CD006349StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Percutaneous vertebroplasty for osteoporotic vertebral compression fracture</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/information#CD006349-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Rachelle Buchbinder</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/information#CD006349-cr-0003">Renea V Johnston</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/information#CD006349-cr-0004">Kobi J Rischin</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/information#CD006349-cr-0005">Joanne Homik</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/information#CD006349-cr-0006">C Allyson Jones</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/information#CD006349-cr-0007">Kamran Golmohammadi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006349.pub4/information#CD006349-cr-0008">David F Kallmes</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/information/en#CD006349-sec-0118">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 06 November 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006349.pub4">https://doi.org/10.1002/14651858.CD006349.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006349-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006349-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006349-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006349-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006349-abs-0010">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006349-abs-0001" lang="en"> <section id="CD006349-sec-0001"> <h3 class="title" id="CD006349-sec-0001">Background</h3> <p>Percutaneous vertebroplasty remains widely used to treat osteoporotic vertebral fractures although our 2015 Cochrane review did not support its role in routine practice. </p> </section> <section id="CD006349-sec-0002"> <h3 class="title" id="CD006349-sec-0002">Objectives</h3> <p>To update the available evidence of the benefits and harms of vertebroplasty for treatment of osteoporotic vertebral fractures. </p> </section> <section id="CD006349-sec-0003"> <h3 class="title" id="CD006349-sec-0003">Search methods</h3> <p>We updated the search of CENTRAL, MEDLINE and Embase and trial registries to 15 November 2017. </p> </section> <section id="CD006349-sec-0004"> <h3 class="title" id="CD006349-sec-0004">Selection criteria</h3> <p>We included randomised and quasi‐randomised controlled trials (RCTs) of adults with painful osteoporotic vertebral fractures, comparing vertebroplasty with placebo (sham), usual care, or another intervention. As it is least prone to bias, vertebroplasty compared with placebo was the primary comparison. Major outcomes were mean overall pain, disability, disease‐specific and overall health‐related quality of life, patient‐reported treatment success, new symptomatic vertebral fractures and number of other serious adverse events. </p> </section> <section id="CD006349-sec-0005"> <h3 class="title" id="CD006349-sec-0005">Data collection and analysis</h3> <p>We used standard methodologic procedures expected by Cochrane.</p> </section> <section id="CD006349-sec-0006"> <h3 class="title" id="CD006349-sec-0006">Main results</h3> <p>Twenty‐one trials were included: five compared vertebroplasty with placebo (541 randomised participants), eight with usual care (1136 randomised participants), seven with kyphoplasty (968 randomised participants) and one compared vertebroplasty with facet joint glucocorticoid injection (217 randomised participants). Trial size varied from 46 to 404 participants, most participants were female, mean age ranged between 62.6 and 81 years, and mean symptom duration varied from a week to more than six months. </p> <p>Four placebo‐controlled trials were at low risk of bias and one was possibly susceptible to performance and detection bias. Other trials were at risk of bias for several criteria, most notably due to lack of participant and personnel blinding. </p> <p>Compared with placebo, high‐ to moderate‐quality evidence from five trials indicates that vertebroplasty provides no clinically important benefits with respect to pain, disability, disease‐specific or overall quality of life or treatment success at one month. Evidence for quality of life and treatment success was downgraded due to possible imprecision. Evidence was not downgraded for potential publication bias as only one placebo‐controlled trial remains unreported. Mean pain (on a scale zero to 10, higher scores indicate more pain) was five points with placebo and 0.7 points better (0.3 better to 1.2 better) with vertebroplasty, an absolute pain reduction of 7% (3% better to 12% better, minimal clinical important difference is 15%) and relative reduction of 10% (4% better to 17% better) (five trials, 535 participants). Mean disability measured by the Roland‐Morris Disability Questionnaire (scale range zero to 23, higher scores indicate worse disability) was 14.2 points in the placebo group and 1.5 points better (0.4 better to 2.6 better) in the vertebroplasty group, absolute improvement 7% (2% to 11% better), relative improvement 9% better (2% to 15% better) (four trials, 472 participants). </p> <p>Disease‐specific quality of life measured by the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO) (scale zero to 100, higher scores indicating worse quality of life) was 62 points in the placebo group and 2.3 points better (1.4 points worse to 6.7 points better), an absolute imrovement of 2% (1% worse to 6% better); relative improvement 4% better (2% worse to 10% better) (three trials, 351 participants). Overall quality of life (European Quality of Life (EQ5D), zero = death to 1 = perfect health, higher scores indicate greater quality of life) was 0.38 points in the placebo group and 0.05 points better (0.01 better to 0.09 better) in the vertebroplasty group, absolute improvement: 5% (1% to 9% better), relative improvement: 18% (4% to 32% better) (three trials, 285 participants). In one trial (78 participants), 9/40 (or 225 per 1000) people perceived that treatment was successful in the placebo group compared with 12/38 (or 315 per 1000; 95% CI 150 to 664) in the vertebroplasty group, RR 1.40 (95% CI 0.67 to 2.95), absolute difference: 9% more reported success (11% fewer to 29% more); relative change: 40% more reported success (33% fewer to 195% more). </p> <p>Low‐quality evidence (downgraded due to imprecision and potential for bias from the usual‐care controlled trials) indicates uncertainty around the risk estimates of harms with vertebroplasty. The incidence of new symptomatic vertebral fractures (from six trials) was 48/418 (95 per 1000; range 34 to 264)) in the vertebroplasty group compared with 31/422 (73 per 1000) in the control group; RR 1.29 (95% CI 0.46 to 3.62)). The incidence of other serious adverse events (five trials) was 16/408 (34 per 1000, range 18 to 62) in the vertebroplasty group compared with 23/413 (56 per 1000) in the control group; RR 0.61 (95% CI 0.33 to 1.10). Notably, serious adverse events reported with vertebroplasty included osteomyelitis, cord compression, thecal sac injury and respiratory failure. </p> <p>Our subgroup analyses indicate that the effects did not differ according to duration of pain (acute versus subacute). Including data from the eight trials that compared vertebroplasty with usual care in a sensitivity analyses altered the primary results, with all combined analyses displaying considerable heterogeneity. </p> </section> <section id="CD006349-sec-0007"> <h3 class="title" id="CD006349-sec-0007">Authors' conclusions</h3> <p>We found high‐ to moderate‐quality evidence that vertebroplasty has no important benefit in terms of pain, disability, quality of life or treatment success in the treatment of acute or subacute osteoporotic vertebral fractures in routine practice when compared with a sham procedure. Results were consistent across the studies irrespective of the average duration of pain. </p> <p>Sensitivity analyses confirmed that open trials comparing vertebroplasty with usual care are likely to have overestimated any benefit of vertebroplasty. Correcting for these biases would likely drive any benefits observed with vertebroplasty towards the null, in keeping with findings from the placebo‐controlled trials. </p> <p>Numerous serious adverse events have been observed following vertebroplasty. However due to the small number of events, we cannot be certain about whether or not vertebroplasty results in a clinically important increased risk of new symptomatic vertebral fractures and/or other serious adverse events. Patients should be informed about both the high‐ to moderate‐quality evidence that shows no important benefit of vertebroplasty and its potential for harm. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006349-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006349-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD006349-abs-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD006349-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006349-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006349-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD006349-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD006349-abs-0005">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006349-abs-0003" lang="en"> <h3>Vertebroplasty for treating spinal fractures due to osteoporosis</h3> <p><b>Background</b> </p> <p>Osteoporosis is characterised by thin, fragile bones and may result in minimal trauma fractures of the spine bones (vertebrae). They can cause severe pain and disability. </p> <p>Vertebroplasty involves injecting medical‐grade cement into a fractured vertebra, under light sedation or general anaesthesia. The cement hardens in the bone space to form an internal cast. </p> <p><b>Study characteristics</b> </p> <p>This Cochrane review is current to November 2017. Studies compared vertebroplasty versus placebo (no cement injected) (five studies, 541 participants); usual care (eight studies, 1136 participants); kyphoplasty (similar, but before cement is injected a balloon is expanded in the fractured vertebra; seven studies, 968 participants) and facet joint steroid injection (one study, 217 participants). Trials were performed in hospitals in 15 countries, the majority of participants were female, mean age ranged between 63.3 and 80 years, and symptom duration ranged from a week to six months or more. Eight trials received at least some funding from medical device manufacturers and only two reported that they had no role in the trial. </p> <p><b>Key results</b> </p> <p>Compared with a placebo (fake) procedure, vertebroplasty resulted in little benefit at one month: </p> <p>Pain (lower scores mean less pain) </p> <p>Improved by 7% (3% better to 12% better), or 0.7 points (0.3 better to 1.2 better) on a zero‐0 to 10‐point scale. </p> <p>• People who had vertebroplasty rated their pain as 4.3 points.</p> <p>• People who had placebo rated their pain as 5 points.</p> <p>Disability (lower scores mean less disability) </p> <p>Improved by 7% (2% better to 11% better), or 1.5 points (0.4 better to 2.6 better) on a zero to 23‐point scale. </p> <p>• People who had vertebroplasty rated their disability as 12.7 points.</p> <p>• People who had placebo rated their disability as 14.2 points.</p> <p>Vertebral fracture or osteoporosis‐specific quality of life (lower scores mean better quality of life) </p> <p>Better by 2% (1% worse to 6% better), or 2.33 points better (1.41 worse to 6.06 better) on a zero to 100‐point scale. </p> <p>• People who had vertebroplasty rated their quality of life related to their fracture as 59.7 points. </p> <p>• People who had placebo rated their quality of life related to their fracture as 62 points. </p> <p>Overall quality of life (higher scores mean better quality of life) </p> <p>Improved by 5% (1% better to 9% better), or 0.05 units (0.01 better to 0.09 better) on a zero = death to one = perfect health scale. </p> <p>• People who had vertebroplasty rated their general quality of life as 0.43 points.</p> <p>• People who had placebo rated their general quality of life as 0.38 points.</p> <p>Treatment success (defined as pain moderately or a great deal better) </p> <p>9% more people rated their treatment a success (11% fewer to 29% more), or nine more people out of 100. </p> <p>• 32 out of 100 people reported treatment success with vertebroplasty.</p> <p>• 23 out of 100 people reported treatment success with placebo.</p> <p>Compared with a placebo or usual care:</p> <p>New symptomatic vertebral fractures (at 12 to 24 months) </p> <p>3% more new fractures with vertebroplasty (8% fewer to 13% more), or one more person out of 100. </p> <p>• 10 out of 100 people had a new fracture with vertebroplasty.</p> <p>• 7 out of 100 people had a new fracture with placebo or usual care.</p> <p>Other serious adverse events: </p> <p>1% fewer people (6% fewer to 4% more), had other serious adverse events with vertebroplasty; relative change 39% fewer (67% fewer to 10% more). </p> <p>• 4 out of 100 people reported other serious adverse events with vertebroplasty.</p> <p>• 5 out of 100 people reported other serious adverse events with placebo.</p> <p><b>Quality of the evidence</b> </p> <p>High‐quality evidence shows that vertebroplasty does not provide more clinically important benefits than placebo. We are less certain of the risk of new vertebral fractures or other serious effects; quality was moderate due to the small number of events. </p> <p>Serious adverse events that may occur include spinal cord or nerve root compression due to cement leaking out from the bone, cement leaking into the blood stream, rib fractures, infection in the bone, fat leaking into the bloodstream, damage to the covering of the spinal cord that could result in leakage of cerebrospinal fluid, anaesthetic complications and death. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006349-sec-0100" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006349-sec-0100"></div> <h3 class="title" id="CD006349-sec-0101">Implications for practice</h3> <section id="CD006349-sec-0101"> <p>Based upon the currently available high‐ to moderate‐quality evidence, vertebroplasty has little meaningful effect on pain, disability, quality of life or treatment success for the treatment of acute or subacute osteoporotic vertebral fractures in routine clinical care. There were no demonstrable clinically important benefits compared with a placebo (sham procedure) and the results were consistent across the studies irrespective of the duration of fracture pain. Sensitivity analyses confirmed that open trials that compared vertebroplasty with usual care are likely to have overestimated any benefit of vertebroplasty. Correcting for these biases would likely drive any observed improvements seen with vertebroplasty over usual care towards the null, in keeping with the findings from the placebo‐controlled trials. </p> <p>Although we did not demonstrate an increased risk of incident symptomatic vertebral fractures or other serious adverse events associated with vertebroplasty, a clinically important increased risk cannot be excluded based upon our review due to the small number of events. Furthermore, serious adverse events related to vertebroplasty were reported in several trials. Patients should be informed about the lack of high‐quality evidence supporting benefits of vertebroplasty and its potential for harm. </p> </section> <h3 class="title" id="CD006349-sec-0102">Implications for research</h3> <section id="CD006349-sec-0102"> <p>Further high‐quality research is unlikely to substantially change the conclusions of this review regarding the potential benefits of vertebroplasty but may resolve whether or not it increases the risk of further vertebral fracture and serious adverse events. Current literature does not support the likelihood of identifying subsets of patients who would benefit from vertebroplasty. It is questionable whether further trials testing the efficacy of vertebroplasty are necessary. Any future review updates will restrict inclusion to only placebo‐controlled trials. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD006349-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD006349-sec-0022"></div> <div class="table" id="CD006349-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Vertebroplasty for osteoporotic vertebral compression fracture</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Vertebroplasty for osteoporotic vertebral compression fracture</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with osteoporotic vertebral compression fracture<br/> <b>Settings:</b> hospital, various countries including Australia, USA, UK, Canada, several European countries, Iran, China, Taiwan<br/> <b>Intervention:</b> vertebroplasty versus placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo<sup>1</sup> </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Vertebroplasty</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain</b> <br/> Scale from: 0 to 10, 0 is no pain.<br/> Follow‐up: 1 month </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain in the control groups was<br/> <b>5 points</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain in the intervention groups was<br/> <b>0.7 points better</b><br/> (0.3 better to 1.2 better) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>535<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute change 7% better (3% better to 12% better); relative change 10% better (4% better to 17% better)<sup>3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Disability (Roland‐Morris Disability Questionnaire)</b><br/> Scale from: 0 to 23; 0 is no disability.<br/> Follow‐up: 1 month </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean disability in the control groups was<br/> <b>14.2 points</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean disability in the intervention groups was<br/> <b>1.5 points better</b><br/> (0.4 better to 2.6 better) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>472<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute change 7% better (2% better to 11% better); relative change 9% better (2% better to 15% better)<sup>3</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Disease‐specific quality of Life (QUALEFFO)</b> <br/> Scale from: 0 to 100; 0 is best.<br/> Follow‐up: 1 month </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life (QUALEFFO) in the control groups was<br/> <b>62 points</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean quality of life in the intervention groups was<br/> <b>2.33 points better</b><br/> (1.41 worse to 6.06 better) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>351<br/> (3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute change 2% better (1% worse to 6% better); relative change 4% better (2% worse to 10% better)<sup>3</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall quality of Life (EQ5D)</b> <br/> Scale from: 0 to 1; 1 is best.<br/> Follow‐up: 1 month </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life (EQ‐5D) in the control groups was<br/> <b>0.38 points</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean quality of life in the intervention groups was<br/> <b>0.05 points better</b><br/> (0.01 better to 0.09 better) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>285<br/> (3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute change 5% better (1% better to 9% better); relative change 18% improvement (4% better to 32% better)<sup>3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant global assessment of success</b> </p> <p>(People perceived their pain as better)</p> <p>Follow‐up: 1 month</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>225 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>315 per 1000</b><br/> (150 to 664) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.40</b> <br/> (0.67 to 2.95) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute difference 9% more reported success (11% fewer to 29% more); relative change 40% more reported success (33% fewer to 195% more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incident symptomatic vertebral fractures</b> </p> <p>Follow‐up: 12 ‐24 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>73 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>95 per 1000</b> </p> <p>(34 to 264)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.29</b> <br/> (0.46 to 3.62) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>840<br/> (6 studies)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>4,6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Absolute difference 3% more fractures with vertebroplasty (8% fewer to 13% more); relative difference 29% more (54% fewer to 262% more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Other serious adverse events</b><br/> Follow‐up: 12‐24 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>56 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>34 per 1000</b><br/> (18 to 62) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.61</b><br/> (0.33 to 1.10) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>821<br/> (5 studies)<sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>4,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute difference 1% fewer events with vertebroplasty (6% fewer to 4% more); relative change 39% fewer (67% fewer to 10% more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>SMD:</b> Standardised mean difference; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> For incident vertebral fractures the comparison includes two placebo (sham)‐controlled trials and three trials that compared vertebroplasty versus usual care. </p> <p><sup>2</sup> The internal validity of the five placebo‐controlled trials that have full or some results available is high. Four trials have published their results in peer‐reviewed journals (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>; <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>; <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>) while a fifth trial (<a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>), completed in April 2014, was published as a thesis (http://www.forskningsdatabasen.dk/en/catalog/2371744560), and reported at a conference. Therefore we did not downgrade the evidence due to suspected publication bias although the results of one additional placebo‐controlled trial (<a href="./references#CD006349-bbs2-0052" title="NCT01963039 . A trial of vertebroplasty for painful chronic osteoporotic vertebral fractures (VERTOS V). clinicaltrials.gov/show/NCT01963039 First registered 28 August 2013. ">VERTOS V</a>) remain unpublished. This trial was previously reported as completed in June 2015, but its status has been changed to 'enrolling by invitation', at: https://clinicaltrials.gov/ct2/show/NCT01963039. While publication bias is possible, it is unlikely the conclusions will change when data from this trial become available. </p> <p><sup>3</sup> Relative changes calculated as absolute change (mean difference) divided by mean at baseline in the placebo group from <a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a> (values were: 7.1 points on 0 to 10 point VAS pain; 17.3 points on 0 to 23 point Roland‐Morris Disability questionnaire; 0.28 points on EQ‐5D quality of life scale; 59.6 points on the QUALEFFO scale). </p> <p><sup>4</sup> Downgraded due to imprecision: the 95% confidence intervals do not exclude a clinically important change (defined as 1.5 points on the 0 to 10 pain scale; 2 to 3 points on the 0 to 23 point RMDQ scale; 0.074 on the 0 to 1 EQ‐5D quality of life scale, and 10 points on the 0 to 100 QUALEFFO scale); or for dichotomous outcomes the total number of participants was small, or number of events was small (&lt;200); or data were from a single trial only </p> <p><sup>5</sup> Pooled both placebo and usual care comparisons in the safety analyses. </p> <p><sup>6</sup> Downgraded due to the possibility of detection bias in the studies with a usual care control group. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006349-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006349-sec-0023"></div> <section id="CD006349-sec-0024"> <h3 class="title" id="CD006349-sec-0024">Description of the condition</h3> <p>Vertebral compression fractures are among the most common type of fracture in patients with osteoporosis (<a href="./references#CD006349-bbs2-0117" title="StrömO , BorgströmF , KanisJA , CompstonJ , CooperC , McCloskeyEV , et al. Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Archives of Osteoporosis2011;6:59‐155. ">Ström 2011</a>). The estimated incidence of osteoporotic vertebral compression fractures in individuals 50 years or older has been reported to be 307 per 100,000 year based upon a German study, with the rate in women aged between 85 and 89 years almost eight‐fold higher that in women aged 60 to 64 years (<a href="./references#CD006349-bbs2-0078" title="HernlundE , SvedbomA , IvergårdM , CompstonJ , CooperC , StenmarkJ , et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. Archives of Osteoporosis2013;8(1‐2):136. ">Hernlund 2013</a>). The same study estimated that the direct costs associated with a new osteoporotic vertebral fracture in the first year after its occurrence is about 6490 Euros, signifying that these fractures are costly. A Swedish study estimated that the lifetime risk for a symptomatic osteoporotic vertebral fracture for a person of the age of 45 is 15% for a woman and 8% for a man (<a href="./references#CD006349-bbs2-0085" title="KanisJA , JohnellO , OdenA , SernboI , Redlund‐JohnellI , DawsonA , et al. Long‐term risk of osteoporotic fracture in Malmo. Osteoporosis International2000;11(8):669‐774. ">Kanis 2000</a>). In the USA, approximately 750,000 new osteoporotic vertebral fractures occur each year (<a href="./references#CD006349-bbs2-0100" title="MeltonLJ3rd , ThamerM , RayNF , ChanJK , ChesnutCH3rd , EinhornTA , et al. Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. Journal of Bone and Mineral Research1997;12(1):16‐23. ">Melton 1997</a>). </p> <p>A recent population‐based study examining trends in fracture incidence over time in Olmstead County, Minnesota, observed a dramatic increase in the incidence of vertebral fractures, from 1989 to 1991 to 2009 to 2011, and this was associated with an apparent earlier onset of vertebral fracture over time (<a href="./references#CD006349-bbs2-0054" title="Amin S. Achenbach SJ. Atkinson EJ. Khosla S. MeltonLJ3rd . Trends in fracture incidence: a population‐based study over 20 years. Journal of Bone and Mineral Research2014;29(3):581‐9. ">Amin 2014</a>). The vast majority of these (83.4%) were considered osteoporotic, defined in the study as resulting from no more than moderate trauma (by convention, equivalent to a fall from standing height or less). While some of the observed increase could have been partially attributable to incidentally diagnosed vertebral fractures, the findings are in keeping with a Dutch study that observed a rise in the number of emergency department visits due to osteoporotic vertebral fractures between 1986 and 2008, due to an increase in falls among the most elderly (<a href="./references#CD006349-bbs2-0105" title="OudshoornC , HartholtKA , ZillikensMC , PannemanMJ , van derVeldeN , ColinEM , et al. Emergency department visits due to vertebral fractures in the Netherlands, 1986–2008: steep increase in the oldest old, strong association with falls. Injury2012;43(4):458‐61. ">Oudshoorn 2012</a>). The results are also consistent with a Canadian study that observed a decline in the rate of all low‐trauma osteoporotic fractures over 20 years from 1986 to 2006 in the Province of Manitoba, except for vertebral fractures, which did not decline significantly in either sex (<a href="./references#CD006349-bbs2-0093" title="LeslieWD , SadatsafaviM , LixLM , AzimaeeM , MorinS , MetgeCJ , et al. Secular decreases in fracture rates 1986–2006 for Manitoba, Canada: a population‐based analysis. Osteoporosis International2011;22:2137‐43. ">Leslie 2011</a>). </p> <p>Osteoporotic vertebral compression fractures are a common cause of both acute and chronic back pain in older populations, although only about a third of radiographic osteoporotic vertebral compression deformities present with acute pain. Both symptomatic and asymptomatic osteoporotic vertebral fractures can lead to substantial spinal deformity, functional limitation, pulmonary compromise and lowered quality of life. They are associated with an increased risk of further vertebral fractures and increased mortality (<a href="./references#CD006349-bbs2-0090" title="LauE , OngKL , KurtzSM , SchmierJ , EdidinAA . Mortalityfollowing the diagnosis of a vertebral compression fracture in theMedicare population. Journal of Bone &amp; Joint Surgery. American volume2008;90(7):1479‐86. ">Lau 2008</a>). </p> <p>Management options for treating acutely painful osteoporotic vertebral fractures are limited and include provision of adequate analgesia, bed rest and physical therapy, as well as assessment and appropriate management of osteoporosis and risk factors for further fractures such as falls prevention. While most fractures generally heal within a few months, some people have persistent pain and disability, and require hospitalisation, long‐term care, or both (<a href="./references#CD006349-bbs2-0084" title="KanisJA , JohnellO . The burden of osteoporosis. Journal of Endocrinological Investment1999;22:583‐8. ">Kanis 1999</a>). </p> </section> <section id="CD006349-sec-0025"> <h3 class="title" id="CD006349-sec-0025">Description of the intervention</h3> <p>Percutaneous vertebroplasty was first described in 1987 as a treatment for vertebral angioma (<a href="./references#CD006349-bbs2-0072" title="GalibertP , DeramondH , RosatP , LeGarsD . Preliminary note on the treatment of vertebral angioma by percutaneous acrylic vertebroplasty [Note preliminaire sur le traitement des angiomes vertebraux par vertebroplastie acrylique percutanee.]. Neuro‐Chirurgie1987;33(2):166‐8. [PUBMED: 3600949] ">Galibert 1987</a>), and subsequently it has been used to treat both benign and malignant vertebral fractures. The procedure may be performed under intravenous sedation or general anaesthesia by interventional radiologists, neurosurgeons or orthopaedic surgeons. Under imaging guidance, most often fluoroscopy, a large calibre needle is inserted into the affected vertebral body usually via a transpedicular route and bone cement, usually polymethylmethacrylate (PMMA), is injected (<a href="./references#CD006349-bbs2-0079" title="HideIG , GangiA . Percutaneous vertebroplasty: history, technique and current perspectives. Clinical Radiology2004;59(6):461‐7. ">Hide 2004</a>). </p> <p>Early open‐label, and uncontrolled studies consistently reported dramatic immediate improvements in pain, and adverse events were reportedly uncommon (<a href="./references#CD006349-bbs2-0082" title="HochmuthK , ProschekD , SchwarzW , MackM , KurthAA , VoglTJ . Percutaneous vertebroplasty in the therapy of osteoporotic vertebral compression fractures: a critical review. European Radiology2006;16(5):998‐1004. [PUBMED: 16395532] ">Hochmuth 2006</a>). Despite the absence of evidence from high‐quality randomised controlled trials (RCTs) confirming its benefits, over the last 20 years the procedure has become incorporated into standard care in many parts of the world, most commonly reserved for patients who fail a period of conservative therapy. In the USA, dramatic increases in the use of vertebroplasty have been observed over the last two decades (<a href="./references#CD006349-bbs2-0075" title="GrayD , HollingworthW , OnwudiweN , DeyoRA , JarvikJG . Thoracic and lumbar vertebroplasties performed in US Medicare enrollees, 2001‐2005. JAMA2007;298(15):1760‐2. ">Gray 2007a</a>; <a href="./references#CD006349-bbs2-0088" title="LadSP , PatilCG , LadEM , HaydenMG , BoakyeM . National trends in vertebral augmentation procedures for the treatment of vertebral compression fractures. Surgical Neurology2009;71(5):580‐4. ">Lad 2009</a>; <a href="./references#CD006349-bbs2-0091" title="LeakeCB , BrinjikjiW , CloftHJ , KallmesDF . Trends of inpatient spine augmentation: 2001‐2008. AJNR: American Journal of Neuroradiology2011;32:1464‐8. ">Leake 2011</a>). </p> <p>Documented adverse events occurring either during or after the procedure have included cord compression due to extension of the cement outside of the vertebral body, cement pulmonary embolism, infection, rib fractures and new adjacent or non‐adjacent vertebral fractures, osteolysis in the bone surrounding the injected material and death (<a href="./references#CD006349-bbs2-0091" title="LeakeCB , BrinjikjiW , CloftHJ , KallmesDF . Trends of inpatient spine augmentation: 2001‐2008. AJNR: American Journal of Neuroradiology2011;32:1464‐8. ">Leake 2011</a>). </p> </section> <section id="CD006349-sec-0026"> <h3 class="title" id="CD006349-sec-0026">How the intervention might work</h3> <p>The mechanism by which percutaneous vertebroplasty is purported to reduce pain is not known. At least three possible mechanisms have been proposed: (1) mechanical stabilisation of the fractured bone; (2) thermal destruction of nerve endings due to the high temperature reached during polymerisation of the injected cement; and (3) chemical destruction of the nerve endings due to the chemical composition of the cement (<a href="./references#CD006349-bbs2-0057" title="BelkoffS , MathisJM , JasperLE , DeramondH . The biomechanics of vertebroplasty: The effect of cement volume on mechanical behavior. Spine2001;26(14):1537‐41. ">Belkoff 2001</a>). The semisolid mixture of PMMA has been shown to restore strength and stiffness of vertebral bodies in post‐mortem studies (<a href="./references#CD006349-bbs2-0057" title="BelkoffS , MathisJM , JasperLE , DeramondH . The biomechanics of vertebroplasty: The effect of cement volume on mechanical behavior. Spine2001;26(14):1537‐41. ">Belkoff 2001</a>). </p> </section> <section id="CD006349-sec-0027"> <h3 class="title" id="CD006349-sec-0027">Why it is important to do this review</h3> <p>Percutaneous vertebroplasty has been widely adopted into clinical practice to treat painful osteoporotic vertebral compression fractures prior to supporting evidence of its efficacy and safety from high‐quality RCTs. The first RCT of vertebroplasty compared with usual care was published in 2007 (<a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a>), while the first two placebo‐controlled trials were published in 2009 (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>). </p> <p>Numerous systematic reviews and/or meta‐analyses of vertebroplasty for osteoporotic spinal fractures have been published (<a href="./references#CD006349-bbs2-0055" title="AndersonPA , FroyshteterAB , TontzWLJr . Meta‐analysis of vertebral augmentation compared with conservative treatment for osteoporotic spinal fractures. Journal of Bone and Mineral Research2013;28(2):378‐32. ">Anderson 2013</a>; <a href="./references#CD006349-bbs2-0060" title="BliemelC , OberkircherL , BueckingB , TimmesfeldN , RuchholtzS , KruegerA . Higher incidence of new vertebral fractures following percutaneous vertebroplasty and kyphoplasty‐‐fact or fiction?. Acta Orthopaedica Belgica2012;78(2):220‐9. ">Bliemel 2012</a>; <a href="./references#CD006349-bbs2-0069" title="EckJC , NachtigallD , HumphreysSC , HodgesSD . Comparison of vertebroplasty and balloon kyphoplasty for treatment of vertebral compression fractures: a meta‐analysis of the literature. Spine Journal2008;8(3):488‐97. ">Eck 2008</a>; <a href="./references#CD006349-bbs2-0074" title="GillJB , KuperM , ChinPC , ZhangY , SchuttRJr . Comparing pain reduction following kyphoplasty and vertebroplasty for osteoporotic vertebral compression fractures. Pain Physician2007;10(4):583‐90. ">Gill 2007</a>; <a href="./references#CD006349-bbs2-0077" title="HanS , WanS , NingL , TongY , ZhangJ , FanS . Percutaneous vertebroplasty versus balloon kyphoplasty for treatment of osteoporotic vertebral compression fracture: a meta‐analysis of randomised and non‐randomised controlled trials. International Orthopaedics2011;35(9):1349‐58. ">Han 2011</a>; <a href="./references#CD006349-bbs2-0082" title="HochmuthK , ProschekD , SchwarzW , MackM , KurthAA , VoglTJ . Percutaneous vertebroplasty in the therapy of osteoporotic vertebral compression fractures: a critical review. European Radiology2006;16(5):998‐1004. [PUBMED: 16395532] ">Hochmuth 2006</a>; <a href="./references#CD006349-bbs2-0083" title="HulmePA , KrebsJ , FergusonSJ , BerlemannU . Vertebroplasty and kyphoplasty: a systematic review of 69 clinical studies. Spine2006;31(17):1983‐2001. ">Hulme 2006</a>; <a href="./references#CD006349-bbs2-0092" title="LeeMJ , DumonskiM , CahillP , StanleyT , ParkD , SinghK . Percutaneous treatment of vertebral compression fractures: a meta‐analysis of complications. Spine2009;34(11):1228‐32. ">Lee 2009</a>; <a href="./references#CD006349-bbs2-0095" title="LiuJ , LiX , TangD , CuiX , LiX , YaoM , et al. Comparing pain reduction following vertebroplasty and conservative treatment for osteoporotic vertebral compression fractures: a meta‐analysis of randomized controlled trials. Pain Physician2013;16(5):455‐64. ">Liu 2013</a>; <a href="./references#CD006349-bbs2-0096" title="MaXL , XingD , MaJX , XuWG , WangJ , ChenY . Balloon kyphoplasty versus percutaneous vertebroplasty in treating osteoporotic vertebral compression fracture: grading the evidence through a systematic review and meta‐analysis. European Spine Journal2012;21(9):1844‐59. ">Ma 2012</a>; <a href="./references#CD006349-bbs2-0099" title="McGirtMJ , ParkerSL , WolinskyJP , WithamTF , BydonA , GokaslanZL . Vertebroplasty and kyphoplasty for the treatment of vertebral compression fractures: an evidenced‐based review of the literature. Spine Journal2011;9(6):501‐8. [PUBMED: 19251485] ">McGirt 2009</a>; <a href="./references#CD006349-bbs2-0106" title="PapanastassiouID , PhillipsFM , VanMeirhaegheJ , BerensonJR , AnderssonGB , ChungG , et al. Comparing effects of kyphoplasty, vertebroplasty, and non‐surgical management in a systematic review of randomized and non‐randomized controlled studies. European Spine Journal2012;21(9):1826‐43. ">Papanastassiou 2012</a>; <a href="./references#CD006349-bbs2-0107" title="PloegWT , VeldhuizenAG , TheB , SietsmaMS . Percutaneous vertebroplasty as a treatment for osteoporotic vertebral compression fractures: a systematic review. European Spine Journal2006;15(12):1749‐58. ">Ploeg 2006</a>; <a href="./references#CD006349-bbs2-0108" title="RobinsonY , OlerudC . Vertebroplasty and kyphoplasty—a systematic review of cement augmentation techniques for osteoporotic vertebral compression fractures compared to standard medical therapy. Maturitas2012;72:42‐9. ">Robinson 2012</a>; <a href="./references#CD006349-bbs2-0113" title="ShiMM , CaiXZ , LinT , WangW , YanSG . Is there really no benefit of vertebroplasty for osteoporotic vertebral fractures? A meta‐analysis. Clinical Orthopaedics &amp; Related Research2012;470(10):2785‐99. ">Shi 2012</a>; <a href="./references#CD006349-bbs2-0116" title="StevensonM , GomersallT , Lloyd JonesM , RawdinA , HernandezM , DiasS , et al. Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for the treatment of osteoporotic vertebral fractures: a systematic review and cost‐effectiveness analysis. Health Technology Assessment (Winchester, England)2014;18(17):1‐290. ">Stevenson 2014</a>; <a href="./references#CD006349-bbs2-0120" title="TaylorRS , TaylorRJ , FritzellP . Balloon kyphoplasty and vertebroplasty for vertebral compression fractures: a comparative systematic review of efficacy and safety. Spine2006;31(23):2747‐55. ">Taylor 2006</a>; <a href="./references#CD006349-bbs2-0122" title="TroutAT , KallmesDF . Does vertebroplasty cause incident vertebral fractures? A review of available data. AJNR: American Journal of Neuroradiology2006;27(7):1397‐403. ">Trout 2006</a>; <a href="./references#CD006349-bbs2-0125" title="WangLJ , YangHL , ShiYX , JiangWM , ChenL . Pulmonary cement embolism associated with percutaneous vertebroplasty or kyphoplasty: a systematic review. Orthopaedic Audio‐Synopsis Continuing Medical Education2012;4(3):182‐9. ">Wang 2012</a>; <a href="./references#CD006349-bbs2-0126" title="XingD , MaJX , MaXL , WangJ , XuWG , ChenY , et al. A meta‐analysis of balloon kyphoplasty compared to percutaneous vertebroplasty for treating osteoporotic vertebral compression fractures. Journal of Clinical Neuroscience2013;20(6):795‐803. ">Xing 2013</a>; <a href="./references#CD006349-bbs2-0128" title="ZhangYZ , KongLD , CaoJM , DingWY , ShenY . Incidence of subsequent vertebral body fractures after vertebroplasty. Journal of Clinical Neuroscience2014;21(8):1292‐7. ">Zhang 2013</a>; <a href="./references#CD006349-bbs2-0130" title="ZouJ , MeiX , ZhuX , ShiQ , YangH . The long‐term incidence of subsequent vertebral body fracture after vertebral augmentation therapy: a systemic review and meta‐analysis. Pain Physician2012;15(4):E515‐22. ">Zou 2012</a>). These have varied in inclusion criteria and methodologic rigour, and have reported conflicting results. </p> <p>In 2015, we published a Cochrane systematic review that synthesised the best available evidence for the efficacy and safety of this procedure including 11 RCTs and one quasi‐RCT (1320 participants) (<a href="./references#CD006349-bbs2-0132" title="BuchbinderR , GolmohammadiK , JohnstonRV , OwenRJ , HomikJ , JonesA , et al. Percutaneous vertebroplasty for osteoporotic vertebral compression fracture. Cochrane Database of Systematic Reviews2015, Issue 4. [DOI: 10.1002/14651858.CD006349.pub2] ">Buchbinder 2015</a>). Based upon moderate‐quality evidence, our review did not support a role for vertebroplasty for treating osteoporotic vertebral fractures in routine practice. Since then the results of further trials have been published and/or presented including two additional placebo‐controlled trials. It is important to determine whether or not incorporation of the findings of the additional trials in an updated review alters our previous conclusions. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006349-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006349-sec-0028"></div> <p>To assess the benefits and harms of percutaneous vertebroplasty for treating patients with osteoporotic vertebral compression fractures. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006349-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006349-sec-0029"></div> <section id="CD006349-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006349-sec-0031"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs) of any design (e.g. parallel, cross‐over, factorial) and controlled clinical trials using a quasi‐randomised method of allocation, such as by alternation or date of birth. Reports of trials were eligible regardless of the language or date of publication. Only trials published as full articles or available as a full trial report were considered for inclusion. </p> </section> <section id="CD006349-sec-0032"> <h4 class="title">Types of participants</h4> <p>We included trials that enrolled adults with a diagnosis of osteoporotic vertebral compression fracture/s of any duration. The diagnosis of osteoporosis could have been based upon bone mineral densitometry or explicit clinical diagnostic criteria as defined by the studies. Trials enrolling participants with vertebral fractures due to another cause such as major trauma and malignancy were excluded. </p> </section> <section id="CD006349-sec-0033"> <h4 class="title">Types of interventions</h4> <p>We included trials that evaluated percutaneous vertebroplasty, defined as percutaneous injection of bone cement (usually polymethylmethacrylate (PMMA)) or similar substances into a vertebral body under imaging guidance. </p> <p>Comparators could be any of the following.</p> <p> <ul id="CD006349-list-0001"> <li> <p>Placebo or sham procedure</p> </li> <li> <p>Usual care (best supportive care)</p> </li> <li> <p>Balloon kyphoplasty (similar to a percutaneous vertebroplasty, but prior to injection of bone cement a balloon is inserted into the vertebral body and expanded), or other similar procedures </p> </li> <li> <p>Pharmacologic treatment (e.g. calcitonin, bisphosphonates, complementary medicine)</p> </li> <li> <p>Non‐pharmacologic interventions (e.g. bracing, physical therapy or surgery)</p> </li> </ul> </p> </section> <section id="CD006349-sec-0034"> <h4 class="title">Types of outcome measures</h4> <section id="CD006349-sec-0035"> <h5 class="title">Major outcomes</h5> <p>The following outcomes were selected as the most important.</p> <p> <ul id="CD006349-list-0002"> <li> <p>Mean overall pain measured on a visual analogue scale (VAS) or numerical rating scale (NRS) </p> </li> <li> <p>Disability measured by the Roland‐Morris Disability Questionnaire (RMDQ) or other back‐specific disability measure </p> </li> <li> <p>Vertebral fracture and/or osteoporosis‐specific health‐related quality of life, e.g. the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO) </p> </li> <li> <p>Overall health‐related quality of life, e.g. European Quality of Life with 5 Dimensions (EQ‐5D) or Assessment of Quality of Life (AQoL) questionnaire </p> </li> <li> <p>Treatment success measured by a participant‐reported global impression of clinical change (much or very much improved), or similar measure </p> </li> <li> <p>New (incident) symptomatic vertebral fractures (the denominator was the number of participants, but the numerator could include more than one new fracture per participant) </p> </li> <li> <p>Number of serious other adverse events judged to be due to the procedure (e.g. infection, clinical complications arising from cement leakage) </p> </li> </ul> </p> </section> <section id="CD006349-sec-0036"> <h5 class="title">Minor outcomes</h5> <p> <ul id="CD006349-list-0003"> <li> <p>Proportion of participants with pain improved by a clinically relevant amount, for example improvement of at least 2.5 units or 30% on a zero or one to 10 scale </p> </li> <li> <p>New (incident) radiographic vertebral fractures (the denominator was the number of participants, but the numerator could include more than one new fracture per participant) </p> </li> <li> <p>Other adverse events</p> </li> </ul> </p> <section id="CD006349-sec-0037"> <h6 class="title">Timing of outcome assessment</h6> <p>We extracted outcome measures that assessed benefits of treatment (e.g. pain or function) at the following time points: </p> <p> <ul id="CD006349-list-0004"> <li> <p>one to two weeks;</p> </li> <li> <p>one month;</p> </li> <li> <p>two to three months;</p> </li> <li> <p>six months;</p> </li> <li> <p>12 months;</p> </li> <li> <p>24 months.</p> </li> </ul> </p> <p>If data were available in a trial at multiple time points within each of the above periods (e.g. at one and two weeks), we only extracted data at the latest possible time point of each period. We extracted new vertebral fractures at 12 and 24 months, where available. We extracted other adverse events at all time points. </p> <p>We collated the main results of the review into a 'Summary of findings' table which provides key information concerning the quality of evidence and the magnitude and precision of the effect of the interventions. We included the major outcomes (see above) in the 'Summary of findings' table at one month for outcomes assessing potential benefits of treatment (pain, disability, vertebral fracture and/or osteoporosis and overall quality of life and treatment success), 12 months for new symptomatic vertebral fractures (the most data available), and one month for serious other adverse events (judged to be related to the procedure). </p> </section> </section> </section> </section> <section id="CD006349-sec-0038"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD006349-sec-0039"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases on 15 November 2017; updated from the search in the earlier version of this review, which was conducted on 12 November 2014. </p> <p> <ul id="CD006349-list-0005"> <li> <p>The Cochrane Central Register of Controlled Trials (CENTRAL) (via <i>t</i>he Cochane Library to Issue 11 of 12, 2017) </p> </li> <li> <p>MEDLINE (via Ovid from January 2014 to 15 November 2017)</p> </li> <li> <p>Embase (via Ovid from January 2014 to 15 November 2017)</p> </li> </ul> </p> <p>The search strategies are shown in <a href="./appendices#CD006349-sec-0106">Appendix 1</a>; <a href="./appendices#CD006349-sec-0107">Appendix 2</a>; <a href="./appendices#CD006349-sec-0108">Appendix 3</a>). </p> <p>We also searched for ongoing trials and protocols of published trials in the clinical trials register that is maintained by the US National Institute of Health (http://clinicaltrials.gov) and the Clinical Trial Register at the International Clinical Trials Registry Platform of the World Health Organization (http://www.who.int/ictrp/en/) on 18 November 2017 (see <a href="./appendices#CD006349-sec-0109">Appendix 4</a>). </p> <p>No language restrictions were applied.</p> </section> <section id="CD006349-sec-0040"> <h4 class="title">Searching other resources</h4> <p>We also reviewed the reference lists of the included trials and any relevant review articles retrieved from the electronic searches, to identify any other potentially relevant trials. </p> </section> </section> <section id="CD006349-sec-0041"> <h3 class="title" id="CD006349-sec-0041">Data collection and analysis</h3> <section id="CD006349-sec-0042"> <h4 class="title">Selection of studies</h4> <p>Two review authors (SD and RO (for previous version of the review) or RB and RJ or KR and RJ) independently selected trials for possible inclusion against a predetermined checklist of inclusion criteria (see <a href="#CD006349-sec-0030">Criteria for considering studies for this review</a>). We screened titles and abstracts and initially categorised studies into the following groups: </p> <p> <ul id="CD006349-list-0006"> <li> <p>possibly relevant ‐ studies that met the inclusion criteria and studies from which it was not possible to determine whether they met the criteria either from their title or abstract; </p> </li> <li> <p>excluded ‐ those clearly not meeting the inclusion criteria.</p> </li> </ul> </p> <p>If a title or abstract suggested that the study was eligible for inclusion, or we could not tell, we obtained a full‐text version of the article and two review authors independently assessed it to determine whether it met the inclusion criteria. The review authors resolved discrepancies through discussion or adjudication by a third author. </p> </section> <section id="CD006349-sec-0043"> <h4 class="title">Data extraction and management</h4> <p>At least two review authors in various combinations (JH, AJ, RJ, KR) independently extracted data using a standard data extraction form developed for this review. The authors resolved any discrepancies through discussion or adjudication by a third author (RB). For each included study we recorded the following: </p> <p> <ul id="CD006349-list-0007"> <li> <p>trial characteristics, including type (e.g. parallel or cross‐over), country, source of funding, and trial registration status (with registration number recorded if available); </p> </li> <li> <p>participant characteristics, including age, sex, duration of symptoms, and inclusion/exclusion criteria; </p> </li> <li> <p>intervention characteristics for each treatment group, and use of co‐interventions;</p> </li> <li> <p>outcomes reported, including the measurement instrument used and timing of outcome assessment. </p> </li> </ul> </p> <p>Five review authors (JH, AJ, RB, RJ and KR) in various combinations independently extracted all outcome data. </p> <p>For a particular systematic review outcome there may be a multiplicity of results available in the trial reports (e.g. multiple scales, time points and analyses). To prevent selective inclusion of data based on the results, we used the following <i>a priori</i> defined decision rules to select data from trials. </p> <p> <ul id="CD006349-list-0008"> <li> <p>Where trialists reported both final values and change from baseline values for the same outcome, we extracted final values. </p> </li> <li> <p>Where trialists reported both unadjusted and adjusted values for the same outcome, we extracted unadjusted values. </p> </li> <li> <p>Where trialists reported data analysed based on the intention‐to‐treat (ITT) sample and another sample (e.g. per‐protocol, as‐treated), we extracted ITT‐analysed data. </p> </li> <li> <p>For cross‐over RCTs, we preferentially extracted data from the first period only.</p> </li> </ul> </p> <p>Where trials did not include a measure of overall pain but included one or more other measures of pain, for the purpose of combining data for the primary analysis of overall pain, we planned to combine overall pain with other types of pain in the following hierarchy: unspecified pain; pain with activity; or daytime pain. For trials that included more than one back‐specific measure of disability we preferentially extracted data for the RMDQ if reported. </p> <p>Review authors who were also authors of relevant trials had no involvement in determining whether or not their trials met the inclusion criteria for this review, and also had no involvement in data extraction or 'Risk of bias' assessment of their own trials. </p> </section> <section id="CD006349-sec-0044"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>At least two review authors (JH, AJ, RJ, KR) in various combinations independently assessed the risk of selection, performance, detection, attrition and reporting biases for all included RCTs by evaluating the following domains: random sequence generation, allocation concealment, blinding of participants, care provider, and outcome assessor for each outcome measure, incomplete outcome data and other biases, conforming to the methods recommended by Cochrane (<a href="./references#CD006349-bbs2-0081" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). ">Higgins 2011</a>). </p> <p>Each criterion was rated as low risk of bias, high risk of bias or unclear risk (either lack of information or uncertainty over the potential for bias). Disagreements among the review authors were discussed and resolved. </p> </section> <section id="CD006349-sec-0045"> <h4 class="title">Measures of treatment effect</h4> <p>We used Cochrane's statistical software, Review Manager 5.3, to perform data analysis. We expressed dichotomous outcomes as risk ratios (RRs) with 95% confidence intervals (CIs) and continuous outcomes as mean differences (MDs) with 95% CIs if different trials used the same measurement instrument to measure the same outcome. Alternatively, we analysed continuous outcomes using the standardised mean difference (SMD) when trials measured the same outcome but employed different measurement instruments to measure the same conceptual outcome (e.g. disability). </p> <p>To enhance interpretability of continuous outcomes, pooled SMDs of disability were back‐transformed to an original zero to 23 scale RMDQ, by multiplying the SMD and 95% CIs by a representative pooled standard deviation (SD) at baseline of the trial with the highest weight in the meta‐analysis and the least susceptibility to bias (<a href="./references#CD006349-bbs2-0111" title="SchünemannHJ , OxmanAD , VistGE , HigginsJPT , DeeksJJ , GlasziouP , et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011b</a>). We assumed VAS and NRS were comparable scales, and combined them in a meta‐analysis using the MD statistic (<a href="./references#CD006349-bbs2-0058" title="BijurPE , LatimerCT , GallagherEJ . Validation of a verbally administered numerical rating scale of acute pain for use in the emergency department. Academic Emergency Medicine2003;10:390‐2. ">Bijur 2003</a>; <a href="./references#CD006349-bbs2-0059" title="BirnbaumerDM . Visual Analog Scale vs. Numerical Rating Scale: Much Ado About Nothing?. NEJM Journal Watch. Available from: https://www.jwatch.org/em200305140000005/2003/05/14/visual‐analog‐scale‐vs‐numerical‐rating‐scale2013. ">Birnbaumer 2003</a>). </p> <p>For studies comparing vertebroplasty with placebo, we used SD 2.9 for RMDQ (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>). </p> <p>For analyses comparing vertebroplasty with usual care that included <a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a>, </p> <p>we used SMD for pain as (<a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a> used a one to 10 pain scale in comparison to all other trials that used a zero to 10 pain scale), but back‐transformed the SMD to MD on a zero to 10 scale by multiplying the SMD and 95% CIs by the SD of pain at baseline from the control group of the <a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a> trial (SD 1.6). For disability (vertebroplasty versus usual care), which included data for the RMDQ and Oswestry Disability Index (ODI), we back‐transformed the SMD to MD on the RMDQ (zero to 23 scale) by multiplying the SMD and 95% CIs by the SD of disability at baseline also from the control group of the <a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a> trial (SD 4.2). </p> <p>For analyses comparing vertebroplasty with kyphoplasty that included <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a>, we used SMD for disability (as <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a> used the RMDQ compared to all other trials that used ODI), but back‐transformed the SMD to MD on the RMDQ (zero to 23 scale) by multiplying the SMD and 95% CIs by the standard deviation (SD) of pain at baseline from the control group of the <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a> trial (SD 6.6). </p> </section> <section id="CD006349-sec-0046"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the participant, rather than the number of fractures treated. For studies containing more than two intervention groups, making multiple pair‐wise comparisons between all possible pairs of intervention groups possible, we planned to include the same group of participants only once in the meta‐analysis. </p> </section> <section id="CD006349-sec-0047"> <h4 class="title">Dealing with missing data</h4> <p>Where important data were missing or incomplete, we sought further information from the trial authors. </p> <p>In cases where individuals were missing from the reported results, we assumed the missing values to have a poor outcome. For dichotomous outcomes that measured serious and other adverse events (e.g. incident fractures), we calculated the adverse event rate using the number of patients that received treatment as the denominator (worst‐case analysis). For dichotomous outcomes that measured benefits (e.g. proportion of participants reporting pain relief of 30% or greater), we calculated the worst‐case analysis using the number of randomised participants as the denominator. For continuous outcomes (e.g. pain), we calculated the MD or SMD based on the number of patients analysed at that time point. If the number of patients analysed was not presented for each time point, we used the number of randomised patients in each group at baseline. </p> <p>For continuous outcomes with no SD reported, we calculated SDs from standard errors (SEs), 95% CIs or P values. If no measures of variation were reported and SDs could not be calculated, we planned to impute SDs from other trials in the same meta‐analysis, using the median of the other SDs available (<a href="./references#CD006349-bbs2-0068" title="EbrahimS , AklEA , MustafaRA , SunX , WalterSD , Heels‐AnsdellD , et al. Addressing continuous data for participants excluded from trial analysis: a guide for systematic reviewers. Journal of Clinical Epidemiology2013;66(9):1014‐21. ">Ebrahim 2013</a>). For continuous outcomes presented only graphically, we extracted the mean and 95% CIs from the graphs using plotdigitizer (<a href="http://plotdigitizer.sourceforge.net/" target="_blank">http://plotdigitizer.sourceforge.net/</a>). For dichotomous outcomes, we used percentages to estimate the number of events or the number of people assessed for an outcome. </p> <p>Where data were imputed or calculated (e.g. SDs calculated from SEs, 95% CIs or P values, or imputed from graphs or from SDs in other trials), we reported this in the <a href="./references#CD006349-sec-0124" title="">Characteristics of included studies</a> tables. </p> </section> <section id="CD006349-sec-0048"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed clinical heterogeneity by determining whether the characteristics of participants, interventions, outcome measures and timing of outcome measurement were similar across trials. </p> <p>We assessed statistical heterogeneity by visually assessing the scatter of effect estimates on the forest plots, and by using the Chi<sup>2</sup> statistic and the I<sup>2</sup> statistic (<a href="./references#CD006349-bbs2-0080" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ. 2003/09/06 2003; Vol. 327, issue 7414:557‐60. [1468‐5833: (Electronic)] ">Higgins 2003</a>). We interpreted the I<sup>2</sup> statistic using the following as an approximate guide: </p> <p> <ul id="CD006349-list-0009"> <li> <p>0% to 40% may not be important heterogeneity;</p> </li> <li> <p>30% to 60% may represent moderate heterogeneity;</p> </li> <li> <p>50% to 90% may represent substantial heterogeneity;</p> </li> <li> <p>75% to 100% may represent considerable heterogeneity (<a href="./references#CD006349-bbs2-0067" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Deeks 2011</a>). </p> </li> </ul> </p> <p>In cases of considerable heterogeneity, we intended to explore the data further by comparing the characteristics of individual studies and any subgroup analyses. </p> </section> <section id="CD006349-sec-0049"> <h4 class="title">Assessment of reporting biases</h4> <p>To assess publication bias, we planned to generate funnel plots if at least 10 trials examining the same intervention comparison were included in the review, and comment on whether any asymmetry in the funnel plot was due to publication bias, or methodological or clinical heterogeneity of the trials (<a href="./references#CD006349-bbs2-0115" title="SterneJAC , EggerM , MoherD (editors) . Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Sterne 2011</a>). </p> <p>To assess for potential small‐study effects in meta‐analyses (i.e. the intervention effect is more beneficial in smaller studies), we planned to compare effect estimates derived from a random‐effects model and a fixed‐effect model of meta‐analysis. In the presence of small‐study effects, the random‐effects model will give a more beneficial estimate of the intervention than the fixed‐effect estimate (<a href="./references#CD006349-bbs2-0115" title="SterneJAC , EggerM , MoherD (editors) . Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Sterne 2011</a>). However, as no statistically significant results were found, we could not perform this analysis. </p> <p>To assess outcome reporting bias, we compared the outcomes specified in trial protocols with the outcomes reported in the corresponding trial publications. </p> </section> <section id="CD006349-sec-0050"> <h4 class="title">Data synthesis</h4> <p>Included studies were grouped based on whether percutaneous vertebroplasty was compared with a placebo or sham procedure, usual care or another active intervention. </p> <p>For benefit, we considered the first comparison, vertebroplasty versus placebo, to be the least prone to bias and it was therefore the primary comparison for addressing the objectives of this review. </p> <p>For safety (new vertebral fractures and other serious and other adverse events), as the results were similar for both placebo and usual care comparisons, to simplify the presentation we presented safety data in the same analyses. </p> <p>We combined results of trials with similar characteristics (participants, interventions, outcome measures and timing of outcome measurement) to provide estimates of benefits and harms. To combine results we used a random‐effects meta‐analysis model based on the assumption that clinical and methodological heterogeneity was likely to exist and to have an impact on the results. </p> <section id="CD006349-sec-0051"> <h5 class="title">'Summary of findings' table</h5> <p>We presented the major outcomes for the primary comparison of vertebroplasty of the review in a 'Summary of findings' table (mean pain, disability, disease‐specific quality of life, overall quality of life, treatment success, incident fractures, and total number of serious adverse events). This table reports the quality of evidence, the magnitude of effect of the interventions examined, and the sum of available data for each major outcome as recommended by Cochrane (<a href="./references#CD006349-bbs2-0110" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and ‘Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011a</a>), and was produced using GRADEpro software. The overall quality of the evidence was graded for each of the major outcomes using the GRADE approach (<a href="./references#CD006349-bbs2-0111" title="SchünemannHJ , OxmanAD , VistGE , HigginsJPT , DeeksJJ , GlasziouP , et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011b</a>). We included evidence only from trials with adequate treatment allocation concealment and blinding of participants and outcome assessment. </p> <p>In the comments column, we calculated the absolute percentage change and the relative percentage change. Relative changes were calculated as absolute change (MD) divided by mean at baseline in the placebo group from <a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a> (values were: 7.1 points on zero‐ to 10‐point VAS pain; 17.3 points on zero‐ to 23‐point Roland‐Morris Disability questionnaire; 0.28 points on EQ‐5D quality of life scale; 59.6 points on the QUALEFFO scale). In interpreting results, we assumed a minimal clinically important difference of 1.5 points on a 10‐point pain scale (<a href="./references#CD006349-bbs2-0076" title="GrotleM , BroxJI , VøllestadNK . Concurrent comparison of responsiveness in pain and functional status measurements used for patients with low back pain. Spine2004;29:E492‐E501. ">Grotle 2004</a>); two to three points on the zero‐ to 23‐point RMDQ (<a href="./references#CD006349-bbs2-0121" title="TroutAT , KallmesDF , GrayLA , GoodnatureBA , EversonSL , ComstockBA , et al. Evaluation of vertebroplasty with a validated outcome measure: the Roland‐Morris Disability Questionnaire. AJNR: American Journal of Neuroradiology2005;26:2652‐7. ">Trout 2005</a>), 10 points on the zero to 100 QUALEFFO scale (<a href="./references#CD006349-bbs2-0094" title="LipsP , CooperC , AgnusdeiD , CaulinF , EggerP , JohnellO , et al. Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Osteoporosis International1999;10:150‐60. ">Lips 1999</a>), and 0.074 points on the EQ‐5D quality of life scale, zero = death to one = perfect health (<a href="./references#CD006349-bbs2-0124" title="WaltersSJ , BrazierJE . Comparison ofthe minimally important difference for two health state utility measures: EQ‐5Dand SF‐6D. Quality of Life Research2005;14(6):1523‐32. ">Walters 2005</a>). </p> </section> </section> <section id="CD006349-sec-0052"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Where sufficient data were available, the following subgroup analysis was performed.</p> <p> <ul id="CD006349-list-0010"> <li> <p>Duration of symptoms ('acute' fractures versus 'subacute fractures')</p> </li> </ul> </p> </section> <section id="CD006349-sec-0053"> <h4 class="title">Sensitivity analysis</h4> <p>Sensitivity analyses were performed to investigate the robustness of the treatment effect (of main outcomes) by performing an analysis that included all trials combined, i.e. trials with placebo or usual care comparator groups, to see if inclusion of trials that did not blind participants changed the overall treatment effect. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006349-sec-0054" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006349-sec-0054"></div> <section id="CD006349-sec-0055"> <h3 class="title">Description of studies</h3> <section id="CD006349-sec-0056"> <h4 class="title">Results of the search</h4> <p>We updated the search for the current review on 15 November 2017, searching for studies published since 2014 (the date of the search in the first version of the review). </p> <p>The results of the search are presented in <a href="#CD006349-fig-0001">Figure 1</a>. The updated search strategy identified 776 new citations (426 after de‐duplication). Of these, 37 were assessed in full text and nine new studies were included (<a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>; <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a>; <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a>; <a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a>; <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>; <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>; <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a>; <a href="./references#CD006349-bbs2-0020" title="HaoD , GuoH , WangB , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal; http://eposterlyon.eurospine.org/cm_data/eposter/P17.PDF. 2014; Vol. 23, Issue 5:Supplement, pp 527‐557. HaoD , WangB , GuoH , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal2014;23(1):S533. WangB , GuoH , YuanL , HuangD , ZhangH , HaoD . A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. European Spine Journal2016;25:3486‐94. [DOI: 10.1007/s00586‐016‐4425‐4] ">Wang 2016</a>; <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a>). Six of these were identified as ongoing or completed studies in the 2015 version of this review and have since reported results (<a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>; <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a>; <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>; <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>; <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a>), (<a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>), and are included in this review update. The partially reported results of <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a> were presented at a conference, and were identified in the last full search (15 November 2017). The results of the trial were published subsequent to the search and were available on 9 May 2018; thus we included information from this publication as a minor amendment to the review. </p> <div class="figure" id="CD006349-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD006349-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>Thus, in total in this update we included 21 trials (<a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a>; <a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>; <a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a>; <a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a>; <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a>; <a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a>; <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>; <a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a>; <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a>; <a href="./references#CD006349-bbs2-0013" title="LiuJT , LiCS , ChangCS , LiaoWJ . Long‐term follow‐up study of osteoporotic vertebral compression fracture treated using balloon kyphoplasty and vertebroplasty. Journal of Neurosurgery Spine2015;23(1):94‐8. LiuJT , LiaoWJ , TanWC , LeeJK , LiuCH . Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis International2010;21:359–64. ">Liu 2010</a>; <a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a>; <a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a>; <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>; <a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a>; <a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a>; <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>; <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a>; <a href="./references#CD006349-bbs2-0020" title="HaoD , GuoH , WangB , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal; http://eposterlyon.eurospine.org/cm_data/eposter/P17.PDF. 2014; Vol. 23, Issue 5:Supplement, pp 527‐557. HaoD , WangB , GuoH , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal2014;23(1):S533. WangB , GuoH , YuanL , HuangD , ZhangH , HaoD . A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. European Spine Journal2016;25:3486‐94. [DOI: 10.1007/s00586‐016‐4425‐4] ">Wang 2016</a>; <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a>). </p> <p>Ten randomised controlled trials (RCTs) were registered in a trial registry (<a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a>; <a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>; <a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a>; <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a>; <a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a>; <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>; <a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a>; <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>; <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>), although one was registered retrospectively (<a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a>). One RCT reports that it is registered on clinicaltrials.gov (NCT00576546) (<a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a>), but this could not be verified. No trial registration was found for the other trials (<a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a>; <a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a>; <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a>; <a href="./references#CD006349-bbs2-0013" title="LiuJT , LiCS , ChangCS , LiaoWJ . Long‐term follow‐up study of osteoporotic vertebral compression fracture treated using balloon kyphoplasty and vertebroplasty. Journal of Neurosurgery Spine2015;23(1):94‐8. LiuJT , LiaoWJ , TanWC , LeeJK , LiuCH . Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis International2010;21:359–64. ">Liu 2010</a>; <a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a>; <a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a>; <a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a>; <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a>; <a href="./references#CD006349-bbs2-0020" title="HaoD , GuoH , WangB , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal; http://eposterlyon.eurospine.org/cm_data/eposter/P17.PDF. 2014; Vol. 23, Issue 5:Supplement, pp 527‐557. HaoD , WangB , GuoH , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal2014;23(1):S533. WangB , GuoH , YuanL , HuangD , ZhangH , HaoD . A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. European Spine Journal2016;25:3486‐94. [DOI: 10.1007/s00586‐016‐4425‐4] ">Wang 2016</a>; <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a>). </p> <p>In total, 20 studies were excluded after full‐text assessment (see table of <a href="./references#CD006349-sec-0125" title="">Characteristics of excluded studies</a>): 17 studies identified in the updated search were excluded (<a href="./references#CD006349-bbs2-0022" title="CaiJ , HaoYW , LiC , YangHQ . Percutaneous vertebroplasty with bone cement injection for osteoporotic vertebral compression fractures via transpedicular approach [Chinese]. Chinese Journal of Tissue Engineering Research2015;19(30):4892‐7. ">Cai 2015</a>; <a href="./references#CD006349-bbs2-0023" title="ChenC , BianJ , ZhangW , ZhaoC , WeiH . Unilateral versus bilateral vertebroplasty for severe osteoporotic vertebral compression fractures. Journal of Spinal Disorders &amp; Techniques2014;27(8):E301‐4. ">Chen 2014b</a>; <a href="./references#CD006349-bbs2-0024" title="Chen‐leiL , Yi‐heH , Gui‐qingW , Yong‐zhiT , Xiang‐jiangW , Han‐taoH . Curative effects of unipedicular and bipedicular vertebroplasty in treating osteoporotic vertebral compression fractures in the elderly population. Journal of Xi'an Jiatong University2015;36:6. ">Chun‐lei 2015</a>; <a href="./references#CD006349-bbs2-0025" title="DuJ , LiX , LinX . Kyphoplasty versus vertebroplasty in the treatment of painful osteoporotic vertebral compression fractures: two‐year follow‐up in a prospective controlled study. Acta Orthopaedica Belgica2014;80(4):477‐86. ">Du 2014</a>; <a href="./references#CD006349-bbs2-0027" title="GuYT , ZhuDH , LiuHF , ZhangF , McGuireR . Minimally invasive pedicle screw fixation combined with percutaneous vertebroplasty for preventing secondary fracture after vertebroplasty. Journal of Orthopaedic Surgery2015;10:31 doi: 10.1186/s13018‐015‐0172‐1. [DOI: 10.1186/s13018‐015‐0172‐1] ">Gu 2015</a>; <a href="./references#CD006349-bbs2-0029" title="LiJ , ShenWL , ChangXH . Comparison of clinical effects between unilateral and bilateral percutaneous vertebroplasty for osteoporotic vertebral compression fractures. [Chinese]. Journal of Dalian Medical University2015;37(2):145‐7. ">Li 2015a</a>; <a href="./references#CD006349-bbs2-0030" title="LiuCL , HuYH , WangGQ , TangYZ , WangXJ , HouHT . Curative effects of unipedicular and bipedicular vertebroplasty in treating osteoporotic vertebral compression fractures in the elderly population. [Chinese]. Journal of Xi'an Jiaotong University (Medical Sciences)2015;36(6):857‐61. ">Liu 2015</a>; <a href="./references#CD006349-bbs2-0031" title="MinP , ZhangYP , CaoH . CT‐guided bone cement injection combined with artificial tiger bone meal to repair osteoporotic vertebral compression fractures: Callus growth and bone healing [Chinese]. Chinese Journal of Tissue Engineering Research2015;19(3):335‐9. ">Min 2015</a>; <a href="./references#CD006349-bbs2-0032" title="SonS , LeeSG , KimWK , ParkCW , YooCJ . Early vertebroplasty versus delayed vertebroplasty for acute osteoporotic compression fracture: Are the results of the two surgical strategies the same?. Journal of Korean Neurosurgical Society2014;56(3):211‐7. ">Son 2014</a>; <a href="./references#CD006349-bbs2-0033" title="Xiao‐nanH . Percutaneous vertebroplasty for treatment of osteoporotic vertebral fractures: high viscosity versus low‐viscosity bone cement. Chinese Journal of Tissue Engineering Research2014;18(16):2461‐7. ">Xiao‐nan 2014</a>; <a href="./references#CD006349-bbs2-0034" title="YangDH , ChoKH , ChungYS , KimYR . Effect of vertebroplasty with bone filler device and comparison with balloon kyphoplasty. European Spine Journal2014;23(12):2718‐25. ">Yang 2014</a>; <a href="./references#CD006349-bbs2-0036" title="YiHJ , JeongJH , ImSB , LeeJK . Percutaneous vertebroplasty versus conservative treatment for one level thoracolumbar osteoporotic compression fracture: results of an over 2‐year follow‐up. Pain Physician2016;19(5):E743‐50. ">Yi 2016</a>; <a href="./references#CD006349-bbs2-0037" title="Ying L. ChenZ , YangG . Clinical study of high viscosity bone cement in the treatment of osteoporotic vertebral compression fracture. Biomedical Research (India)2017;28(18):7837‐40. ">Ying 2017</a>; <a href="./references#CD006349-bbs2-0038" title="YokoyamaK , KawanishiM , YamadaM , TanakaH , ItoY , KawabataS , et al. Comparison of vertebroplasty versus vertebral perforation for the treatment of acute vertebral compression fractures. Turkish Neurosurgery2016;26(3):423‐9. YokoyamaK , KawanishiM , YamadaM , TanakaH , ItoY , KuroiwaT . Long‐term therapeutic effects of vertebroplasty for painful vertebral compression fracture: a retrospective comparative study. British Journal of Neurosurgery2017;31(2):184‐8. ">Yokoyama 2016</a>; <a href="./references#CD006349-bbs2-0039" title="ZhangL , WangJ , FengX , TaoY , YangJ , WangY , et al. A comparison of high viscosity bone cement and low viscosity bone cement vertebroplasty for severe osteoporotic vertebral compression fractures. Clinical Neurology and Neurosurgery2015;129:10‐6. ">Zhang 2015a</a>; <a href="./references#CD006349-bbs2-0040" title="ZhangL , LiuZ , WangJ , FengX , YangJ , TaoY , et al. Unipedicular versus bipedicular percutaneous vertebroplasty for osteoporotic vertebral compression fractures: a prospective randomized study. BMC Musculoskeletal Disorders2015;16:145. ">Zhang 2015b</a>; <a href="./references#CD006349-bbs2-0041" title="ZhangL , GuX , ZhangH , ZhangQ , CaiX , TaoK . Unilateral or bilateral percutaneous vertebroplasty for acute osteoporotic vertebral fracture: a prospective study. Journal of Spine Disorders &amp; Techniques2015; Vol. 28, issue 2:85‐8. ">Zhang 2015c</a>), in addition to the three studies excluded in the earlier version of this review (<a href="./references#CD006349-bbs2-0026" title="GilulaL , PersenaireM . Subsequent fractures post–vertebral augmentation: Analysis of a prospective randomized trial in osteoporotic vertebral compression fractures. AJNR: American Journal of Neuroradiology2013;34(2):221‐7. ">Gilula 2013</a>; <a href="./references#CD006349-bbs2-0028" title="HuangXN . Percutaneous vertebroplasty for treatment of osteoporotic vertebral fractures: High‐viscosity versus low‐viscosity bone cement [Chinese]. Chinese Journal of Tissue Engineering Research2014;18(16):2461‐7. ">Huang 2014</a>; <a href="./references#CD006349-bbs2-0035" title="YiX , LuH , TianF , WangY , LiC , LiuH , et al. Recompression in new levels after percutaneous vertebroplasty and kyphoplasty compared with conservative treatment. Archives of Orthopaedic and Trauma Surgery2014;134(1):21‐30. ">Yi 2014</a>). </p> <p>Three trials are classified as ongoing, although it is unclear if the trials are completed. We could not find any trial registration details for one study (<a href="./references#CD006349-bbs2-0050" title="LongoUG , LoppiniM , DenaroL , BrandiML , MaffulliN , DenaroV . The effectiveness and safety of vertebroplasty for osteoporotic vertebral compression fractures. A double blind, prospective, randomized, controlled study. Clinical Cases in Mineral and Bone Metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases2010;7(2):109‐13. [PUBMED: 22460014] ">Longo 2010</a>), while a second trial is registered at ClinicalTrials.gov with an expected completion date of December 2014 (<a href="./references#CD006349-bbs2-0051" title="NCT01677806 . Investigational percutaneous vertebroplasty efficacy and safety trial. clinicaltrials.gov/show/NCT01677806 (first received 23 August 2012). ">Sun 2012</a>), but the current recruitment status is unknown. The third trial (<a href="./references#CD006349-bbs2-0052" title="NCT01963039 . A trial of vertebroplasty for painful chronic osteoporotic vertebral fractures (VERTOS V). clinicaltrials.gov/show/NCT01963039 First registered 28 August 2013. ">VERTOS V</a>), was recorded as completed in June 2015 at clinicaltrials.gov, but the trialists subsequently altered the recruitment status in January 2017 to state that the study is now 'enrolling by invitation', with a new estimated completion date of July 2018 (see table of <a href="./references#CD006349-sec-0127" title="">Characteristics of ongoing studies</a>). </p> <p>Based upon a search of trial registries, we identified an additional four registered RCTs that are reported to have been completed but we were unable to find results (<a href="./references#CD006349-bbs2-0043" title="DoinS . A randomised controlled trial of vertebroplasty for the treatment of osteoporotic vertebral crush fractures. http://www.isrctn.com/ISRCTN14442024 (first received 12 September 2003) Trial completed. ">Dolin 2003</a>; <a href="./references#CD006349-bbs2-0044" title="NCT00749060 . Prospective randomized comparative study of balloon kyphoplasty, vertebroplasty and conservative management in acute osteoporotic vertebral fractures of less than 6 weeks. clinicaltrials.gov/show/NCT00749060 (first received September 8, 2008) Trial completed June 2012. ">Laredo (OSTEO‐6)</a>; <a href="./references#CD006349-bbs2-0045" title="NCT00749086 . Prospective randomized study of balloon kyphoplasty and vertebroplasty in subacute (older than 6 weeks) osteoporotic vertebral fractures (STIC2). clinicaltrials.gov/show/NCT00749086 Trial registered: NCT00749086. Recruitment commenced Dec 2007. Trial completed June 2012. ">Laredo (STIC2)</a>; <a href="./references#CD006349-bbs2-0047" title="NCT00203554 . Percutaneous vertebroplasty versus conservative treatment of pain: a prospective, randomized controlled study of osteoporotic fractures in the spine. clinicaltrials.gov/show/NCT00203554 (first received 16 September 2005). ">Sorensen 2005</a>) (see table of <a href="./references#CD006349-sec-0126" title="">Characteristics of studies awaiting classification</a>). We also identified four completed RCTs that likely meet inclusion criteria of the review, but results are published in Chinese and we did not translate these prior to publication of this review update: two trials compare vertebroplasty with kyphoplasty (<a href="./references#CD006349-bbs2-0048" title="TanB , LiuXW , LiuG , LiYS , QinZJ , YangCP . Percutaneous kyphoplasty versus percutaneous vertebroplasty for osteoporotic vertebral compression fractures: A randomized comparison [Chinese]. Chinese Journal of Tissue Engineering Research2016;20(4):539‐43. ">Tan 2016</a>; <a href="./references#CD006349-bbs2-0049" title="ZhouW . Percutaneous vertebroplasty with high‐viscosity bone cement for treatment of severe osteoporotic thoracolumbar vertebral compression fractures [Chinese]. Chinese Journal of Tissue Engineering Research2015;19(46):7534‐8. ">Zhou 2015</a>), another compared vertebroplasty with kyphoplasty and bone‐filling mesh container (<a href="./references#CD006349-bbs2-0046" title="LiDH , LiuXW , PengXT , WangZG , WangBC , JinP , et al. Bone filling mesh container for treatment of vertebral compression fractures can reduce the leakage of bone cement. [Chinese]. Chinese Journal of Tissue Engineering Research 15 Jan 2015;19(3):358‐3. ">Li 2015b</a>) and the third vertebroplasty with usual care (<a href="./references#CD006349-bbs2-0042" title="ChenJP , QiXW , LiSJ , KuangLP , YuanXH , WangGS , et al. Bone cement injection as vertebral augmentation therapy for osteoporotic vertebral compression fractures. [Chinese]. Chinese Journal of Tissue Engineering Research2015;19(21):3292‐6. [DOI: dx.doi.org/10.3969/j.issn.2095‐4344.2015.21.003] ">Chen 2015</a>). </p> <p>Since the last version of the review, we have removed three ongoing trials (<a href="./references#CD006349-bbs2-0066" title="DamaskinosM . Study about the effect of preventive adjacent level cement augmentation after osteoporotic vertebral compression fractures. clinicaltrials.gov/show/NCT0248925 (first received 25 June 2015)2015. ">Damaskinos 2015</a> NCT02489825; <a href="./references#CD006349-bbs2-0104" title="NTR3282 . Viscosity of PMMA bone cement in percutaneous vertebroplasty for osteoporotic vertebral compression fractures: a randomized controlled trial. http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=3282 14 Feb 2012. ">Nieuwenhuijse 2012</a> NTR3282); and <a href="./references#CD006349-bbs2-0129" title="ZhaoJ , LiuB . ChiCTR‐TRC‐14004835. A clinical trial of percutaneous vertebroplasty with high viscosity bone cement. 23 June 2014. Trial pending. chictr.org/en/proj/show.aspx?proj=8628. ">Zhao 2014</a> ChiCTR‐TRC‐14004835), as percutaneous vertebroplasty was given to participants in both treatment arms and thus, when trial results become available, they will not be eligible for inclusion in this review. An additional trial that was reportedly suspended due to difficulty recruiting participants prior to completion and which was included as a study awaiting classification in the last version of the review (<a href="./references#CD006349-bbs2-0103" title="NCT00635297 . Percutaneous vertebroplasty. Study of refracture rates after prophylactic vertebroplasty of adjacent vertebrae. clinicaltrials.gov/show/NCT00635297 (first received 5 March 2008). ">Nakstad 2008</a> NCT00635297) has also been removed from this current version of the review as if the trial had been completed it would not be eligible for inclusion. </p> <p>Detailed descriptions of all unpublished trials that are either completed, suspended or ongoing are provided in either the table of <a href="./references#CD006349-sec-0126" title="">Characteristics of studies awaiting classification</a> or table of <a href="./references#CD006349-sec-0127" title="">Characteristics of ongoing studies</a> and a summary of all unpublished trials is provided in <a href="#CD006349-tbl-0002">Table 1</a>. </p> <div class="table" id="CD006349-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Study characteristics of unpublished, ongoing and suspended or terminated trials</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Trial registration number</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Principle Investigator/s and Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparator/s</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Main selection criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Registration date</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Recruitment commenced</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Status 8 January 2018</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Planned sample size</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Final sample size</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NCT00749060</p> <p>‘OSTEO‐6’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Laredo JD</p> <p>France</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Kyphoplasty; Usual care with or without brace</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age ≥ 50 years</p> <p>Fracture &lt; 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 Sept 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dec 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Completed June 2012; results unpublished</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NCT00749086</p> <p>‘STIC2’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Laredo JD</p> <p>France</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Kyphoplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age ≥ 50 years</p> <p>Fracture &gt; 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 Sept 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dec 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Completed June 2012; results unpublished</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NCT00203554</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sorensen L</p> <p>Denmark</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fracture &lt; 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16/09/2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mar 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Completed Jan 2008; results unpublished</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ISRCTN14442024</p> <p>(Also</p> <p>N0213112414)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dolin, S</p> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fracture &gt; 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 Sep 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nov 28 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Completed (last updated 6 Feb 2014); results unpublished</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not provided</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not provided</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NCT01677806</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sun G</p> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age ≥ 50 years</p> <p>Fracture &lt; 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23 Aug 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oct 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recruitment status unknown (last updated 11 Sep 2014)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Registration details not found.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Longo UG</p> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 weeks bed rest, rigid hyperextension corset, followed by 2‐3 months in a Cheneau brace (called ‘double‐blind) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age ≥ 50 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Trial registration not found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unknown (protocol published)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NCT01963039</p> <p>‘VERTOS V’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Carli D</p> <p>the Netherlands</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sham</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age ≥ 50 years</p> <p>Fracture ≥ 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28 Aug 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>May 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Previously reported as completed (Nov 2015) then recruiting again (Feb 2017) (protocol published) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Record of trial registration not found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chen JP</p> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trial registration not found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Completed; study awaiting translation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Record of trial registration not found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Li DH</p> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kyphoplasty</p> <p>Bone filling mesh container</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trial registration not found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Completed; study awaiting translation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Record of trial registration not found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tan B</p> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kyphoplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trial registration not found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Completed; study awaiting translation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>106</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Record of trial registration not found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Zhou W</p> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kyphoplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trial registration not found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Completed; study awaiting translation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>* Abstract reported that analysis favoured vertebroplasty at 1 day and 1 week for pain, and disability measured by RMDQ and ODI (data not provided), but no evidence of important differences between groups at 1, 3, 6, 12 months for pain, RMDQ, ODI and SF‐36 function and SF‐36 physical and mental component scores. After 12 months follow‐up, there were 13 new fractures in the percutaneous vertebroplasty group and 11 new fractures in the facet joint block group. Abstract did not report method of randomisation, whether or not treatment allocation was concealed and whether or not participants and investigators were blinded to treatment allocation. </p> </div> </div> </section> <section id="CD006349-sec-0057"> <h4 class="title">Included studies</h4> <p>A full description of all included trials is provided in the table of <a href="./references#CD006349-sec-0124" title="">Characteristics of included studies</a> and a summary of trial and participant characteristics is provided in <a href="#CD006349-tbl-0003">Table 2</a>. </p> <div class="table" id="CD006349-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Baseline demographic and clinical characteristics of the trial participants</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Treatment Groups</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean age, yrs</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean symptom duration</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean (SD) baseline pain (0‐10 scale<sup>$</sup>)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean (SD) baseline RMDQ<sup>+</sup> (0‐24 scale</b><sup>†</sup><b>)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean (SD) baseline QUALEFFO (0‐100 scale)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Procedures performed by</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean (range) volume cement injected (mL)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Follow‐up</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Spain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>140.3 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.2 (0.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65.2 (2.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interventional radiologists</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 weeks, 2, 6, 12 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>143.1 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.3 (0.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59.2 (2.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Australia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9 weeks^</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.4 (2.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.3 (2.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56.9 (13.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interventional radiologists</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.8 (1.2 ‐ 5.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 week, 1, 3, 6, 12, 24 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.5 weeks^</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.1 (2.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.3 (2.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59.6 (17.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Australia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.1 (1.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19.5 (3.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65.4 (11.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interventional radiologists</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.5 (4.7 ‐ 10.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 days, 14 days, 1, 3 and 6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.2 (1.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19.8 (3.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67.7 (11.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.5 (0.9)<sup>&amp;</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.6 (1.8)<sup>#&amp;</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic surgeons</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.6 (3 ‐ 6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 day, 1 week, 1, 3, 6, 12 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care and brace</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29.5 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.4 (0.9)<sup>&amp;</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.7 (1.3)<sup>#&amp;</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA and Canada</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐¤</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>˜7.6<sup>µ</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interventional radiologists and neuroradiologists, orthopaedic surgeons, neuroradiologists</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.0 (3.0 to 6.0)<sup>¢</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7 days, 1, 3, 12 and 24 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Balloon kyphoplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐¤</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>˜7.6<sup>µ</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.6 (3.4 to 6.0)<sup>¢</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Germany</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐<sup>§</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.8 (0.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic surgeon</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.1 (2 – 4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately, mean 5.8 months (range: 4 to 7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Balloon kyphoplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐<sup>§</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.0 (0.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic surgeon</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.9 (3 – 5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shield kyphoplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐<sup>§</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.8 (1.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic surgeon</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.6 (3 – 6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.9 (2.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.3 (7.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 days, 1, 6 and 12 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kyphoplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.4 (1.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.3 (6.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Iran</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.4 (1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neurosurgeons</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.5 (1 ‐ 5.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 week, 2, 6, 12, 24, 36 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.2 (1.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>the Netherlands</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29.2 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.7 (1.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18 (4.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68.4 (17.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interventional radiologists</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.11 (1 ‐ 11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 day, 1 week, 1, 3, 6, 12 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25.9 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.9 (1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.8 (4.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69.7 (17.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>US, UK, Australia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.9 (2.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.6 (3.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interventional radiologists</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.8 (1 ‐ 5.5)*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 days, 2 weeks, 1 month</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.2 (2.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.5 (4.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>the Netherlands, Belgium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29.3 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.8 (1.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.6 (3.6)<sup>#</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58.7 (13.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interventional radiologists</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.1 (1 ‐ 9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 day, 1 week, 1, 3, 6, 12 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26.8 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.5 (1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.2 (4.2)<sup>#</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.7 (14.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐<sup>§</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.8 (‐)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53.6 (‐)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 (‐)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 and 2 days, 6 weeks, 3 and 6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐<sup>§</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐<sup>§</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0013" title="LiuJT , LiCS , ChangCS , LiaoWJ . Long‐term follow‐up study of osteoporotic vertebral compression fracture treated using balloon kyphoplasty and vertebroplasty. Journal of Neurosurgery Spine2015;23(1):94‐8. LiuJT , LiaoWJ , TanWC , LeeJK , LiuCH . Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis International2010;21:359–64. ">Liu 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Taiwan</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.8 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.9 (0.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.9 (0.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 days, 6 months, 1, 3 and 5 years</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Balloon kyphoplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.0 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.0 (0.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.6 (0.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Denmark</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.4 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.5 (2.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic surgeons</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care and brace</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.7 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.8 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.5 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70.6 (8.6)<sup>×</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.4 (0.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 days, 12 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kyphoplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.2 (0.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71.7(8.5)<sup>×</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.2 (0.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Germany and USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐<sup>¥</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.5 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.0 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 day, 3 and 12 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shield kyphoplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐<sup>¥</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.3 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.8 (0.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>the Netherlands</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>85 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.1 (5 ‐ 9)<sup>+</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.7 (8‐24)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60.0 (37 to 86)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interventional radiologists</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.2 (1.0 ‐ 5.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.6 (5‐10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.8 (8‐22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60.7 (38 to 86)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Denmark</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐ª</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.47 ()</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic surgeons</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported<sup>˜</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 hours, weekly to 3 months, 12 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (lidocaine injected)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐ª</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.61 ()</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic surgeons</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69.43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.1 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71.22 (10.56)<sup>×</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.31 (0.77)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 day, 3 and 12 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Balloon kyphoplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68.63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.0 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71.30 (10.22)<sup>×</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.22 (1.29)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0020" title="HaoD , GuoH , WangB , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal; http://eposterlyon.eurospine.org/cm_data/eposter/P17.PDF. 2014; Vol. 23, Issue 5:Supplement, pp 527‐557. HaoD , WangB , GuoH , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal2014;23(1):S533. WangB , GuoH , YuanL , HuangD , ZhangH , HaoD . A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. European Spine Journal2016;25:3486‐94. [DOI: 10.1007/s00586‐016‐4425‐4] ">Wang 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐ª</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.65 (1.11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.3 (1.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Spine surgeon</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.5 (3.0 ‐ 9.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Facet joint injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐ª</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.76 (1.06)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.45 (0.98)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Spine surgeon</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.5 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80.2 (9.9)<sup>×</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78.1 (8.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.5 (3‐6.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 week, 3, 6 and 12 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.7 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>81.5 (9.7)<sup>×</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77.5 (8.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>$</sup>1‐10 point scale used by <a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a>, 0 to 100 scale used by <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a> and we report pain with forward bending for this trial as overall pain not reported and have converted SE to SD; <sup>+</sup>RMDQ: Roland‐Morris Disability Questionnaire; <sup>†</sup>modified RMDQ (0‐23 scale) used by <a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>, <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a> and <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>; <sup>×</sup>Oswestry Disability Index (0 to 100) used by <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a>, <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a>, <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a>; ^ median duration of symptoms; <sup>¤</sup>Not reported but symptom duration 6 months or less; <sup>µ</sup>Mean symptom duration reported graphically only; <sup>¢</sup>Median and interquartile range;<sup>§</sup>Not reported but symptom duration 6 weeks or less; ªNot reported but symptom duration 8 weeks or less; <sup>&amp;</sup>Data only included for the 42/46 in VP group and 43/50 in the usual care group who completed 12‐month follow‐up in groups assigned to at baseline; <sup>#</sup>Disability significantly higher in the vertebroplasty group; *from n = 20 treated at Mayo (personal communication); <sup>¥</sup>Not reported but at least 6 weeks of conservative treatment; <sup>+</sup>Only range provided; <sup>˜</sup>up to 2 mL. </p> </div> </div> <section id="CD006349-sec-0058"> <h5 class="title">Trial design, setting and characteristics</h5> <p>Five trials compared vertebroplasty with a placebo (a sham vertebroplasty procedure) (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>; <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>; <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>; <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>), eight trials compared vertebroplasty with usual care/optimum pain management (<a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a>; <a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a>; <a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a>; <a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a>; <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a>; <a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a>; <a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a>; <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a>), one trial compared vertebroplasty with injection of local anaesthetic and glucocorticosteroid into the facet joint of the fractured vertebra in the spine (facet joint injection) (<a href="./references#CD006349-bbs2-0020" title="HaoD , GuoH , WangB , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal; http://eposterlyon.eurospine.org/cm_data/eposter/P17.PDF. 2014; Vol. 23, Issue 5:Supplement, pp 527‐557. HaoD , WangB , GuoH , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal2014;23(1):S533. WangB , GuoH , YuanL , HuangD , ZhangH , HaoD . A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. European Spine Journal2016;25:3486‐94. [DOI: 10.1007/s00586‐016‐4425‐4] ">Wang 2016</a>), while seven trials compared vertebroplasty with different kyphoplasty techniques (<a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a>; <a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a>; <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a>; <a href="./references#CD006349-bbs2-0013" title="LiuJT , LiCS , ChangCS , LiaoWJ . Long‐term follow‐up study of osteoporotic vertebral compression fracture treated using balloon kyphoplasty and vertebroplasty. Journal of Neurosurgery Spine2015;23(1):94‐8. LiuJT , LiaoWJ , TanWC , LeeJK , LiuCH . Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis International2010;21:359–64. ">Liu 2010</a>; <a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a>; <a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a>; <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a>). </p> <p>Trials were conducted in 15 different countries including: Australia (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>), USA (<a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a>), USA, Australia and UK (<a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>), the Netherlands (<a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>; <a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a>), the Netherlands and Belgium <a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a>), Denmark (<a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a>; <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>), Iran (<a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a>), Italy, France and Switzerland (<a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a>), Spain (<a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a>), China (<a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a>; <a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a>; <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a>; <a href="./references#CD006349-bbs2-0020" title="HaoD , GuoH , WangB , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal; http://eposterlyon.eurospine.org/cm_data/eposter/P17.PDF. 2014; Vol. 23, Issue 5:Supplement, pp 527‐557. HaoD , WangB , GuoH , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal2014;23(1):S533. WangB , GuoH , YuanL , HuangD , ZhangH , HaoD . A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. European Spine Journal2016;25:3486‐94. [DOI: 10.1007/s00586‐016‐4425‐4] ">Wang 2016</a>; <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a>), Taiwan (<a href="./references#CD006349-bbs2-0013" title="LiuJT , LiCS , ChangCS , LiaoWJ . Long‐term follow‐up study of osteoporotic vertebral compression fracture treated using balloon kyphoplasty and vertebroplasty. Journal of Neurosurgery Spine2015;23(1):94‐8. LiuJT , LiaoWJ , TanWC , LeeJK , LiuCH . Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis International2010;21:359–64. ">Liu 2010</a>), Germany (<a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a>), USA and Canada (<a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a>), and Germany and the USA (<a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a>). Eight trials received at least some funding from medical device companies who manufacture vertebral augmentation systems (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>; <a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a>; <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a>; <a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a>; <a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a>; <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>; <a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a>); two clearly reported that they had no role in the trial (design, data collection, data analysis, preparation of the manuscript)(<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>); while five trials did not report source of funding (<a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a>; <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a>; <a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a>; <a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a>; <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a>). </p> <p>Trial duration varied from two weeks (<a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a>) to three years (<a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a>). Seven trials allowed cross‐over: <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a> allowed blinded cross‐over to the alternate procedure at one month or later if adequate pain relief was not achieved; both <a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a> and <a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a> allowed participants assigned to the control arm still in severe pain after two weeks to undergo vertebroplasty; <a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a>, <a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a> and <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a> allowed participants in the conservative therapy group to be considered for vertebroplasty if there was no improvement in pain but the timing of this decision was not provided; and in <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a> cross‐over between groups was allowed after three months although no details about who could cross over were not provided. </p> </section> <section id="CD006349-sec-0059"> <h5 class="title">Trial participants</h5> <p>The 21 trials included 2852 randomised participants with trial sizes varying from 46 participants (<a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a>) to 404 participants (<a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a>). In general, inclusion criteria for all trials were similar requiring a clinical history and imaging findings consistent with one or more acute osteoporotic vertebral fractures (see <a href="./references#CD006349-sec-0124" title="">Characteristics of included studies</a> table). Across all trials the majority of participants were female and <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a> only included women (see <a href="#CD006349-tbl-0003">Table 2</a>). Mean age of participants ranged between 62.6 and 81 years. </p> <p>Symptom duration varied across trials with mean duration ranging from around a week (<a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a>) to more than six months (<a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a>). For the placebo‐controlled trials, mean duration of symptoms ranged from less than three weeks to 20 weeks across treatment groups in the individual trials (vertebroplasty and placebo: <a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a> nine and 9.5 weeks; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a> 2.8 and 2.4 weeks; <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a> 16 and 20 weeks; <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a> 29.2 and 25.9 days; and <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a> did not report mean duration but trial inclusion specified a symptom duration of eight weeks or less). </p> <p>Mean baseline pain and disability scores were similar across trials. Mean pain at baseline was greater than seven out of 10 (where 10 is the worst pain) in most trials, except the usual care group of <a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a> (mean 6.3), both arms of <a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a> (means 6.5 and 6.4 in the vertebroplasty and usual care arms, respectively), the vertebroplasty arm of <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a> (mean 6.9), and was low in <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a> (mean 4.8 in vertebroplasty, not reported in usual care) and <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a> (mean pain score 4.8 out of 25 and Oswestry Disability Index (ODI) 53.6% in the vertebroplasty group and not reported in the conservative care group). In <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>, the mean baseline pain was greater than 70 out of 100 for activity pain( 74.68 in the vertebroplasty group and 76.08 in the placebo group), but not for rest pain (40.55 in the vertebroplasty group and 53.04 in the placebo group). <a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a> did not report baseline pain or disability scores. </p> </section> <section id="CD006349-sec-0060"> <h5 class="title">Interventions</h5> <p>Details of interventions in each trial are presented in the <a href="./references#CD006349-sec-0124" title="">Characteristics of included studies</a> table. Vertebroplasty was performed by different specialists in the included trials: interventional radiologists in seven trials (<a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a>; <a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>; <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>; <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>; <a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a>; <a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a>), orthopaedic surgeons in four trials (<a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a>; <a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a>; <a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a>; <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>), neurosurgeons in one trial (<a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a>), spine surgeons in one trial (<a href="./references#CD006349-bbs2-0020" title="HaoD , GuoH , WangB , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal; http://eposterlyon.eurospine.org/cm_data/eposter/P17.PDF. 2014; Vol. 23, Issue 5:Supplement, pp 527‐557. HaoD , WangB , GuoH , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal2014;23(1):S533. WangB , GuoH , YuanL , HuangD , ZhangH , HaoD . A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. European Spine Journal2016;25:3486‐94. [DOI: 10.1007/s00586‐016‐4425‐4] ">Wang 2016</a>), a combination of interventional radiologists and neuroradiologists, orthopaedic surgeons and neurosurgeons in one trial (<a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a>), and the background of the interventionalist was not reported in seven trials (<a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a>; <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a>; <a href="./references#CD006349-bbs2-0013" title="LiuJT , LiCS , ChangCS , LiaoWJ . Long‐term follow‐up study of osteoporotic vertebral compression fracture treated using balloon kyphoplasty and vertebroplasty. Journal of Neurosurgery Spine2015;23(1):94‐8. LiuJT , LiaoWJ , TanWC , LeeJK , LiuCH . Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis International2010;21:359–64. ">Liu 2010</a>; <a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a>; <a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a>; <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a>; <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a>). </p> <p>Vertebroplasty appeared to have been performed in a similar way across all trials. However in <a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a>, the majority of participants in both treatment arms (75.1% in the vertebroplasty group and 80.6% in the kyphoplasty group) also had perioperative postural reduction in an attempt to correct vertebral deformity, and in <a href="./references#CD006349-bbs2-0020" title="HaoD , GuoH , WangB , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal; http://eposterlyon.eurospine.org/cm_data/eposter/P17.PDF. 2014; Vol. 23, Issue 5:Supplement, pp 527‐557. HaoD , WangB , GuoH , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal2014;23(1):S533. WangB , GuoH , YuanL , HuangD , ZhangH , HaoD . A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. European Spine Journal2016;25:3486‐94. [DOI: 10.1007/s00586‐016‐4425‐4] ">Wang 2016</a> postural reduction was performed before surgery in both groups. </p> <p>Mean vertebroplasty cement volume was not specified in four trials (<a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a>; <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a>; <a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a>; <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>) (see <a href="./references#CD006349-sec-0124" title="">Characteristics of included studies</a> table and <a href="#CD006349-tbl-0002">Table 1</a>). <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a> reported that up to 2 mL of cement was inserted but it was not clear if a uni‐ or bipedicular approach was used (which may mean that up to 4 mL was inserted). For the remaining trials, the mean cement volume ranged from 2.8 mL (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>) to 7.5 mL (<a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>). Mean (range) cement volume in the four placebo‐controlled trials was 2.8 mL (1.2 ml to 5.5 mL) (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>), 7.5 mL (4.7 mL to 10.3 mL) (<a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>), 2.8 mL (1 mL to 5.5 mL) (based upon a subset of 20 participants) (<a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>) and 5.11 mL (1 mL to 11 mL) (<a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>). </p> <p>There was diversity in the way that the sham vertebroplasty procedure was delivered in the five placebo‐controlled trials. <a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a> most closely simulated vertebroplasty using an identical procedure to that performed in the vertebroplasty group up to the insertion of the needle into the bone, at which point the vertebral body was gently tapped with a blunt stylet and bone cement was prepared to permeate the strong smell of the polymethylmethacrylate (PMMA) in the room. The sham procedure in the second placebo‐controlled trial was similar except that the vertebral body was not tapped with a blunt stylet (<a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>). For <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>, both the trial registry and protocol paper reported that the placebo involved a 4 mm skin incision and light tapping of the skin, while the results paper states that a short needle was passed into the skin incision but not as far as the periosteum and that manual skin pressure and regular tapping on the needle was performed. The published protocol of <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a> indicates that no needles would be placed periosteally in the placebo group but the methacrylate monomer would be opened to simulate the odour of mixing the bone cement and participants would receive verbal and physical cues (e.g. pressure on the back) to simulate the procedure.. The published reported noted that bone biopsy needles were positioned periosteally bilaterally with preparation of the cement occurring in close proximity to the participants (so that the mixing sound could be heard and the polymethylmethacrylate smelt by everyone in the room). In <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>, PMMA was also opened for the odour but instead of cement, 2 mL of local anaesthetic (lidocaine) was injected into the fractured vertebrae. </p> <p>Eight trials used variations on usual care as the comparator group (<a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a>; <a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a>; <a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a>; <a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a>; <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a>; <a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a>; <a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a>; <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a>) (see <a href="./references#CD006349-sec-0124" title="">Characteristics of included studies</a> table). This included analgesics including acetaminophen, codeine, tramadol and/or opioids in all instances, and these could be adjusted as needed. Five trials specified the use of non‐steroidal anti‐inflammatory drugs (NSAIDs), which could have been in addition to analgesics, when simple analgesia was ineffective or for those intolerant to opioid derivatives (<a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a>; <a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a>; <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a>; <a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a>; <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a>). Three trials also prescribed calcitonin (<a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a>; <a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a>; <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a>) and three also offered brace treatment (<a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a>; <a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a>; <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a>). </p> <p>Seven trials compared vertebroplasty with kyphoplasty (<a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a>; <a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a>; <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a>; <a href="./references#CD006349-bbs2-0013" title="LiuJT , LiCS , ChangCS , LiaoWJ . Long‐term follow‐up study of osteoporotic vertebral compression fracture treated using balloon kyphoplasty and vertebroplasty. Journal of Neurosurgery Spine2015;23(1):94‐8. LiuJT , LiaoWJ , TanWC , LeeJK , LiuCH . Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis International2010;21:359–64. ">Liu 2010</a>; <a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a>; <a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a>; <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a>). <a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a>, <a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a>, <a href="./references#CD006349-bbs2-0013" title="LiuJT , LiCS , ChangCS , LiaoWJ . Long‐term follow‐up study of osteoporotic vertebral compression fracture treated using balloon kyphoplasty and vertebroplasty. Journal of Neurosurgery Spine2015;23(1):94‐8. LiuJT , LiaoWJ , TanWC , LeeJK , LiuCH . Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis International2010;21:359–64. ">Liu 2010</a> and <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a> compared vertebroplasty with balloon kyphoplasty. <a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a> also compared vertebroplasty with a shield kyphoplasty which instead of a balloon, uses specialised instrumentation to create a central cavity in the vertebral body and inserts a self‐expanding implant that controls the cement flow. <a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a> compared vertebroplasty with the same shield kyphoplasty. <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a> compared vertebroplasty with kyphoplasty, however it did not report the kyphoplasty technique used. <a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a> compared high‐viscosity cement vertebroplasty with low‐viscosity cement kyphoplasty. </p> <p>A single trial injected a mixture of prednisolone (125 mg:5 mL) and lidocaine (100 mg:5 mL) under fluoroscopic monitoring into the facet joint of the fractured vertebra as the control intervention (<a href="./references#CD006349-bbs2-0020" title="HaoD , GuoH , WangB , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal; http://eposterlyon.eurospine.org/cm_data/eposter/P17.PDF. 2014; Vol. 23, Issue 5:Supplement, pp 527‐557. HaoD , WangB , GuoH , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal2014;23(1):S533. WangB , GuoH , YuanL , HuangD , ZhangH , HaoD . A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. European Spine Journal2016;25:3486‐94. [DOI: 10.1007/s00586‐016‐4425‐4] ">Wang 2016</a>). </p> </section> <section id="CD006349-sec-0061"> <h5 class="title">Outcomes</h5> <section id="CD006349-sec-0062"> <h6 class="title">Pain</h6> <p>All trials included at least one measure of pain, but its measurement varied across trials. Three trials specified pain over the preceding 24 hours (<a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>; <a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a>; <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>), one trial specified pain over the course of the previous week (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>), and 16 trials did not specify a time period (<a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a>; <a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a>; <a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a>; <a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a>; <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a>; <a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a>; <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a>; <a href="./references#CD006349-bbs2-0013" title="LiuJT , LiCS , ChangCS , LiaoWJ . Long‐term follow‐up study of osteoporotic vertebral compression fracture treated using balloon kyphoplasty and vertebroplasty. Journal of Neurosurgery Spine2015;23(1):94‐8. LiuJT , LiaoWJ , TanWC , LeeJK , LiuCH . Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis International2010;21:359–64. ">Liu 2010</a>; <a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a>; <a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a>; <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>, <a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a>; <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>; <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a>; <a href="./references#CD006349-bbs2-0020" title="HaoD , GuoH , WangB , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal; http://eposterlyon.eurospine.org/cm_data/eposter/P17.PDF. 2014; Vol. 23, Issue 5:Supplement, pp 527‐557. HaoD , WangB , GuoH , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal2014;23(1):S533. WangB , GuoH , YuanL , HuangD , ZhangH , HaoD . A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. European Spine Journal2016;25:3486‐94. [DOI: 10.1007/s00586‐016‐4425‐4] ">Wang 2016</a>; <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a>). <a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a> only reported baseline pain in their published trial report but measurement of pain (and disability assessed by the Oswestry Disability Index (ODI)) was referred to in a congress abstract of the same trial published in German; whether or not a time period was specified is not known. </p> <p><a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a> measured overall pain, pain at rest and pain in bed at night, while <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a> measured average back pain intensity. <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a> specified the measurement of pain at rest and pain with standing or activity in addition to average pain intensity but these results were not reported. <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a> measured pain on a visual analogue scale (VAS) (zero ‐ no pain to five ‐ maximum pain) during walking, sitting and rising from a chair, bathing, dressing, and at rest, and summed all five scores to derive a total score out of 25. <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a> measured rest pain and pain during forward bending resembling a patient in activity (both on a zero to 100 VAS). All remaining trials referred to pain or mean pain unqualified by additional descriptors. </p> <p>All but two trials, included a measure of pain using either a zero to 10 VAS or zero to 10 numerical rating scale, although the descriptor for a score of 10 differed across trials (e.g. maximum pain (<a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>), maximal imaginable pain (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>), worst pain imaginable (<a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a>), worst possible (<a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a>), pain as bad as could be (<a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>), worst pain ever (<a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010;</a><a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>), worse pain possible (<a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a>), worst pain in the patient's life (<a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a>), and no descriptors specified (<a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a>; <a href="./references#CD006349-bbs2-0013" title="LiuJT , LiCS , ChangCS , LiaoWJ . Long‐term follow‐up study of osteoporotic vertebral compression fracture treated using balloon kyphoplasty and vertebroplasty. Journal of Neurosurgery Spine2015;23(1):94‐8. LiuJT , LiaoWJ , TanWC , LeeJK , LiuCH . Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis International2010;21:359–64. ">Liu 2010</a>; <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a>; <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a>)). The pain scale investigated by <a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a> measured pain on a one (no pain) to 10 (excruciating pain) VAS, while <a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a> did not specify the pain scale explicitly although it was likely to have been on a zero to 100‐point scale (as mean baseline scores varied between 78.2 and 90). As described above, <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a> used a zero to five VAS to measure pain during five activities and summed them for a score out of 25. <a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a> used a VAS to measure pain, but the scale range and descriptors (if any), were not reported. <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a> used a zero to 100 VAS and the descriptor (if any), were not reported. </p> <p>Four trials also included a dichotomous measure of pain. <a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a> measured the number of participants with moderate (pain ≥ 4) or severe (pain ≥ 7) pain at 12 months. Three trials included the proportion of participants with pain improved by a clinically relevant amount although the definitions varied. <a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a> reported the proportion of people with improvement of overall pain, pain at rest and pain in bed at night of ≥ 2.5 units as post‐hoc analyses performed at the request of the publishing journal (external reviewer request). <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a> reported the proportion of participants achieving an NRS pain score of &lt;4 out of 10 (from a baseline score of ≥ 7 out of 10). <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a> measured the proportion of participants with clinically important improvement in pain defined as at least 30% improvement. </p> <p>Four trials also included other measures of pain. <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a> and <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a> included the Pain Frequency and Pain Bothersomeness Indices (each measured on a zero to four‐point scale, with higher scores indicating more severe pain). <a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a> measured the number of pain‐free days (defined as days with a VAS score of three or lower) and <a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a> included the Dallas Pain Questionnaire (DPQ), a 16‐item instrument that assesses four aspects of daily living affected by chronic back pain (day‐to‐day activities, work and leisure activities, anxiety and depression and social interest), measured as a percentage of pain interference in each of the four aspects (0% is no pain and 100% is pain all the time). </p> </section> <section id="CD006349-sec-0063"> <h6 class="title">Disability</h6> <p>All except four trials (<a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a>; <a href="./references#CD006349-bbs2-0013" title="LiuJT , LiCS , ChangCS , LiaoWJ . Long‐term follow‐up study of osteoporotic vertebral compression fracture treated using balloon kyphoplasty and vertebroplasty. Journal of Neurosurgery Spine2015;23(1):94‐8. LiuJT , LiaoWJ , TanWC , LeeJK , LiuCH . Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis International2010;21:359–64. ">Liu 2010</a>; <a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a>; <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>), included a back‐specific measure of disability or function and two trials included two back‐specific measures (<a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a>; <a href="./references#CD006349-bbs2-0020" title="HaoD , GuoH , WangB , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal; http://eposterlyon.eurospine.org/cm_data/eposter/P17.PDF. 2014; Vol. 23, Issue 5:Supplement, pp 527‐557. HaoD , WangB , GuoH , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal2014;23(1):S533. WangB , GuoH , YuanL , HuangD , ZhangH , HaoD . A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. European Spine Journal2016;25:3486‐94. [DOI: 10.1007/s00586‐016‐4425‐4] ">Wang 2016</a>). Nine trials included the Roland‐Morris Disability Questionnaire (RMDQ) (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>; <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a>; <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>; <a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a>; <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>; <a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a>; <a href="./references#CD006349-bbs2-0020" title="HaoD , GuoH , WangB , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal; http://eposterlyon.eurospine.org/cm_data/eposter/P17.PDF. 2014; Vol. 23, Issue 5:Supplement, pp 527‐557. HaoD , WangB , GuoH , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal2014;23(1):S533. WangB , GuoH , YuanL , HuangD , ZhangH , HaoD . A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. European Spine Journal2016;25:3486‐94. [DOI: 10.1007/s00586‐016‐4425‐4] ">Wang 2016</a>) and 10 trials included the ODI (<a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a>; <a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a>; <a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a>; <a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a>; <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a>; <a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a>; <a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a>; <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a>; <a href="./references#CD006349-bbs2-0020" title="HaoD , GuoH , WangB , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal; http://eposterlyon.eurospine.org/cm_data/eposter/P17.PDF. 2014; Vol. 23, Issue 5:Supplement, pp 527‐557. HaoD , WangB , GuoH , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal2014;23(1):S533. WangB , GuoH , YuanL , HuangD , ZhangH , HaoD . A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. European Spine Journal2016;25:3486‐94. [DOI: 10.1007/s00586‐016‐4425‐4] ">Wang 2016</a>; <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a>) (although no data were presented in <a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a>). In <a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a>, section eight, regarding sexual activity was removed from the ODI. Three trials also included the physical function dimension component of the SF‐36 (<a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a>; <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a>; <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>). Two trials only included the physical function dimension component of the SF‐36 as a measure of disability (<a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a>; <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>) and two trials included no measures of disability (<a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a>; <a href="./references#CD006349-bbs2-0013" title="LiuJT , LiCS , ChangCS , LiaoWJ . Long‐term follow‐up study of osteoporotic vertebral compression fracture treated using balloon kyphoplasty and vertebroplasty. Journal of Neurosurgery Spine2015;23(1):94‐8. LiuJT , LiaoWJ , TanWC , LeeJK , LiuCH . Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis International2010;21:359–64. ">Liu 2010</a>). </p> <p><a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a> and <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a> also included the Study of Osteoporotic Fractures‐Activities of Daily Living (SOF‐ADL) scale and <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a> measured the proportion with clinically important improvement in disability (at least 30% improvement), while <a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a> also included the Barthel Index and <a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a> included ability to walk after one day. </p> </section> <section id="CD006349-sec-0064"> <h6 class="title">Health‐related quality of life</h6> <p>Eight trials did not include a measure of health‐related quality of life (<a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a>; <a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a>; <a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a>; <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a>; <a href="./references#CD006349-bbs2-0013" title="LiuJT , LiCS , ChangCS , LiaoWJ . Long‐term follow‐up study of osteoporotic vertebral compression fracture treated using balloon kyphoplasty and vertebroplasty. Journal of Neurosurgery Spine2015;23(1):94‐8. LiuJT , LiaoWJ , TanWC , LeeJK , LiuCH . Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis International2010;21:359–64. ">Liu 2010</a>; <a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a>; <a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a>; <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a>). </p> <p>Seven trials included the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO) (<a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a>; <a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>; <a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a>; <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>; <a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a>; <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a>) as a vertebral fracture and/or osteoporosis‐specific measure. </p> <p>Six trials included an overall measure of health‐related quality of life: five trials included the Mental Component Summary (MCS) subscale of the SF‐36 (<a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a>; <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>; <a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a>; <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>; <a href="./references#CD006349-bbs2-0020" title="HaoD , GuoH , WangB , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal; http://eposterlyon.eurospine.org/cm_data/eposter/P17.PDF. 2014; Vol. 23, Issue 5:Supplement, pp 527‐557. HaoD , WangB , GuoH , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal2014;23(1):S533. WangB , GuoH , YuanL , HuangD , ZhangH , HaoD . A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. European Spine Journal2016;25:3486‐94. [DOI: 10.1007/s00586‐016‐4425‐4] ">Wang 2016</a>), eight trials included the European Quality of Life with 5 Dimensions (EQ‐5D) (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>; <a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a>; <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a>; <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>; <a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a>; <a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a>; <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>), one trial included the Assessment of Quality of Life (AQoL) (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>), and one trial included the Study of Osteoporotic Fractures‐Activities of Daily Living (SOF‐ADL6), Modified Deyo Patrick Pain Frequency and Bothersomeness Scale and the Osteoporotic Assessment Questionnaire (OPAQ) Body Image Scale (<a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a>). </p> </section> <section id="CD006349-sec-0065"> <h6 class="title">Treatment success</h6> <p>Two trials included a specific patient‐reported measure of treatment success. <a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a> defined treatment success as 'moderately better' or 'a great deal better' for pain, fatigue and overall health on seven‐point ordinal scales, ranging from a 'great deal worse' to a 'great deal better'. <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a> measured patient satisfaction as 'very satisfied' 'satisfied' or 'unsatisfied'. </p> <p>As described above, three trials included one or more investigator‐specified measures of treatment success as determined by the number of participants who achieved various thresholds of pain and/or disability improvement (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>; <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>). </p> </section> <section id="CD006349-sec-0066"> <h6 class="title">Incident symptomatic and/or radiographically apparent vertebral fractures</h6> <p>Most trials recorded the occurrence of new symptomatic and/or radiologically apparent vertebral fractures. </p> <p>Three trials reported the occurrence of both (<a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a> up to 12 months; <a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a> up to 24 months; <a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a> up to 24 months). </p> <p>Four trials reported new symptomatic vertebral fractures (<a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a> up to one year; <a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a> up to 24 months; <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a> up to six months; <a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a> up to two weeks) and five trials only reported occurrence of incident radiographic vertebral fractures (<a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a> at six months; <a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a> at one, three and 12 months; <a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a> at three and 12 months; <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a> at 12 months; <a href="./references#CD006349-bbs2-0020" title="HaoD , GuoH , WangB , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal; http://eposterlyon.eurospine.org/cm_data/eposter/P17.PDF. 2014; Vol. 23, Issue 5:Supplement, pp 527‐557. HaoD , WangB , GuoH , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal2014;23(1):S533. WangB , GuoH , YuanL , HuangD , ZhangH , HaoD . A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. European Spine Journal2016;25:3486‐94. [DOI: 10.1007/s00586‐016‐4425‐4] ">Wang 2016</a> at 12 months; <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a> at one, three, six and 12 months). </p> <p><a href="./references#CD006349-bbs2-0013" title="LiuJT , LiCS , ChangCS , LiaoWJ . Long‐term follow‐up study of osteoporotic vertebral compression fracture treated using balloon kyphoplasty and vertebroplasty. Journal of Neurosurgery Spine2015;23(1):94‐8. LiuJT , LiaoWJ , TanWC , LeeJK , LiuCH . Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis International2010;21:359–64. ">Liu 2010</a>, <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a> and <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a> reported new vertebral fractures but did not specify if they were symptomatic or only detected on imaging, and <a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a> reported radiographic refractures and adjacent level fractures up to 12 months and whether or not these were symptomatic. <a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a> only reported upon new adjacent fractures up to six months, while <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a>, <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a> and <a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a> did not report occurrence of new vertebral fractures during the period of follow‐up. </p> </section> <section id="CD006349-sec-0067"> <h6 class="title">Other serious adverse events</h6> <p>Adverse events, other than reporting of new symptomatic or asymptomatic vertebral fractures were variably reported across trials. Ten trials made specific reference to presence/absence of other adverse events in both treated groups (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>; <a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a>; <a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a>; <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>; <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a>; <a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a>; <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>; <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>; <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a>). </p> <p><a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a>, <a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a>, <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a> and <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a> reported on the presence/absence of clinical complications from cement leakage in the vertebroplasty‐treated group but did not report whether or not other adverse events occurred in either group; <a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a>, <a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a> and <a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a> reported adverse events that occurred in the vertebroplasty‐treated group but did not report whether or not adverse events occurred in the usual care group. <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a>, <a href="./references#CD006349-bbs2-0013" title="LiuJT , LiCS , ChangCS , LiaoWJ . Long‐term follow‐up study of osteoporotic vertebral compression fracture treated using balloon kyphoplasty and vertebroplasty. Journal of Neurosurgery Spine2015;23(1):94‐8. LiuJT , LiaoWJ , TanWC , LeeJK , LiuCH . Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis International2010;21:359–64. ">Liu 2010</a>, <a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a> and <a href="./references#CD006349-bbs2-0020" title="HaoD , GuoH , WangB , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal; http://eposterlyon.eurospine.org/cm_data/eposter/P17.PDF. 2014; Vol. 23, Issue 5:Supplement, pp 527‐557. HaoD , WangB , GuoH , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal2014;23(1):S533. WangB , GuoH , YuanL , HuangD , ZhangH , HaoD . A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. European Spine Journal2016;25:3486‐94. [DOI: 10.1007/s00586‐016‐4425‐4] ">Wang 2016</a> did not report the presence or absence of other adverse events. </p> </section> </section> </section> <section id="CD006349-sec-0068"> <h4 class="title">Excluded studies</h4> <p>One controlled trial was excluded because participants were not assigned treatment at random but rather the authors stated that a surgeon at the outpatient ward blindly chose one of three different treatment modalities (vertebroplasty, kyphoplasty or usual care) to ensure similar pre‐treatment age, symptoms, grade and level of spinal diseases among the patients (<a href="./references#CD006349-bbs2-0035" title="YiX , LuH , TianF , WangY , LiC , LiuH , et al. Recompression in new levels after percutaneous vertebroplasty and kyphoplasty compared with conservative treatment. Archives of Orthopaedic and Trauma Surgery2014;134(1):21‐30. ">Yi 2014</a>). In addition, the vertebroplasty and kyphoplasty groups were combined in the data analysis and separate data for the vertebroplasty group were not provided. Another three studies were also excluded because participants were not assigned treatment at random (<a href="./references#CD006349-bbs2-0025" title="DuJ , LiX , LinX . Kyphoplasty versus vertebroplasty in the treatment of painful osteoporotic vertebral compression fractures: two‐year follow‐up in a prospective controlled study. Acta Orthopaedica Belgica2014;80(4):477‐86. ">Du 2014</a>; <a href="./references#CD006349-bbs2-0034" title="YangDH , ChoKH , ChungYS , KimYR . Effect of vertebroplasty with bone filler device and comparison with balloon kyphoplasty. European Spine Journal2014;23(12):2718‐25. ">Yang 2014</a>; <a href="./references#CD006349-bbs2-0038" title="YokoyamaK , KawanishiM , YamadaM , TanakaH , ItoY , KawabataS , et al. Comparison of vertebroplasty versus vertebral perforation for the treatment of acute vertebral compression fractures. Turkish Neurosurgery2016;26(3):423‐9. YokoyamaK , KawanishiM , YamadaM , TanakaH , ItoY , KuroiwaT . Long‐term therapeutic effects of vertebroplasty for painful vertebral compression fracture: a retrospective comparative study. British Journal of Neurosurgery2017;31(2):184‐8. ">Yokoyama 2016</a>), and one study excluded was a retrospective study (<a href="./references#CD006349-bbs2-0032" title="SonS , LeeSG , KimWK , ParkCW , YooCJ . Early vertebroplasty versus delayed vertebroplasty for acute osteoporotic compression fracture: Are the results of the two surgical strategies the same?. Journal of Korean Neurosurgical Society2014;56(3):211‐7. ">Son 2014</a>). </p> <p>Other trials were excluded as vertebroplasty was administered to both treatment groups: with a different cement type in each group (<a href="./references#CD006349-bbs2-0022" title="CaiJ , HaoYW , LiC , YangHQ . Percutaneous vertebroplasty with bone cement injection for osteoporotic vertebral compression fractures via transpedicular approach [Chinese]. Chinese Journal of Tissue Engineering Research2015;19(30):4892‐7. ">Cai 2015</a>; <a href="./references#CD006349-bbs2-0023" title="ChenC , BianJ , ZhangW , ZhaoC , WeiH . Unilateral versus bilateral vertebroplasty for severe osteoporotic vertebral compression fractures. Journal of Spinal Disorders &amp; Techniques2014;27(8):E301‐4. ">Chen 2014b</a>; <a href="./references#CD006349-bbs2-0026" title="GilulaL , PersenaireM . Subsequent fractures post–vertebral augmentation: Analysis of a prospective randomized trial in osteoporotic vertebral compression fractures. AJNR: American Journal of Neuroradiology2013;34(2):221‐7. ">Gilula 2013</a>; <a href="./references#CD006349-bbs2-0027" title="GuYT , ZhuDH , LiuHF , ZhangF , McGuireR . Minimally invasive pedicle screw fixation combined with percutaneous vertebroplasty for preventing secondary fracture after vertebroplasty. Journal of Orthopaedic Surgery2015;10:31 doi: 10.1186/s13018‐015‐0172‐1. [DOI: 10.1186/s13018‐015‐0172‐1] ">Gu 2015</a>; <a href="./references#CD006349-bbs2-0028" title="HuangXN . Percutaneous vertebroplasty for treatment of osteoporotic vertebral fractures: High‐viscosity versus low‐viscosity bone cement [Chinese]. Chinese Journal of Tissue Engineering Research2014;18(16):2461‐7. ">Huang 2014</a>; <a href="./references#CD006349-bbs2-0029" title="LiJ , ShenWL , ChangXH . Comparison of clinical effects between unilateral and bilateral percutaneous vertebroplasty for osteoporotic vertebral compression fractures. [Chinese]. Journal of Dalian Medical University2015;37(2):145‐7. ">Li 2015a</a>; <a href="./references#CD006349-bbs2-0030" title="LiuCL , HuYH , WangGQ , TangYZ , WangXJ , HouHT . Curative effects of unipedicular and bipedicular vertebroplasty in treating osteoporotic vertebral compression fractures in the elderly population. [Chinese]. Journal of Xi'an Jiaotong University (Medical Sciences)2015;36(6):857‐61. ">Liu 2015</a>; <a href="./references#CD006349-bbs2-0031" title="MinP , ZhangYP , CaoH . CT‐guided bone cement injection combined with artificial tiger bone meal to repair osteoporotic vertebral compression fractures: Callus growth and bone healing [Chinese]. Chinese Journal of Tissue Engineering Research2015;19(3):335‐9. ">Min 2015</a>; <a href="./references#CD006349-bbs2-0033" title="Xiao‐nanH . Percutaneous vertebroplasty for treatment of osteoporotic vertebral fractures: high viscosity versus low‐viscosity bone cement. Chinese Journal of Tissue Engineering Research2014;18(16):2461‐7. ">Xiao‐nan 2014</a>; <a href="./references#CD006349-bbs2-0037" title="Ying L. ChenZ , YangG . Clinical study of high viscosity bone cement in the treatment of osteoporotic vertebral compression fracture. Biomedical Research (India)2017;28(18):7837‐40. ">Ying 2017</a>; <a href="./references#CD006349-bbs2-0039" title="ZhangL , WangJ , FengX , TaoY , YangJ , WangY , et al. A comparison of high viscosity bone cement and low viscosity bone cement vertebroplasty for severe osteoporotic vertebral compression fractures. Clinical Neurology and Neurosurgery2015;129:10‐6. ">Zhang 2015a</a>), or trials compared unipedicular vertebroplasty with bipedicular vertebroplasty (<a href="./references#CD006349-bbs2-0024" title="Chen‐leiL , Yi‐heH , Gui‐qingW , Yong‐zhiT , Xiang‐jiangW , Han‐taoH . Curative effects of unipedicular and bipedicular vertebroplasty in treating osteoporotic vertebral compression fractures in the elderly population. Journal of Xi'an Jiatong University2015;36:6. ">Chun‐lei 2015</a>; <a href="./references#CD006349-bbs2-0040" title="ZhangL , LiuZ , WangJ , FengX , YangJ , TaoY , et al. Unipedicular versus bipedicular percutaneous vertebroplasty for osteoporotic vertebral compression fractures: a prospective randomized study. BMC Musculoskeletal Disorders2015;16:145. ">Zhang 2015b</a>), or unilateral and bilateral vertebroplasty (<a href="./references#CD006349-bbs2-0041" title="ZhangL , GuX , ZhangH , ZhangQ , CaiX , TaoK . Unilateral or bilateral percutaneous vertebroplasty for acute osteoporotic vertebral fracture: a prospective study. Journal of Spine Disorders &amp; Techniques2015; Vol. 28, issue 2:85‐8. ">Zhang 2015c</a>). </p> </section> </section> <section id="CD006349-sec-0069"> <h3 class="title">Risk of bias in included studies</h3> <p>Risk of bias assessment for each study is reported in the <a href="./references#CD006349-sec-0124" title="">Characteristics of included studies</a> table and summarised in <a href="#CD006349-fig-0002">Figure 2</a> and <a href="#CD006349-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD006349-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006349-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD006349-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias summary': review authors' judgements about the risk of bias of the available evidence presented as percentages across all included studies." data-id="CD006349-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias summary': review authors' judgements about the risk of bias of the available evidence presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD006349-sec-0070"> <h4 class="title">Allocation</h4> <p>Six trials described adequate sequence generation and allocation concealment and were assessed as being at low risk of selection bias (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>; <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a>; <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>; <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>; <a href="./references#CD006349-bbs2-0020" title="HaoD , GuoH , WangB , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal; http://eposterlyon.eurospine.org/cm_data/eposter/P17.PDF. 2014; Vol. 23, Issue 5:Supplement, pp 527‐557. HaoD , WangB , GuoH , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal2014;23(1):S533. WangB , GuoH , YuanL , HuangD , ZhangH , HaoD . A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. European Spine Journal2016;25:3486‐94. [DOI: 10.1007/s00586‐016‐4425‐4] ">Wang 2016</a>). <a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a> reported that randomisation was prepared by computer using a dynamic minimisation technique stratified by the number of prevalent vertebral fractures, aetiology and study centre, but treatment allocation was not concealed. Stratification by aetiology was unexplained as the selection criteria indicated that participants were included on the basis of osteoporotic fractures while fractures due to cancer and high‐energy trauma were excluded. </p> <p>Three additional trials were also assessed as being at low risk of selection bias even though randomisation or allocation concealment was not explicitly reported (<a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a>; <a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a>; <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>). <a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a> reported that the treatment assignment was kept in sealed envelopes. It is not clearly reported who prepared and opened the envelopes, but it is likely that allocation was concealed as they reported that neither the neurosurgeon (performing vertebroplasty) nor the physician (administering usual care) knew about the other study group and had no role in allocation. <a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a> reported that an independent telephone operator allocated participants by telephone, therefore the allocation was likely concealed from the investigators. <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a> reported block randomisation design using 52 envelopes but no further details were provided. However participants and the single outcome assessor, as well as the biostatistician who performed the analysis were reportedly blinded to treatment allocation. </p> <p><a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a>, <a href="./references#CD006349-bbs2-0013" title="LiuJT , LiCS , ChangCS , LiaoWJ . Long‐term follow‐up study of osteoporotic vertebral compression fracture treated using balloon kyphoplasty and vertebroplasty. Journal of Neurosurgery Spine2015;23(1):94‐8. LiuJT , LiaoWJ , TanWC , LeeJK , LiuCH . Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis International2010;21:359–64. ">Liu 2010</a> and <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a> reported that they prepared a computer‐generated random list but no information is provided regarding concealment of treatment allocation. In <a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a>, <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a>; <a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a>; <a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a> and <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a>, participants were "randomised" into treatment groups, however the trialists did not report the method of randomisation or whether concealment of treatment allocation was attempted. In <a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a>, sealed envelopes containing the treatment allocation were prepared beforehand by the investigating surgeon and 'sorted randomly' and type of treatment was unknown to the patient and the investigators until after the patient had provided written consent. In <a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a>, the patients were randomised in two groups by an independent central operator but no further information is provided regarding concealment of treatment allocation. <a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a> was assessed as being at high risk of selection bias with respect to random sequence generation as participants were reported to have been distributed quasi‐randomly into three groups and the method was not reported. It was judged to be at unclear risk of selection bias as the single investigator was not blinded to treatment allocation although participants were reported to be blinded and all procedures were performed under general anaesthesia. </p> </section> <section id="CD006349-sec-0071"> <h4 class="title">Blinding</h4> <p>Two trials were judged to be at low risk of performance and detection bias for all clinical outcomes as they blinded participants and all study personnel other than the person performing the intervention, and success of participant blinding was assessed to be successful (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>). However, after the one‐month follow‐up, <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a> was considered to be at high risk of performance bias because more participants in the placebo group crossed over (27/63, 36%) compared with the vertebroplasty group (8/68, 12%) by the three‐month follow‐up. <a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a> was judged to be at high risk of bias for the one‐ and two‐year assessment of radiographically‐apparent incident fractures as it was not possible to blind radiologists to treatment allocation due to the opacity of the cement. <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a> was also judged to be at low risk of performance and detection bias for all clinical outcomes as they blinded participants although they did not explicitly report blinding of study personnel. Success of blinding was also assessed to be successful. In <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a> it was not reported if incident fractures were detected clinically or radiographically. <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a> was also judged to be at low risk of performance and detection bias for all clinical outcomes as it appeared participants were blinded and the single assessor was blinded for all clinical outcomes, although blinding success was not evaluated. It was judged to be at high risk of bias for the assessment of radiographically‐apparent incident fractures as it was not possible to blind radiologists to treatment allocation due to the opacity of the cement. </p> <p>In <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>, success of blinding was only reported for a subset of participants (35/55 (60%) and 35/57 (61.4%) in the vertebroplasty and placebo groups, respectively at 14 days, and not reported at three days. In those in whom this outcome was reported, results differed with 80% (28/35) of the of the vertebroplasty group correctly guessing that they had undergone vertebroplasty compared with 54% (19/35) of the control group correctly guessing that they had received a placebo. Thus, we judged this trial as having an unclear risk of performance bias and detection bias for participant‐reported endpoints. <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a> was judged to be at high risk of bias for radiographic outcomes as radiologists were not blinded due to the opacity of cement on imaging. </p> <p>Ten trials were judged to be at high risk of performance and detection bias as participants and study personnel were likely aware of the treatment received (<a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a>; <a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a>; <a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a>; <a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a>; <a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a>; <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a>; <a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a>; <a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a>; <a href="./references#CD006349-bbs2-0020" title="HaoD , GuoH , WangB , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal; http://eposterlyon.eurospine.org/cm_data/eposter/P17.PDF. 2014; Vol. 23, Issue 5:Supplement, pp 527‐557. HaoD , WangB , GuoH , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal2014;23(1):S533. WangB , GuoH , YuanL , HuangD , ZhangH , HaoD . A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. European Spine Journal2016;25:3486‐94. [DOI: 10.1007/s00586‐016‐4425‐4] ">Wang 2016</a>; <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a>). <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a> did not report clearly if participants and personnel were blinded to treatment; the trial registry record reports the study was single‐blinded, in that participants were masked, but the results paper reports that site co‐ordinators and other personnel who collected trial participant data were unaware of treatment assignment. Two trials (<a href="./references#CD006349-bbs2-0013" title="LiuJT , LiCS , ChangCS , LiaoWJ . Long‐term follow‐up study of osteoporotic vertebral compression fracture treated using balloon kyphoplasty and vertebroplasty. Journal of Neurosurgery Spine2015;23(1):94‐8. LiuJT , LiaoWJ , TanWC , LeeJK , LiuCH . Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis International2010;21:359–64. ">Liu 2010</a>; <a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a>) were judged to be at unclear risk of detection bias for participant‐reported endpoints as it was unclear whether or not participants were blinded to treatment allocation. <a href="./references#CD006349-bbs2-0013" title="LiuJT , LiCS , ChangCS , LiaoWJ . Long‐term follow‐up study of osteoporotic vertebral compression fracture treated using balloon kyphoplasty and vertebroplasty. Journal of Neurosurgery Spine2015;23(1):94‐8. LiuJT , LiaoWJ , TanWC , LeeJK , LiuCH . Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis International2010;21:359–64. ">Liu 2010</a> was judged to be at unclear risk of bias for radiographic outcomes of vertebral height and kyphotic angle as while these were measured by technicians who were blinded to treatment allocation, it was not clear how variability of assessment was 'controlled via inter‐ and intra‐observer comparisons' (these outcomes were not reported in this review). </p> <p><a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a> and <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a> were judged to be at unclear risk of performance bias and low risk of detection bias for participant‐reported outcomes as participants were blinded to treatment allocation. However both, <a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a> and <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a> were judged to be at high risk of detection bias for investigator‐reported outcomes (In <a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a>, investigators were aware of treatment allocation and in <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a>, radiologists would have been able to tell the difference between vertebroplasty and kyphoplasty on imaging). <a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a> was assessed as being at unclear risk of performance bias as participants, but not the single investigator, were blinded to treatment allocation, low risk of bias for self‐assessed outcomes as participants were blinded and another orthopaedic surgeon not involved in the primary surgery performed the final follow‐up, and high risk of bias for investigator‐reported outcomes as radiologic outcomes were analysed by the unblinded orthopaedic surgeon who performed all procedures as well as another radiologist (status of radiologist with respect to blinding not reported). </p> </section> <section id="CD006349-sec-0072"> <h4 class="title">Incomplete outcome data</h4> <p>Five trials were assessed as at low risk for attrition bias (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a>; <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>; <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>; <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a>), while the other trials were either considered to be at unclear (<a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>; <a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a>; <a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a>; <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a>; <a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a>; <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a>; <a href="./references#CD006349-bbs2-0013" title="LiuJT , LiCS , ChangCS , LiaoWJ . Long‐term follow‐up study of osteoporotic vertebral compression fracture treated using balloon kyphoplasty and vertebroplasty. Journal of Neurosurgery Spine2015;23(1):94‐8. LiuJT , LiaoWJ , TanWC , LeeJK , LiuCH . Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis International2010;21:359–64. ">Liu 2010</a>; <a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a>; <a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a>; <a href="./references#CD006349-bbs2-0020" title="HaoD , GuoH , WangB , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal; http://eposterlyon.eurospine.org/cm_data/eposter/P17.PDF. 2014; Vol. 23, Issue 5:Supplement, pp 527‐557. HaoD , WangB , GuoH , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal2014;23(1):S533. WangB , GuoH , YuanL , HuangD , ZhangH , HaoD . A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. European Spine Journal2016;25:3486‐94. [DOI: 10.1007/s00586‐016‐4425‐4] ">Wang 2016</a>) or high risk (<a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a>; <a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a>; <a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a>; <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a>). </p> <p><a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a> had small and equal loss to follow‐up across treatment groups for shorter‐term benefit and safety outcomes although loss to follow‐up was greater when considering longer‐term outcomes. At two years, 29/38 (76%) and 28/40 (70%) had completed follow‐up in the vertebroplasty and sham groups, respectively. </p> <p><a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a> had a small and balanced loss to follow‐up across treatment groups up to one month. </p> <p><a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a> was at unclear risk for attrition bias because while the proportion lost to follow‐up at 12 months was similar between groups (17/64 (27%) from the vertebroplasty group and 13/61 (21%) from the usual care group), the authors reported that the losses may not have been random, but related to worse pain in the usual care group. </p> <p><a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a> was judged to be at high risk of attrition bias as they performed a completers' analysis and excluded 7/50 participants allocated to receive conservative care on the basis that four refused conservative treatment and decided to have vertebroplasty at the three‐month follow‐up and an additional three were lost to follow‐up. However, while they stated that four participants in the vertebroplasty group were lost to follow‐up, they appeared to include all 46 participants allocated to receive vertebroplasty in the analysis to 12 months. </p> <p><a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a> was at unclear risk for attrition bias because while the proportion lost to follow‐up at three and six months was similar between groups (i.e. 8/61 (13.1%) from the vertebroplasty group and 7/59 (11.9%) from the placebo group at three months, and 10/61 (16.7%) from the vertebroplasty group and 8/59 (13.6%) from the placebo group at six months), the proportion lost to follow‐up at 14 days and one month were different (6/61 (9.8%) from the vertebroplasty group and 2/59 (3.4%) from the control group at both 14 days and one month). Reasons for withdrawal were also not reported. In addition, some data were missing for some outcomes reportedly due to inability to complete questionnaires by sick elderly participants. Most data were missing for the outcome of success of blinding at 14 days although the proportion missing was equal across treatment groups (data reported for 35/55 (60%) in the vertebroplasty group and 35/57 (61.4%) in the placebo group). </p> <p><a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a> had small and equal loss to follow‐up across treatment groups for shorter‐term efficacy and safety outcomes. However, for the primary endpoints of new radiographic vertebral fracture at 12 and 24 months, loss to follow‐up was much greater. At 12 months 130/190 (68%) and 143/191 (75%) had completed follow‐up in the vertebroplasty and kyphoplasty groups, respectively, while at 24 months complete follow‐up was 91/190 (48%) and 100/191 (52%) in the vertebroplasty and kyphoplasty groups, respectively. While the reasons for loss to follow‐up were similar between groups, a higher proportion of those assigned to vertebroplasty (20/190; 11%) withdrew compared to the kyphoplasty group (11/191; 6%) and it is unclear if the reasons for withdrawal were systematically different. </p> <p>In addition, seven participants who received vertebroplasty and four who received kyphoplasty underwent the alternate treatment for a subsequent vertebral fracture but the timing was not stated. An additional 70/88 (79.5%) participants with a new clinically recognised fracture underwent a subsequent vertebral augmentation during the trial ‐ it is implied that these participants received the same type of procedure as they had received as part of the trial. In all instances of spinal augmentation for a new vertebral fracture, the last observation before surgery was carried forward to later visits. </p> <p><a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a> was judged to be at unclear risk of attrition bias as data were unavailable for seven participants (two deaths and five participants who refused follow‐up although the treatment groups of these seven participants were not explicitly reported). </p> <p><a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a> was judged to be at unclear risk of attrition bias as a quarter of the participants did not complete follow‐up (21.8% of vertebroplasty group, 29.3% of kyphoplasty group). The authors report that the pattern of loss to follow‐up appeared to be missing at random. </p> <p><a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a> was judged to be at unclear risk of attrition bias as a greater number of participants completed one‐year follow‐up in the vertebroplasty group (86/101, 85%) compared with 77/101 (76%) in the usual care group and 15 (15%) participants in the usual care group received vertebroplasty. </p> <p><a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a>; <a href="./references#CD006349-bbs2-0013" title="LiuJT , LiCS , ChangCS , LiaoWJ . Long‐term follow‐up study of osteoporotic vertebral compression fracture treated using balloon kyphoplasty and vertebroplasty. Journal of Neurosurgery Spine2015;23(1):94‐8. LiuJT , LiaoWJ , TanWC , LeeJK , LiuCH . Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis International2010;21:359–64. ">Liu 2010</a>; <a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a>; <a href="./references#CD006349-bbs2-0020" title="HaoD , GuoH , WangB , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal; http://eposterlyon.eurospine.org/cm_data/eposter/P17.PDF. 2014; Vol. 23, Issue 5:Supplement, pp 527‐557. HaoD , WangB , GuoH , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal2014;23(1):S533. WangB , GuoH , YuanL , HuangD , ZhangH , HaoD . A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. European Spine Journal2016;25:3486‐94. [DOI: 10.1007/s00586‐016‐4425‐4] ">Wang 2016</a> were judged to be at unclear risk for attrition bias because completeness of follow‐up was not explicitly reported. </p> <p><a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a> was judged to be at high risk of attrition bias for several irregularities including failure to report baseline and follow‐up data for all participants. </p> <p><a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a> was judged to be at unclear risk of attrition bias as the numbers who were followed up were not reported. </p> <p>In <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>, follow‐up was nearly complete, with a small proportion lost in each group, for reasons that were likely unrelated to treatment. </p> <p><a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a> was judged to be at high risk of attrition bias because of significant loss to follow‐up in both treatment arms (follow‐up complete at 12 months for 19 (68%) and 28 (57%) in the vertebroplasty and kyphoplasty groups, respectively), and the reasons for missing data were not reported. </p> <p><a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a> was judged to be at unclear risk of bias as the treatment group of four participants excluded from the analysis due to refusal to complete two‐week follow‐up was not reported. </p> <p><a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a> was judged to be at unclear risk of bias because no data were presented for six participants who had been randomised. Two participants were excluded due to malignancy on biopsy and four were excluded due to receipt of further surgery during follow‐up. The type of surgery was not specified and the treatment allocation of these exclusions was not reported. </p> <p><a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a> had small and similar loss to follow‐up across treatment groups at three and 12 months. </p> <p><a href="./references#CD006349-bbs2-0020" title="HaoD , GuoH , WangB , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal; http://eposterlyon.eurospine.org/cm_data/eposter/P17.PDF. 2014; Vol. 23, Issue 5:Supplement, pp 527‐557. HaoD , WangB , GuoH , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal2014;23(1):S533. WangB , GuoH , YuanL , HuangD , ZhangH , HaoD . A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. European Spine Journal2016;25:3486‐94. [DOI: 10.1007/s00586‐016‐4425‐4] ">Wang 2016</a> reported that 8/108 (7.4%) in the vertebroplasty group and 3/109 (2.7%) in the facet joint injection group were lost to follow‐up. </p> <p><a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a> was judged to be at high risk of attrition bias as a greater number of participants were missing from the conservative treatment group compared with the vertebroplasty group (8/64 missing (13%) from vertebroplasty group and 15/66 missing (23%) from conservative treatment group). eight (12.1%) participants in the conservative treatment group received vertebroplasty, and two 2 (3%) had open surgery. </p> </section> <section id="CD006349-sec-0073"> <h4 class="title">Selective reporting</h4> <p>Four trials were assessed as at low risk of reporting bias (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a>; <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>; <a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a>), although <a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a> included an additional outcome of time (in days) to new clinical vertebral fracture that was not pre‐specified. </p> <p>Six trials were judged to be at unclear risk of reporting bias because they did not appear to have been registered in a trial registry and did not publish a trial protocol (<a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a>; <a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a>; <a href="./references#CD006349-bbs2-0013" title="LiuJT , LiCS , ChangCS , LiaoWJ . Long‐term follow‐up study of osteoporotic vertebral compression fracture treated using balloon kyphoplasty and vertebroplasty. Journal of Neurosurgery Spine2015;23(1):94‐8. LiuJT , LiaoWJ , TanWC , LeeJK , LiuCH . Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis International2010;21:359–64. ">Liu 2010</a>; <a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a>; <a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a>; <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a>; <a href="./references#CD006349-bbs2-0020" title="HaoD , GuoH , WangB , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal; http://eposterlyon.eurospine.org/cm_data/eposter/P17.PDF. 2014; Vol. 23, Issue 5:Supplement, pp 527‐557. HaoD , WangB , GuoH , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal2014;23(1):S533. WangB , GuoH , YuanL , HuangD , ZhangH , HaoD . A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. European Spine Journal2016;25:3486‐94. [DOI: 10.1007/s00586‐016‐4425‐4] ">Wang 2016</a>; <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a>). In addition <a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a>, only reported one‐day outcomes for mean pain. </p> <p><a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a> was judged to be at unclear risk of reporting bias because adverse events were only reported for the vertebroplasty group and mean pain and quality of life and confidence intervals were reported graphically only. </p> <p><a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a> was judged to be at high risk as the trialists did not report summary statistics for pain and function (only the P value to indicate if there were statistical differences between treatments). Further, the trial did not appear to have been registered and no protocol was published. </p> <p><a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a> was judged to be at unclear risk of reporting bis as it was unclear if any additional outcomes were measured and not reported. </p> <p><a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a> was judged to be at high risk of reporting bias for several reasons. The primary outcome was inconsistently reported in the published protocol as both the proportion of patients whose numerical rating scale (NRS) pain score reduced from 7/10 (or more) to 4/10 (or less) at 14 days, and the proportion of patients achieving a 14‐day pain score of less than four out of 10. The results paper states that the primary endpoint is the proportion of patients achieving an NRS pain score of less than four out of 10. In addition, several outcomes were pre‐specified in the published protocol but not reported in the results paper and several outcomes reported in the results paper were not pre‐specified. </p> <p><a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a> was judged to be at high risk of reported bias as adverse events were to be measured but were not reported. </p> <p><a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a> was judged to be at unclear risk of reporting bias as no registration or protocol were found although all outcomes reported in the methods were presented in the results. </p> <p><a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a> was judged to be at high risk of reporting bias as additional outcomes that were not pre‐planned according to the trial protocol were reported (proportion with pain VAS score ≥ five at 12 months follow up, progressive loss of vertebral body height of treated fractures (defined as ≥4 mm), and incident fractures (not defined). </p> <p><a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a> was judged to be at high risk of report bias because in a published congress abstract of the same trial it was reported that pain intensity on a visual analogue scale (VAS) and disability assessed by the Oswestry Disability Index (ODI) were measured, but only baseline pain was presented in the published paper. In addition, the trial registration information could not be located. </p> <p><a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a> was judged to be at high risk of bias because the number of participants with an incident clinical vertebral fracture was only reported for the vertebroplasty group and measures of variance were not reported for continuous outcomes. </p> <p><a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a> was judged to be at unclear risk of bias because pain on a NRS and spirometry were not reported. </p> </section> <section id="CD006349-sec-0074"> <h4 class="title">Other potential sources of bias</h4> <p>No other sources of bias were detected for 11 trials (<a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a>; <a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a>; <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>; <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a>; <a href="./references#CD006349-bbs2-0013" title="LiuJT , LiCS , ChangCS , LiaoWJ . Long‐term follow‐up study of osteoporotic vertebral compression fracture treated using balloon kyphoplasty and vertebroplasty. Journal of Neurosurgery Spine2015;23(1):94‐8. LiuJT , LiaoWJ , TanWC , LeeJK , LiuCH . Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis International2010;21:359–64. ">Liu 2010</a>; <a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a>; <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>; <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a>; <a href="./references#CD006349-bbs2-0020" title="HaoD , GuoH , WangB , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal; http://eposterlyon.eurospine.org/cm_data/eposter/P17.PDF. 2014; Vol. 23, Issue 5:Supplement, pp 527‐557. HaoD , WangB , GuoH , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal2014;23(1):S533. WangB , GuoH , YuanL , HuangD , ZhangH , HaoD . A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. European Spine Journal2016;25:3486‐94. [DOI: 10.1007/s00586‐016‐4425‐4] ">Wang 2016</a>; <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a>). </p> <p><a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a> did not report on the number of 'prophylactic' vertebroplasties that were performed in the vertebroplasty group and did not specify a source of funding. </p> <p>In <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>, the description of the placebo procedure differed between the published protocol and results papers. The protocol states that a 4‐mm skin incision will be made with light tapping on the skin. The results paper states that a short needle was passed into the skin incision but not as far as the periosteum and that manual skin pressure and regular tapping on the needle was done to mimic vertebroplasty needle advance. </p> <p><a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a> was sponsored by a device company which also contributed to study design, data monitoring, statistical analysis and reporting of results including manuscript authorship, paid for independent core laboratory and data safety‐monitoring board services, and terminated the study early. </p> <p>Although <a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a> reported that there were no significant differences in baseline characteristics or planned vertebral treatment levels between treatment groups at baseline, participants in the vertebroplasty group appeared to be older on average than participants in the two other groups (71.3 versus 63.3 and 67.1 years in the balloon and shield vertebroplasty groups, respectively). In addition, participants in the kyphoplasty groups also appeared to have worse pain and disability scores at baseline compared to the vertebroplasty group (vertebroplasty: 78.2 and 68.2; balloon kyphoplasty: 90.0 and 77.0; and shield kyphoplasty 88.16 and 75.7, respectively). They also did not state whether BioMedEs had any role in the study other than funding translation and copy‐editing. </p> <p>In <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a> the approach, device, and cement used for both the vertebroplasty and kyphoplasty procedures were at the operators’ discretion. </p> <p>Quality of life and disability were worse at baseline in the vertebroplasty group in <a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a>, which may have biased the results in favour of the vertebroplasty group. </p> <p>In the trial by <a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a>, baseline pain was higher in the usual care group (8.8 versus 7.5) and it was only measured in 17/24 and 19/25 participants in the usual care and vertebroplasty‐treated groups, respectively. In addition, participants receiving usual care were hospitalised for longer (11.7 days versus 7.6 days); it is unclear if more pain medication and physiotherapy was offered, and how this would affect outcomes. </p> <p><a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a> reported that Soteira Inc. (Natick, MA) funded the trial and provided the Cement Directed Kyphoplasty Systems but whether or not it had any other role in the trial was not explicitly reported. </p> <p>In <a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a>, eight participants withdrew after randomisation as they were not assigned to their preferred treatment (two in the vertebroplasty group and six in the usual care group). </p> <p><a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a> was completed in April 2014 and results have not been published in a peer‐reviewed journal. Baseline pain at rest in the vertebroplasty group was lower than in the placebo group (40.55 (SE 4.55) compared with 53.04 (SE 4.35), P = 0.0476). This may have biased the results in favour of the placebo group. </p> </section> </section> <section id="CD006349-sec-0075"> <h3 class="title" id="CD006349-sec-0075">Effects of interventions</h3> <p>See: <a href="./full#CD006349-tbl-0001"><b>Summary of findings for the main comparison</b> Vertebroplasty for osteoporotic vertebral compression fracture</a> </p> <section id="CD006349-sec-0076"> <h4 class="title">Benefits</h4> <section id="CD006349-sec-0077"> <h5 class="title">1. Vertebroplasty versus placebo (sham)</h5> <p>We judged the five placebo‐controlled trials to be clinically similar with respect to baseline participant characteristics of mean pain, disability and quality of life, facilitating pooling of data in a meta‐analysis (see <a href="#CD006349-tbl-0003">Table 2</a>). Mean duration of symptoms ranged from less than three weeks to 20 weeks across treatment groups in the individual trials, however the influence of symptoms duration on treatment effect was investigated in a planned subgroup analysis (see below). The major outcomes for the primary comparison of vertebroplasty versus placebo (sham procedure) is shown in <a href="./full#CD006349-tbl-0001">summary of findings Table for the main comparison</a>. </p> <p>Statistical heterogeneity was moderate in the pooled analysis for pain at one to two weeks (I<sup>2</sup> = 35%), driven largely by the data from <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>, the only placebo‐controlled trial to have been judged as having unclear risk of performance bias and detection bias for participant‐reported endpoints. <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a> found a slight benefit in terms of pain relief with vertebroplasty, while the other studies found no evidence of an important difference with treatment. Heterogeneity was unimportant at the other time points. </p> <p>There was no evidence of important differences between groups with respect to mean pain at one to two weeks (five studies, 539 participants) and a small, clinically unimportant improvement with vertebroplasty at one month (five studies, 535 participants), (mean difference (MD) and 95% confidence interval (95% CI) (MD ‐0.25 0 to 10, 95% CI ‐0.82 to 0.33; I<sup>2</sup> = 35%) at one to two weeks and MD ‐0.73 0 to 10, 95% CI ‐1.18 to ‐0.28; I<sup>2</sup> = 0%) at one month, on a 0 to 10 point pain scale) (<a href="./references#CD006349-fig-0004" title="">Analysis 1.1</a>). </p> <p>At one month, mean pain was five points on a zero to 10 scale with placebo and 0.7 points lower (0.3 lower to 1.2 lower) with vertebroplasty, an absolute pain reduction of 7% (3% better to 12% better) and relative reduction of 10% (4% better to 17% better) (<a href="./full#CD006349-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>Based upon four trials (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>; <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>; <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>), there was no evidence of important differences between groups in pain at three months (SMD ‐0.19, 95% CI ‐0.39 to 0.00, 395 participants), which translates to a mean reduction of 0.44 points (95% CI 0.90 to 0) on a 10‐point VAS scale. </p> <p>Based upon three trials (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>; <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>), there was no evidence of important differences between groups in pain at six months (SMD ‐0.22 (‐0.43 to ‐0.00), 338 participants), which translates to a mean reduction of 0.51 points (95% CI ‐0.99 to 0.00) on a 10‐point VAS scale. Based upon data from three trials (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>; <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>), there was no evidence of important differences between groups in pain at 12 months (SMD ‐0.17 (‐0.41 to 0.07, 265 participants), which translates to a mean reduction of 0.37 points (95% CI ‐0.94 to 0.16) on a 10‐point VAS scale; and based on data from a single trial (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>), no differences at 24 months were observed (MD ‐1.10 points on a zero to 10 VAS scale, 95% CI ‐2.68 to 0.48, 57 participants), although the lower limit of the 95% CI means that an important difference can neither be confirmed or excluded. </p> <p>We combined data from three trials that included a measure of the proportion of participants whose pain improved from baseline by a 'clinically important' amount although the definitions varied by trial (&gt; 2.5 units from baseline (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>), 30% or more from baseline (<a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>), four or less out of 10 (<a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>; <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>)). Statistical heterogeneity was moderate to substantial at one to two weeks (I<sup>2</sup> = 51%), and one month (I<sup>2</sup> = 61%), but was unimportant at other time points that included combined data. Similar to the data for mean pain, this appeared to be driven by data from <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>, which showed a benefit in terms of this outcome, while the other studies found no evidence of important differences with treatment. There was a benefit of vertebroplasty only at three, six and 12 months although the effect estimates were all greater than one: one to two weeks (data from two trials (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>): vertebroplasty: 38/99 versus placebo: 26/99, RR 1.43, 95% CI 0.78 to 2.60); one month (data from three trials (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>; <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>): vertebroplasty: 89/166 versus placebo: 56/160, RR 1.53, 95% CI 0.99 to 2.36); three months (data from two trials (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>): vertebroplasty: 48/99 versus placebo: 30/99, RR 1.60, 95% CI 1.12 to 2.30); six months (data from two trials (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>): vertebroplasty: 54/99 versus placebo: 39/99, RR 1.38, 95% CI 1.02 to 1.87); 12 months (data from two trials (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>): vertebroplasty: 75/114 versus placebo: 59/116, RR 1.29, 95% CI 1.06 to 1.58); and 24 months (data from one trial (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>): vertebroplasty: 19/38 versus placebo: 14/40, RR 1.43, 95% CI 0.84 to 2.42)(<a href="./references#CD006349-fig-0005" title="">Analysis 1.2</a>). These results may be sensitive to different cut‐off values (e.g. if <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a> had utilised a cut‐off pain score of four or less out of 10 for this outcome as also stated in their protocol, rather than &lt; 4 out of 10). </p> <p>We could combine data for up to four trials at any time point for back‐related disability (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>; <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>; <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>). Statistical heterogeneity for disability was moderate to substantial in the pooled analysis at one to two weeks (I<sup>2</sup> = 41%) and three months (I<sup>2</sup> = 59%), and substantial to considerable six months (I<sup>2</sup> = 62%) but was zero at one month. </p> <p>With respect to disability (measured with the RMDQ [zero to 23 scale]), there was a small, clinically unimportant improvement with vertebroplasty at one month (4 studies, 472 participants, MD ‐1.50, 95% CI ‐2.61 to ‐0.38). </p> <p>At one to two weeks (four studies, 475 participants), the MD 0.21 points (95% CI ‐1.23 to 1.65); at three months (three studies, 333 participants) the MD was ‐0.81 points (95% CI ‐3.15 to 1.52); and at six months (three studies, 324 participants), the MD was ‐1.82 points (95% CI ‐4.12 to 0.47) (<a href="./references#CD006349-fig-0006" title="">Analysis 1.3</a>). While the lower 95% CIs in the analyses at three and six mohts means that an important difference between groups can neither be confirmed or refuted, these results were largely driven by the data from <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>, which had unclear risk of performance bias and detection bias for participant‐reported endpoints. </p> <p>There was no evidence of important between‐group differences in RMDQ scores at 12 months, based opon data from two trials (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>) (MD 0.12, 95% CI ‐1.56 to 1.80; 200 participants) and 24 months based upon data from one trial (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-fig-0006" title="">Analysis 1.3</a>). Data from the fifth trial did not measure disability by the RMDQ, but did report SF‐36 physical function data for three and 12 months and also observed no important differences between groups (data not shown) (<a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>). </p> <p>At one month, the mean RMDQ was 14 points with placebo group and 1.5 points lower (0.4 lower to 2.6 lower) in the vertebroplasty group, an absolute improvement in disability of 7% (1% better to 11% better) and relative improvement of 9% (2% better to 15% better) (<a href="./full#CD006349-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>We could combine data from up to three trials at any time point for vertebral fracture or osteoporosis‐specific health‐related quality of life (measured by the QUALEFFO). Statistical heterogeneity was unimportant at one month, six months and 12 months (I<sup>2</sup> &lt; 40%) and moderate at one to two weeks follow‐up (I<sup>2</sup> = 49%) and six three months (I<sup>2</sup> = 48%) There was no difference in vertebral fracture or osteoporosis‐specific health‐related quality of life (measured by the QUALEFFO) between vertebroplasty compared with placebo at one to two weeks (three studies, 352 participants): MD ‐3.10 (95% CI ‐6.96 to 0.75); at one month (three studies, 351 participants): MD ‐2.33, 95% CI ‐6.06 to 1.41); at three months (two studies, 244 participants): MD ‐0.42 (95% CI ‐4.23 to 3.39); at six months (three studies, 330 participants): MD ‐1.88 (95% CI ‐6.66 to 2.91); at 12 months (two studies, 219 participants): MD was ‐1.32 (95% CI ‐5.41 to 2.77); and at 24 months (one study, 57 participants), the MD was 1.30 (95% CI ‐5.48 to 8.08) at (<a href="./references#CD006349-fig-0007" title="">Analysis 1.4</a>). </p> <p>At one month, mean QUALEFFO was 62 points (0 to 100 point scale, where 0 is best quality of life) with placebo and 2.3 points better (1.4 points worse to 6.7 points), an absolute imrovement of 2% (1% worse to 6% better); relative improvement 4% better (2% worse to 10% better (<a href="./full#CD006349-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>One trial found no evidence of important differences between groups in treatment success up to 24 months (<a href="./references#CD006349-fig-0008" title="">Analysis 1.5</a>). </p> <p>There were no important differences between groups with respect to overall quality of life (measured with the EQ5D): MD 0.01 (95% CI ‐0.03 to 0.05) at one to two weeks (two studies, 164 participants); MD 0.05 (95% CI 0.01 to 0.09); at one month (three studies, 285 participants); MD 0.04 (95% CI ‐0.00 to 0.08); at three months (three studies, 203 participants); MD 0.06 (95% CI 0.01 to 0.10); at six months (two studies, 156 participants); MD ‐0.05 (95% CI ‐0.17 to 0.07); at 12 months (two studies, 93 participants); MD 0.00 (95% CI ‐0.24 to 0.24); at 24 months (one study, 44 participants) (<a href="./references#CD006349-fig-0009" title="">Analysis 1.6</a>). </p> </section> <section id="CD006349-sec-0078"> <h5 class="title">2. Vertebroplasty versus usual care</h5> <p>The eight trials that compared vertebroplasty with usual care included participants with similar levels of baseline pain and disability and gender distribution was also similar across trials (see <a href="#CD006349-tbl-0003">Table 2</a>). Although one trial included younger participants (<a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a>), and the duration of symptoms varied from one week to six months, we judged that the trials were sufficiently clinically homogenous to allow data to be pooled. Data for pain and function from <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a> could not be included in meta‐analyses as means and variance were not reported. In instances where analyses within a single data plot required a mix of MD and SMD analyses, we have shown the SMD in the plots and present both the SMD and MD in the results. For clarity, we have indicated where the MD was back‐transformed from the SMD to MD (either because <a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a> was included together with other trials in the same meta‐analysis for mean pain or because both RMDQ and ODI were included in the same meta‐analysis for disability). </p> <p>Based upon data from up to six trials, participants in the vertebroplasty group had greater improvement in mean pain compared with those in the usual care group at one to two weeks (six trials, 627 participants, SMD ‐1.33 (95% CI ‐2.26 to ‐0.39), back‐transformed MD ‐2.13 (95% CI ‐3.62 to ‐0.62); one month (three trials, 384 participants), SMD ‐2.06 (95% CI ‐3.35 to ‐0.76), back‐transformed MD ‐3.30 (95% CI ‐5.36 to ‐1.22); three months (six trials, 627 participants, SMD ‐1.18 (95% CI ‐1.95 to ‐0.40), back‐transformed MD ‐1.89 (95% CI ‐3.12 to ‐0.64); six months (five trials, 573 participants, SMD ‐1.05 95% CI ‐1.82 to ‐0.28), back‐transformed MD ‐1.68 (95% CI ‐2.91 to ‐0.45); and 12 months (six trials, 612 participants, SMD ‐1.02 (95% CI ‐1.74 to ‐0.30), back‐transformed MD ‐1.63 (95% CI ‐2.78 to ‐0.48) (<a href="./references#CD006349-fig-0010" title="">Analysis 2.1</a>). However there was considerable statistical heterogeneity across all pooled pain analyses with the I<sup>2</sup> varying between 94% and 96%. Removing single trials from each analysis did not appreciably alter the results. At 24 months there was no evidence of important differences between groups in mean pain based upon one trial (77 participants, SMD ‐0.45 (95% CI ‐0.90 to 0.01) or MD ‐0.90 (95% CI ‐1.79 to ‐0.01). </p> <p>There was no evidence of important differences between groups in the proportion of participants who reported moderate or severe residual pain at 12 months (vertebroplasty: 36% and 19%; usual care 34% and 18%, respectively) in one trial (<a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a>). </p> <p>Based upon data from up to five trials, improvement in disability also favoured the vertebroplasty group at one to two weeks (five trials, 494 participants) SMD ‐2.06 (95% CI ‐3.28 to ‐0.83), back‐transformed (0 to 23 RMDQ scale) MD ‐8.65 (95% CI ‐13.78 to ‐3.49); one month (three trials, 378 participants) SMD ‐1.52 (95% CI ‐3.00 to ‐0.04), back‐transformed MD ‐6.38 (95% CI ‐12.60 to ‐0.17); three months (four trials, 460 participants) SMD ‐2.76 (95% CI ‐4.65 to ‐0.87), back‐transformed MD ‐11.59 (95% CI ‐19.53 to ‐2.09); six months (four trials, 461 participants) SMD ‐1.84 (95% CI ‐3.37 to ‐0.30), back‐transformed MD ‐7.73 (95% CI ‐14.15 to ‐1.26); 12 months (four trials, 455 participants) SMD ‐1.59 (95% CI ‐2.79 to ‐0.38), back transformed MD ‐6.68 (95% CI ‐11.72 to ‐0.91); and 24 months (one trial, 77 participants) SMD ‐5.65 (95% CI ‐6.67 to ‐4.63) and MD ‐12.00 points on 0 to 100 ODI scale (95% CI ‐12.94 to ‐11.06) (<a href="./references#CD006349-fig-0011" title="">Analysis 2.2</a>). Considerable statistical heterogeneity was also present for all analyses (I<sup>2</sup> ranging from 97% to 98%). Data from the sixth trial did not measure disability by the RMDQ or ODI, but did report SF‐36 physical function data for three and 12 months and observed no important differences between groups (data not shown) (<a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a>). </p> <p>There was no significant between‐group differences with respect to vertebral fracture or osteoporosis‐specific quality of life at any time point measured by the QUALEFFO, based upon data from up to four trials (one to two weeks: four trials, 448 participants, MD ‐5.67 (95% CI ‐11.65 to 0.32); one month: two trials, 289 participants, MD ‐10.18 (95% CI ‐21.49 to 1.13); three months: three trials, 415 participants, MD ‐5.83 (95% CI ‐15.41 to 3.75); six months: three trials, 415 participants, (MD ‐5.14 (95% CI ‐15.02 to 4.74); and 12 months: three trials, 415 participants, MD ‐3.40 (95% CI ‐9.90 to 3.11)) (<a href="./references#CD006349-fig-0012" title="">Analysis 2.3</a>). Considerable statistical heterogeneity was also present for all analyses (I<sup>2</sup> varying between 83% and 95%). </p> <p>Overall quality of life measured by the EQ‐5D marginally favoured the vertebroplasty group at one to two weeks (one trial, 183 participants, MD 0.08 (95% CI 0.00 to 0.15)); one month (one trial, 183 participants, MD 0.09 (95% CI 0.01 to 0.16)); and three months (two trials, 215 participants, MD 0.10 (95% CI 0.00 to 0.20)), but not six months (one trial, 183 participants, MD 0.07 (95% CI ‐0.02 to 0.15)) or 12 months (two trials, 215 participants, MD 0.07 (95% CI ‐0.00 to 0.14))(<a href="./references#CD006349-fig-0013" title="">Analysis 2.4</a>). Statistical heterogeneity was unimportant for the pooled analyses (I<sup>2</sup> 0% to 22%). </p> <p>Treatment success was reported in one trial (<a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a>) at 12 months (RR 1.43, 95% CI 1.03 to 1.98). </p> </section> <section id="CD006349-sec-0079"> <h5 class="title">3. Vertebroplasty versus kyphoplasty</h5> <p>No efficacy data relevant to this review could be extracted from <a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a>. The aim of this trial was to compare leakage rates between treatment groups and only vertebral height and wedge angle were measured as efficacy outcomes. Only one of the four trials reported an <i>a priori</i> sample size calculation (<a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a>). However this trial was terminated after recruiting 404 of the planned sample size of 1234 participants. </p> <p>Based upon data from up to four trials, there was no evidence of important differences between groups in pain at all time points: MD ‐0.06 (95% CI ‐0.37 to 0.25) at one to two weeks (two trials, 462 participants); MD ‐0.05 (95% CI ‐0.59 to 0.48) at one month (two trials, 441 participants); MD 0.14 (95% CI ‐0.11 to 0.39) at three months (two trials, 419 participants); MD ‐0.04 (95% CI ‐0.31 to 0.22) at six months (three trials, 230 participants); MD 0.16 (95% CI ‐0.07 to 0.40) at 12 months (four trials, 558 participants); MD ‐0.15 (95% CI ‐0.56 to 0.27) at 24 months (two trials, 320 participants) (<a href="./references#CD006349-fig-0015" title="">Analysis 3.1</a>). Statistical heterogeneity was unimportant for all analyses (I<sup>2</sup> varying between 0% and 7%). </p> <p>Based upon data from up to four trials, there was no evidence of important differences between groups in degree of improvement in disability at all time points: one to two weeks (one trial, 98 participants) MD (0 to 100 ODI scale) 0.10 95% CI ‐2.12 to 2.32); one month (two trials, 425 participants) SMD ‐0.11 (95% CI ‐0.30 to 0.08), back‐transformed to 0 to 23 RMDQ scale: MD ‐0.73 (95% CI ‐1.98 to 0.53); three months (two trials, 399 participants) MD 0.52 (95% CI ‐1.53 to 2.58); six months (one trial, 93 participants) SMD ‐0.06 (95% CI ‐0.46 to 0.35), back‐transformed MD ‐0.40 (95% CI ‐3.03 to 2.31); 12 months (four trials, 542 participants) SMD 0.00 (95% CI ‐0.16 to 0.17), back‐transformed MD 0.00 (95% CI ‐1.06 to 1.12); and 24 months (one trial, 201 participants) MD ‐1.30 (95% CI ‐6.45 to 3.85) (<a href="./references#CD006349-fig-0016" title="">Analysis 3.2</a>). Statistical heterogeneity was unimportant for all analyses (I<sup>2</sup> = 0%). </p> <p>Based upon up to two trials, there was also no evidence of important differences between groups in degree of improvement in overall quality of life at one, three, six, 12 or 24 months (<a href="./references#CD006349-fig-0017" title="">Analysis 3.3</a>). </p> </section> <section id="CD006349-sec-0080"> <h5 class="title">4. Vertebroplasty versus facet joint injection</h5> <p>Based upon one trial that compared vertebroplasty with facet joint injection with glucocorticosteroid and local anaesthetic, vertebroplasty was reported to be superior to facet joint injection with respect to improvement in pain on a zero‐ to 10‐point scale (MD ‐1.61, 95% CI ‐1.84 to ‐1.38, 206 participants) and disability on the RMDQ 0 to 23‐point scale (MD ‐3.42, 95%CI ‐3.72 to ‐3.12, 206 participants) at one week (<a href="./references#CD006349-fig-0018" title="">Analysis 4.1</a>; <a href="./references#CD006349-fig-0019" title="">Analysis 4.2</a>). There was no evidence of important differences between groups at other time points up to 12 months in pain or disability or quality of life (not reported at the one‐ to two‐week time point). </p> </section> </section> <section id="CD006349-sec-0081"> <h4 class="title">Harms</h4> <section id="CD006349-sec-0082"> <h5 class="title">1. Vertebroplasty versus placebo (sham) or usual care</h5> <section id="CD006349-sec-0083"> <h6 class="title">New clinically apparent and new radiographic fractures</h6> <p>Based upon six trials (control group was placebo for one trial and usual care for the other trials), there were slightly more new clinically apparent vertebral fractures up to 12 to 24 months in the vertebroplasty group (48 fractures in 418 participants (pooled incidence 95 per 1000) in comparison with the control group (31 fractures in 422 participants (73 per 1000)), but this was not statistically significant (RR 1.29 (95% CI 0.46 to 3.62)) (<a href="./references#CD006349-fig-0021" title="">Analysis 5.1</a>). There was substantial statistical heterogeneity (I<sup>2</sup> 70%), and clinical diversity: apart from different comparators, the trials also varied in terms of the age of participants (average age was younger in one trial), duration of follow up, and symptom duration which varied from a mean of nine to 20 weeks. </p> <p>There were no evidence of important differences between groups in the number of new radiographic vertebral fractures up to 12 to 24 months based upon eight trials (vertebroplasty: 110 fractures in 411 participants (26.8%), control: 93 fractures in 393 participants (23.7%); RR 1.14 (95% CI 0.71 to 1.84) (control was placebo in four trials and usual care in four trials) (<a href="./references#CD006349-fig-0022" title="">Analysis 5.2</a>). However there was substantial statistical heterogeneity in the pooled analysis (I<sup>2</sup> 67%). Similar to the above analyses, other than the comparators, participants in the individual trials differed mainly with respect to symptom duration (ranging from mean duration of less than a week to 20 weeks). </p> </section> <section id="CD006349-sec-0084"> <h6 class="title">Other serious adverse events</h6> <p>Data from the three placebo‐controlled trials (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>; <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>) and two usual care‐controlled trials (<a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a>; <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a>) could be pooled. Based upon these trials, there were no significant between‐group differences in the number of other serious adverse events (vertebroplasty: 16/408, placebo: 23/413; RR 0.61 (95% CI 0.33 to 1.10)(<a href="./references#CD006349-fig-0023" title="">Analysis 5.3</a>). Excluding <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a>, who reported serious adverse events that appeared unrelated to the treatment (e.g. depression, pneumonia, sleep disturbance), the results trended towards favouring the control group RR 1.26 (95% CI 0.41 to 3.88). However, several trials reported serious adverse events related to vertebroplasty. </p> <p><a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a> reported that three participants reported new rib fractures (one in the vertebroplasty group and two in the placebo group) and one participant who received vertebroplasty developed an adjacent new fracture and osteomyelitis requiring surgical drainage and antibiotic therapy. Nine other adverse events were reported in the vertebroplasty group up to one month (chest pain (three participants), pain or burning in thigh or leg (three participants), tightness in the back or rib cage (one participant), stomach pain (one participant), increased pain or muscle cramping around puncture site (one participant)) compared to one in the placebo group (pain or burning in thigh or leg (one participant)). </p> <p><a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a> reported that one patient had a respiratory arrest after administration of sedation, before starting the procedure. The patient was resuscitated and underwent the trial procedure two days later without incident. Another patient sustained a supracondylar humerus fracture in a paretic arm during transfer onto the radiology table. The fracture healed with a plaster cast. </p> <p><a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a> reported that one participant in the vertebroplasty group had an injury to the thecal sac during the procedure requiring hospitalisation while one participant in the placebo group was also hospitalised overnight due to tachycardia and rigours of unknown cause. </p> <p><a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a> reported that two participants required atropine because of pain‐induced vasovagal reactions during the vertebroplasty procedure and a third participant developed an acute asthma exacerbation that led to stopping the procedure, although it was successfully completed one week later. These data could not be included in the pooled analysis as no adverse event data were reported for the usual care group. They also reported that asymptomatic cement leakage occurred in 97 of the 134 treated vertebrae (72%); most leakages were discal or into segmental veins and in one participant there was asymptomatic cement migration towards the lungs. </p> <p><a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a> reported that one participant in the usual care group who crossed over and received vertebroplasty after two weeks developed acute pain following the procedure due to an intrapedicular cement spur that broke upon manipulation by the bone biopsy needle causing a small cortical chip fracture at the medial border of the pedicle. </p> <p><a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a> reported that one participant who received vertebroplasty developed severe right lower extremity pain and weakness due to epidural cement leakage which required immediate decompression through a bilateral laminectomy and evacuation of bone cement. After two months there was no radicular pain and the participant could walk unassisted. They reported that there were no instances of venous emboli or infection. </p> <p><a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a> reported that asymptomatic cement leakage into the veins/discs during vertebroplasty occurred in 49% of procedures. </p> <p><a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a> reported that asymptomatic cement leakage occurred in 36 out of 69 (52%) treated vertebrae: intervertebral disc in eight participants (22%), puncture path in seven participants (19%), paravertebral space in nine participants (25%) and venous leakage in 12 participants (33%). There was asymptomatic cement migration into the venous system towards the lungs in two participants (2.9%). </p> </section> </section> <section id="CD006349-sec-0085"> <h5 class="title">2. Vertebroplasty versus kyphoplasty</h5> <section id="CD006349-sec-0086"> <h6 class="title">New clinically apparent and radiographic fractures</h6> <p><a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a> reported 50/190 new clinically apparent vertebral fractures among participants who received vertebroplasty and 38/191 among those who received kyphoplasty over the course of the trial (RR 1.32 (95% CI 0.91 to 1.92)) (<a href="./references#CD006349-fig-0024" title="">Analysis 6.1</a>). Seventeen new clinical fractures were reported to have occurred within 30 days of vertebroplasty and nine within 30 days of kyphoplasty. One participant developed a new symptomatic vertebral fracture within two days of receiving vertebroplasty at the level below the procedure associated with inferior cement leakage, and it was considered to be possibly bone cement‐related. </p> <p>There was no evidence of important differences between groups in the number of new radiographic vertebral fractures at 12 months based upon two trials (vertebroplasty: 58 fractures in 181 participants (32.0%), control: 54 fractures in 191 participants (28.3%); RR 0.81 (95% CI 0.21 to 3.17)(<a href="./references#CD006349-fig-0025" title="">Analysis 6.2</a>). At 24 months, based upon data from one trial (<a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a>) there were reported to be 64/111 new radiographic vertebral fractures in the vertebroplasty group and 54/110 in the kyphoplasty group (RR 1.17 (95% CI 0.92 to 1.51)). The denominators reported in both these analyses differed from the numbers reported to have completed 12‐ and 24‐month follow‐up in both groups according to the flow diagram in the published reports. </p> <p><a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a> reported that there were no adjacent vertebral fractures in any of the three treatment groups (vertebroplasty, balloon or shield kyphoplasty) up to six months. </p> <p><a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a> reported that one participant in the shield kyphoplasty group experienced a symptomatic refracture at the treated level (and was retreated with vertebroplasty), while there were no refractures in the vertebroplasty group up to 12 months. They also reported that three adjacent level fractures were detected in one participant in the vertebroplasty group (3/39 levels treated, 7.7%) compared with two adjacent fractures in two participants (2/65 levels treated, 3.1%) in the kyphoplasty group up to 12 months. </p> </section> <section id="CD006349-sec-0087"> <h6 class="title">Other serious adverse events</h6> <p><a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a> reported device/procedure/anaesthesia‐related (or possibly related) adverse events among 11 participants in the vertebroplasty group and 12 in the kyphoplasty group (RR 0.91, 95% CI 0.42 to 1.97, <a href="./references#CD006349-fig-0026" title="">Analysis 6.3</a>). Most of these occurred within 30 days of the procedures. Adverse events considered to be serious and related (or possibly related) to the anaesthesia included constipation (one kyphoplasty), procedural hypotension (one kyphoplasty), nausea/vomiting (one kyphoplasty), hypersensitivity (one vertebroplasty), postoperative change in mental status (one vertebroplasty), hallucination (one kyphoplasty), exacerbation chronic airways disease (one kyphoplasty), hypoxia (one vertebroplasty), and respiratory failure (one vertebroplasty). Adverse events considered serious and bone cement‐related (or possibly related) included symptomatic cement embolism (one in each group). Three participants in each group had procedural pain considered to be device‐related (or possible related) adverse events (4/4 and 2/3 were judged as serious events in the vertebroplasty and kyphoplasty groups, respectively). Other adverse events reported to be considered serious and device‐related (or possible related) included spinal fracture (one kyphoplasty), symptomatic vertebral fracture (two vertebroplasty, one kyphoplasty) (the distinction between these two adverse events was not clear), back pain (three vertebroplasty, two kyphoplasty), arthralgia (one kyphoplasty) and muscle spasm (one kyphoplasty). </p> <p>Additionally, one participant who received vertebroplasty developed implant site extravasation into the spinal canal considered non serious. A computed tomography (CT) scan demonstrated no significant canal stenosis and the participant required no medical intervention. One participant who received vertebroplasty also developed a haematoma, considered non serious and possibly related to the procedure as a result of lying prone on the operating table. No deaths were noted as device‐ or procedure‐related. </p> <p><a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a> reported that there were no other serious adverse events in the vertebroplasty group but two in the kyphoplasty group (RR 0.20, 95% CI 0.01 to 4.14, <a href="./references#CD006349-fig-0026" title="">Analysis 6.3</a>). One patient experienced severe discogenic back pain related to a disk leak and finally underwent discectomy with posterior spinal fusion. Another patient experienced an asymptomatic cement emboli in the right lung related to venous leakage. </p> <p><a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a> reported that no clinically relevant adverse events were observed in any of the three treatment groups. No clinically relevant complications arose from cement leakage in any of the three treatment groups and there were no significant differences in cement leakage between groups (vertebroplasty: four lateral and four disc leakages; balloon kyphoplasty: three lateral and one disc; shield kyphoplasty: one disc). </p> <p><a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a> reported cement leakage in 9/54 (17%) vertebrae treated with vertebroplasty and 11/60 (18%) vertebrae treated with kyphoplasty. </p> <p><a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a> reported that two participants treated with vertebroplasty and four treated with shield kyphoplasty died during the course of the trial from causes unrelated to the interventions. No clinically relevant complications (or symptoms) were reported to have arisen from cement leakage in either treatment group. Shield kyphoplasty was reported to have resulted in significantly fewer cement leaks overall (six levels had multiple leaks with 42 total leaks compared with 12 levels with multiple leaks, total 54 leaks in the vertebroplasty group, P value reported 0.0132) and cement leaks per level (data only showed graphically in percentages, P value 0.0012), compared with the vertebroplasty group. </p> </section> </section> <section id="CD006349-sec-0088"> <h5 class="title">4. Vertebroplasty versus facet joint injection</h5> <section id="CD006349-sec-0089"> <h6 class="title">New fractures</h6> <p>One trial that evaluated vertebroplasty versus facet joint injection reported no difference in incident radiographic vertebral fractures at 12 months (13/100 in vertebroplasty group versus 11/106 in the facet joint injection group (RR 1.25; 95% CI 0.59 to 2.67; <a href="./references#CD006349-fig-0027" title="">Analysis 7.1</a>). </p> </section> </section> </section> <section id="CD006349-sec-0090"> <h4 class="title"><i>Subgroup Analysis</i> </h4> <p>Data from up to five placebo‐controlled trials were available for subgroup analysis comparing participants with pain duration 'acute' versus 'subacute'. Three trials only included acute fractures. This was defined as pain less than 6 weeks in <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>, and 8 weeks or less in <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>. <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a> altered their inclusion criteria from 6 weeks or less to 9 weeks or less after 6 months due to poor recruitment. Both <a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a> and <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a> performed post‐hoc subgroup analyses comparing data for participants with symptom duration of 6 weeks or less compared to more than 6 weeks. </p> <p>The subgroup analysis found no important differences in outcomes for acute versus subacute pain with respect to pain at one to two weeks (<a href="./references#CD006349-fig-0028" title="">Analysis 8.1</a>) or one month (<a href="./references#CD006349-fig-0029" title="">Analysis 8.2</a>), disability at one to two weeks (<a href="./references#CD006349-fig-0030" title="">Analysis 8.3</a>) or one month (<a href="./references#CD006349-fig-0031" title="">Analysis 8.4</a>), or quality of life at one month (<a href="./references#CD006349-fig-0032" title="">Analysis 8.5</a>). </p> <p>If we make an assumption that 'acute' fractures could only be defined as pain for 6 weeks or less, and thus exclude data from <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a> and <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a> from these analyses, this does not change the findings ‐ there are still no important differences in outcomes between participants with 'acute' fractures and those with 'subacute' fractures. </p> </section> <section id="CD006349-sec-0091"> <h4 class="title"><i>Sensitivity Analyses</i> </h4> <p>Including open trials comparing vertebroplasty with usual care altered the results, and the considerable statistical heterogeneity makes interpretation of these results difficult. In comparison to the lack of important between‐group differences when only placebo‐controlled trials were included in analyses, the addition of trials with a usual care control resulted in the analysis favouring vertebroplasty for all endpoints assessed in the sensitivity analysis with some differences possibly reaching clinically importance (pain at one to two weeks (11 trials, 1166 participants, SMD ‐0.76 (‐1.30 to ‐0.22), back‐transformed MD ‐1.75 (95% CI ‐2.99 to ‐0.51), I<sup>2</sup> 95%); one month (eight trials, 919 participants, SMD ‐0.94 (‐1.55 to ‐0.34), back‐transformed MD ‐2.16 (95% CI ‐3.57 to ‐0.78), I<sup>2</sup> 95%); and three months (10 trials, 1021 participants, SMD ‐0.78 (‐1.28 to ‐0.29), back‐transformed MD ‐1.79 (95% CI ‐2.94 to ‐0.67), I<sup>2</sup> 93%); disability at one to two weeks (eight trials, 793 participants, SMD ‐1.25 (‐2.06 to ‐0.43), back‐transformed MD ‐3.63 (95% CI ‐5.97 to ‐1.25) and I<sup>2</sup> 96%); one month (six trials, 674 participants, SMD ‐0.88 (‐1.60 to ‐0.17), back‐transformed MD ‐2.55 (95% CI ‐4.64 to 0.0.49), I<sup>2</sup> 95%) and three months (six trials, 622 participants, SMD ‐1.85 (‐3.08 to ‐0.61), back‐transformed MD ‐5.37 (95% CI ‐8.93 to ‐1.77), I<sup>2</sup> 98%). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006349-sec-0092" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006349-sec-0092"></div> <section id="CD006349-sec-0093"> <h3 class="title" id="CD006349-sec-0093">Summary of main results</h3> <section id="CD006349-sec-0094"> <h4 class="title">Vertebroplasty versus placebo (sham procedure)</h4> <p>Compared with placebo (sham vertebroplasty), high‐quality evidence based upon five trials (541 randomised participants, one trial with incomplete data reported) indicates that vertebroplasty provides no clinically important benefits with respect to pain, disability or disease‐specific quality of life, and moderate‐quality evidence of no benefits in terms of overall quality of life or treatment success up to one month (<a href="./full#CD006349-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>We did consider downgrading the evidence for all outcomes due to potential publication bias, however there is only one additional placebo‐controlled trial for which results are unavailable. We suspect that if the evidence from this trial becomes available, the conclusion is unlikely to change substantially. The evidence for quality of life and treatment success was downgraded from high to moderate due to imprecision but it is also unlikely that further data will alter our conclusions for these outcomes. </p> <p>At one month, mean pain (on a scale zero to 10, higher scores indicate more pain) was five points with placebo and 0.6 points better (0.2 better to 1 better) with vertebroplasty, an absolute pain reduction of 6% (2% better to 10% better, minimal clinical important difference is 15%) and relative reduction of 8% (3% better to 14% better) (five trials, 535 participants). At one month, mean disability measured by the Roland‐Morris Disability Questionnaire (RMDQ) (scale range zero to 23, higher scores indicate worse disability) was 14.2 points in the placebo group and 1.7 points better (0.3 better to 3.1 better) in the vertebroplasty group, absolute improvement in disability 7% (1% to 14% better), relative change 10% better (3% to 18% better) (four trials, 472 participants). </p> <p>At one month, disease‐specific quality of life measured by the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO) (scale zero to 100, higher scores indicating worse quality of life) was 62 points in the placebo group and 2.3 points better (1.4 points worse to 6.7 points better), an absolute imrovement of 2% (1% worse to 6% better); relative improvement 4% better (2% worse to 10% better) (three trials, 351 participants). At one month, overall quality of life measured by the EQ5D (0 = death to 1 = perfect health, higher scores indicate greater quality of life at one month was 0.38 points in the placebo group and 0.05 points better (0.01 better to 0.09 better) in the vertebroplasty group, absolute improvement in quality of life 5% (1% to 9% better), relative change 18% better (4% to 32% better) (three trials, 285 participants). Based upon one trial (78 participants) at one month, 9/40 (or 225 per 1000) people perceived that treatment was successful in the placebo group compared with 12/38 (or 315 per 1000; 95% CI 150 to 664) in the vertebroplasty group, RR 1.40 (95% CI 0.67 to 2.95), absolute risk difference 9% more reported success (11% fewer to 29% more); relative change 40% more reported success (33% fewer to 195% more). </p> <p>Based upon low‐quality evidence from six trials (one placebo, five usual care, 804 participants), with up to 24 months follow‐up, we are uncertain whether or not vertebroplasty increases the risk of new symptomatic vertebral fractures (95 per 1000; range 34 to 264) observed in the vertebroplasty group compared with 73 per 1000 in the control group; RR 1.29 (95% CI 0.46 to 3.62)). The evidence was downgraded due to imprecision and possibility of detection bias as most of the included trials for this comparison include a usual care comparator. </p> <p>Similarly, based upon low‐quality evidence from five trials (three placebo, two usual care, 821 participants), the risk of serious other adverse events may not differ (34 per 1000, range 18 to 62) were observed in the vertebroplasty group compared with 56 per 1000) in the control group; RR 0.61 (95% CI 0.33 to 1.10)). The evidence was downgraded due to imprecision and possibility of detection bias from two trials and one of these trials that reported serious adverse events probably unrelated to treatment. Notably, serious adverse events reported with vertebroplasty included osteomyelitis, cord compression, thecal sac injury and respiratory failure. </p> <p>Our subgroup analyses provided limited evidence that the effects did not differ according to 'acute' duration of pain (described variously amongst trials as &lt; 6 weeks, ≤ 6 weeks, ≤ 8 weeks, or ≤ 9 weeks) versus 'subacute' duration of pain (&gt; 6 weeks). </p> <p>pain duration 'acute' versus 'subacute'. Three trials only included acute fractures. This was defined as pain less than 6 weeks in <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>, and 8 weeks or less in <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>. <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a> altered their inclusion criteria from 6 weeks or less to 9 weeks or less after 6 months due to poor recruitment. Both <a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a> and <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a> performed post‐hoc subgroup analyses comparing data for participants with symptom duration of 6 weeks or less </p> <p>Including data from the eight trials that compared vertebroplasty with usual care in a sensitivity analyses altered the primary results towards favouring vertebroplasty, with all combined analyses displaying considerable heterogeneity, largely driven by the variation in results amongst the studies with a usual care comparison. These data are explainable on the basis that trials that used a usual care comparator are likely to have provided a biased overestimate of the benefits of vertebroplasty due to the lack of participant blinding. At all analysed time points (one to two weeks, one and three months), sensitivity analyses indicated significant differences in outcome for pain and disability outcomes for trials that included a placebo group in comparison to a usual care control. </p> </section> <section id="CD006349-sec-0095"> <h4 class="title">Vertebroplasty versus other comparators</h4> <p>Consistent with the sensitivity analysis, synthesis of the available data from up to six of the eight trials that compared vertebroplasty with usual care in an open design, generally favoured vertebroplasty with respect to pain and disability at all time points up to 24 months although there was considerable statistical heterogeneity across all pooled pain analyses with I<sup>2</sup> varying between 94% and 98%. There was no significant between‐group differences with respect to vertebral fracture or osteoporosis‐specific quality of life at any time point based upon data from up to four trials and these pooled data also displayed considerable statistical heterogeneity (I<sup>2</sup> varying between 83% and 95%). However, overall quality of life marginally favoured the vertebroplasty group up to three months but not six months and statistical heterogeneity was unimportant for these pooled analyses (I<sup>2</sup> 0% to 22%). </p> <p>Synthesis of the available data from up to three of the seven trials that compared vertebroplasty with kyphoplasty, indicate that there was no important differences between groups with respect to pain, disability or overall quality of life at any time point. Statistical heterogeneity was unimportant for all analyses (I<sup>2</sup> varying between 0% and 7%). There were also no detectable between‐group differences with respect to incident radiographic or symptomatic vertebral fractures, adjacent fractures or other serious adverse events. </p> <p>Based upon one trial that compared vertebroplasty with facet joint injection with glucocorticosteroid and local anaesthetic, vertebroplasty was reported to be superior to facet joint injection with respect to pain and disability at one week, and not superior for any outcomes at other time points up to 12 months. There was also no evidence of important differences between groups with respect to incident radiographic vertebral fractures at 12 months. </p> </section> </section> <section id="CD006349-sec-0096"> <h3 class="title" id="CD006349-sec-0096">Overall completeness and applicability of evidence</h3> <p>This review included evidence provided from 20 randomised controlled trials (RCTs) and one quasi‐RCT undertaken across 15 countries, to assess the effects of vertebroplasty compared with either placebo (sham) (five trials), usual care (eight trials), balloon or shield kyphoplasty (seven trials) and facet joint injection of glucocorticoid and local anaesthetic (one trial). Eight trials reported at least some funding from medical device companies who manufacture vertebral augmentation systems, and, of these, only two reported that they had no other role in the trial. </p> <p>Data from one placebo‐controlled trial has only been published as a thesis (<a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>). A second placebo‐controlled trial (<a href="./references#CD006349-bbs2-0052" title="NCT01963039 . A trial of vertebroplasty for painful chronic osteoporotic vertebral fractures (VERTOS V). clinicaltrials.gov/show/NCT01963039 First registered 28 August 2013. ">VERTOS V</a>), was recorded as completed in June 2015 at clinicaltrials.gov, but the trialists subsequently altered the recruitment status in January 2017 to state that the study is now 'enrolling by invitation', with a new estimated completion date of July 2018. </p> <p>With respect to trials that have used comparators other than placebo, we classified two as ongoing, although it is unclear if the trials are completed; an additional four have been reported to have been completed but we were unable to find published results; and another four completed RCTs that likely meet inclusion criteria have only been published in Chinese and are awaiting assessment. Inclusion of the results of these trials may alter the conclusions of our second and third comparisons (vertebroplasty compared with usual care or kyphoplasty, respectively). </p> <p>Vertebroplasties were performed by interventional radiologists or neuroradiologists, orthopaedic surgeons or neurosurgeons across the different trials, however the procedure itself appeared similar. Mean cement injected varied across the 17 trials that reported these data. The study populations in all included trials appeared to be representative of patients seen in routine care. The age and gender ratio were similar across all trials apart from <a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a>, who included a younger study population. However symptom duration did vary widely across trials reflecting different philosophies on when vertebroplasty should be implemented. Some authors have suggested that vertebroplasty only be offered to patients with recent onset of pain (&lt; 6 weeks) (<a href="./references#CD006349-bbs2-0061" title="BonoC , HeggenessM , MickC , ResnickD , Watters , WC3rd . North American SpineSociety: newly released vertebroplasty randomized controlled trials: a tale of two trials. Spine Journal2010;10(3):238‐40. ">Bono 2010</a>). Our subgroup analysis, as well as the result of an individual patient data meta‐analysis from the same two trials (<a href="./references#CD006349-bbs2-0114" title="StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ 2011;342:d3952.. BMJ2011;342:d3952. ">Staples 2011</a>), suggests that treatment outcome is not influenced by duration of pain ≤ 6 weeks versus &gt; 6 weeks. This supports our decision to include all trials in pooled analyses irrespective of symptom duration. </p> <p>Trials varied in how they measured pain with respect to the scale used (although most used a continuous measure), time period specified and descriptors used. Only four trials included a dichotomous measure of pain. All except two trials included a measure of disability or function, with the RMDQ used most commonly (9/21 trials). Seven trials included the QUALEFFO and six included an overall generic measure of quality of life. Only two trials included a measure of patient‐reported treatment success although three trials did report the number who achieved various thresholds of pain and/or disability improvement. Most trials reported on the presence of new symptomatic and/or radiologically apparent vertebral fractures (although two trials only considered adjacent fractures (<a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a>; <a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a>) and one of these also considered refracture of the treated vertebra (<a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a>). However other adverse events were less well‐reported across trials with three trials only reporting on adverse events that occurred in the vertebroplasty group. </p> <p>The RCTs included in this review also varied in terms of duration of follow‐up (from two weeks to three years). For one placebo‐controlled trial we only included data up to one month, despite the availability of one‐year data, because of an <i>a priori</i> decision that for cross‐over RCTs, we would preferentially extract data only from period before cross‐over. <a href="./references#CD006349-bbs2-0065" title="ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology 2‐13;269:224‐31. ">Comstock 2013</a> reported that after one month, significantly fewer participants in the vertebroplasty group crossed over into the alternate group (11 of 68 participants (16%)) compared with the placebo (sham) group (38 of 63 participants (60%), P = 0.001). At one year, difference in pain favoured the vertebroplasty group (MD 1.02 (95% CI: 0.04 to 2.01); P = 0.042), but there was no evidence of an important difference in disability (MD in RMDQ 1.37 points (95% CI: 3.62 to 20.88), P = .231). In the as‐treated analyses, participants treated with vertebroplasty did not differ from the placebo (sham) group in terms of either mean pain (MD 0.85 (95% CI: 2.05 to 20.35), P = 0.166) or disability (RMDQ, MD 0.66 (95% CI: 3.30 to 21.98); P = 0.625). Therefore, including data from the one‐year intention‐to‐treat (ITT) analysis from this trial would not have appreciably altered our results. Based upon (ITT) pooled data from the two trials, at 12 months, there was no significant between‐group differences with respect to mean pain (MD 0.77 (95% CI ‐1.85 to 3.39) (data not shown). </p> <p>While the lack of significant benefits of vertebroplasty in terms of pain and disability shown in the main analysis of this review would appear to indicate that any other clinical benefits are unlikely, some (<a href="./references#CD006349-bbs2-0063" title="ChenAT , CohenDB , SkolaskyRL . Impact of nonoperative treatment, vertebroplasty, and kyphoplasty on survival and morbidity after vertebral compression fracture in the Medicare population. Journal of Bone &amp; Joint Surgery. American volume2013;95(19):1729‐36. ">Chen 2013</a>; <a href="./references#CD006349-bbs2-0070" title="EdidinAA , OngKL , LauE , KurtzSM . Mortality risk for operated and nonoperated vertebral fracture patients in the Medicare population. Journal of Bone and Mineral Research2011;26(7):1617‐26. ">Edidin 2011</a>; <a href="./references#CD006349-bbs2-0089" title="LangeA , KasperkC , AlvaresL , SauermannS , BraunS . Survival and cost comparison of kyphoplasty and percutaneous vertebroplasty using German claims data. Spine2014;39(4):318‐26. ">Lange 2014</a>; <a href="./references#CD006349-bbs2-0127" title="ZampiniJM , WhiteAP , McGuireKJ . Comparison of 5766 vertebral compression fractures treated with or without kyphoplasty. Clinical Orthopaedics and Related Research2010;468(7):1773–80. ">Zampini 2010</a>), but not all (<a href="./references#CD006349-bbs2-0097" title="McCulloughBJ , ComstockBA , DeyoRA , KreuterW , JarvikJG . Major medical outcomes with spinal augmentation vs conservative therapy. JAMA Internal Medicine2013;173(16):1514‐21. ">McCullough 2013</a>; <a href="./references#CD006349-bbs2-0098" title="McDonaldRJ , AchenbachSJ , AtkinsonEJ , GrayLA , CloftHJ , Melton IIILJ , et al. Mortality in the vertebroplasty population. AJNR: American Journal of Neuroradiology2011;32:1818‐23. ">McDonald 2011</a>), population or clinic‐based observational studies have reported a reduction in mortality associated with spinal augmentation (vertebroplasty or kyphoplasty), compared to those who were untreated. However <a href="./references#CD006349-bbs2-0097" title="McCulloughBJ , ComstockBA , DeyoRA , KreuterW , JarvikJG . Major medical outcomes with spinal augmentation vs conservative therapy. JAMA Internal Medicine2013;173(16):1514‐21. ">McCullough 2013</a> demonstrated that the survival benefit observed with traditional covariate adjustments was no longer in evidence after using propensity score matching to better account for selection bias (<a href="./references#CD006349-bbs2-0097" title="McCulloughBJ , ComstockBA , DeyoRA , KreuterW , JarvikJG . Major medical outcomes with spinal augmentation vs conservative therapy. JAMA Internal Medicine2013;173(16):1514‐21. ">McCullough 2013</a>), suggesting that selection bias from unrecognised confounding explains the observed survival benefit of spinal augmentation seen in other studies. Using propensity score matching <a href="./references#CD006349-bbs2-0097" title="McCulloughBJ , ComstockBA , DeyoRA , KreuterW , JarvikJG . Major medical outcomes with spinal augmentation vs conservative therapy. JAMA Internal Medicine2013;173(16):1514‐21. ">McCullough 2013</a> also reported that one‐year major medical complications were similar between the groups, while rates of health‐care utilisation, including hospital and intensive care unit admissions and discharges to skilled nursing facilities, were higher among those treated with spinal augmentation. </p> <p>Although this review did not demonstrate an increased risk of incident vertebral fractures associated with vertebroplasty, a clinically important increased risk cannot be excluded based upon our review due to the small number of events. Data from the RCTs that compared risk with vertebroplasty compared with placebo or usual care were also inconsistent as evident by the substantial statistical heterogeneity observed in the pooled analyses. </p> <p>Observational studies that have compared the incidence of new vertebral fractures following vertebroplasty to the incidence in a cohort who did not receive the procedure have also reported conflicting results (<a href="./references#CD006349-bbs2-0131" title="ÁlvarezL , AlcarezM , Pérez‐HiguerasA , GranizoJJ , deMiguelI , RossiRE , et al. Percutaneous vertebroplasty: Functional improvement in patients with osteoporotic compression fractures. Spine2006;31:1113‐8. ">Álvarez 2006</a>; <a href="./references#CD006349-bbs2-0064" title="ChosaK , NaitoA , AwaiK . Newly developed compression fractures after percutaneous vertebroplasty: comparison with conservative treatment. Japanese Journal of Radiology2011;29(5):335‐41. ">Chosa 2011</a>; <a href="./references#CD006349-bbs2-0102" title="MudanoAS , BianJ , CopeJU , CurtisJR , GrossTP , AllisonJJ , et al. Vertebroplasty and kyphoplasty are associated with an increased risk of secondary vertebral compression fractures: a population‐based cohort study. Osteoporosis International2009;20:819‐26. ">Mundano 2009</a>; <a href="./references#CD006349-bbs2-0119" title="TangH , ZhaoJ , HaoC . Osteoporotic vertebral compression fractures: surgery versus non‐operative management. Journal of International Medical Research2011;39(4):1438‐47. ">Tang 2011</a>). To conclusively establish whether or not there is an increased risk of further vertebral fracture, particularly adjacent fracture associated with vertebroplasty will require additional large randomised trials with extended follow‐up and/or population‐based studies analysed carefully to account for differences in patient selection as outlined by <a href="./references#CD006349-bbs2-0097" title="McCulloughBJ , ComstockBA , DeyoRA , KreuterW , JarvikJG . Major medical outcomes with spinal augmentation vs conservative therapy. JAMA Internal Medicine2013;173(16):1514‐21. ">McCullough 2013</a>. </p> <p>Based upon the randomised controlled data that we reviewed, cement leakage occurs frequently. While in most cases it does not result in symptoms, serious sequelae may occur. In our review, one trial reported one instance of cement leakage into the epidural space requiring immediate decompression. It is not possible to determine the rate of significant sequelae arising from cement leakage or embolism from our review due to the small number of events. However numerous cases of local cement leakage requiring decompression have been reported, as have reports of cement emboli requiring surgical removal from the inferior vena cava (<a href="./references#CD006349-bbs2-0056" title="BaumannA , TaussJ , BaumannG , TomkaM , HessingerM , TiesenhausenK . Cement embolization into the vena cava and pulmonal arteries after vertebroplasty: interdisciplinary management. European Journal of Vascular and Endovascular Surgery2006;31(5):558‐61. ">Baumann 2006</a>; <a href="./references#CD006349-bbs2-0112" title="SeoJS , KimYJ , ChoiBW , KimTH , ChoeKO . MDCT of pulmonary embolism after percutaneous vertebroplasty. AJR. American Journal of Roentgenology2005;184(4):1364‐5. ">Seo 2005</a>), right heart chambers (<a href="./references#CD006349-bbs2-0062" title="CaynakB , OnanB , SagbasE , DuranC , AkpinarB . Cardiac tamponade and pulmonary embolism as a complication of percutaneous vertebroplasty. Annals of Thoracic Surgery2009;87(1):299‐301. ">Caynak 2009</a>; <a href="./references#CD006349-bbs2-0086" title="KimSP , SonBS , LeeSK , KimDH . Cardiac perforation due to intracardiac bone cement after percutaneous vertebroplasty. Journal of Cardiac Surgery2014;29(4):499‐500. ">Kim 2014</a>), and the right pulmonary artery (<a href="./references#CD006349-bbs2-0071" title="FrançoisK , TaeymansY , PoffynB , VanNootenG . Successful management of a large pulmonary cement embolus after percutaneous vertebroplasty: a case report. Spine2003;28(29):E424‐5. ">François 2003</a>). Cement embolism has also been reported to cause transient respiratory symptoms and death (<a href="./references#CD006349-bbs2-0101" title="MonticelliF , MeyerHJ , Tutsch‐BauerE . Fatal pulmonary cement embolism following percutaneous vertebroplasty (PVP). Forensic Science International2005;149(1):35‐8. ">Monticelli 2005</a>), and deaths from fatal fat embolism after vertebroplasty have also been reported (<a href="./references#CD006349-bbs2-0118" title="SyedMI , JanS , PatelNA , ShaikhA , MarshRA , StewartRV . Fatal fat embolism after vertebroplasty: Identification of the high‐risk patient. AJNR: American Journal of Neuroradiology2006;27:343‐5. ">Syed 2006</a>). In a post‐hoc analysis of data from <a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>, there was an increased odds of cement leakage with higher volumes of injected cement (Odds Ratio (OR) 2.8; 95% CI 1.3 to 6.1), but they found no relationship between cement leakage and efficacy outcome (<a href="./references#CD006349-bbs2-0087" title="KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. ">Kroon 2014</a>). </p> <p>Complications from vertebroplasty reported in the included trials were osteomyelitis requiring surgical drainage, rib fractures, thecal sac injury requiring hospitalisation, pain‐induced vasovagal reactions an acute asthma exacerbation, and fracture of a cement spur. However, as event rates were low in included trials, we cannot be certain if there are, or are not, any between‐group differences for reported adverse events among the trials we reviewed. We also note that severe adverse events such as deaths due to pulmonary thromboembolism, fat embolism, extensive local cement leakage, infection and complications of anaesthesia and infection requiring surgery have all been reported in the literature (<a href="./references#CD006349-bbs2-0053" title="Al‐NakshabandiNA . Percutaneous vertebroplasty complications. Annals of Saudi Medicine2011;31(3):294‐7. ">Al‐Nakshabandi 2011</a>). </p> </section> <section id="CD006349-sec-0097"> <h3 class="title" id="CD006349-sec-0097">Quality of the evidence</h3> <p>The overall quality of evidence for our primary comparison (vertebroplasty versus placebo) was high for the pain, disability and osteoporosis‐specific quality of life outcomes according to the GRADE approach (<a href="./references#CD006349-bbs2-0111" title="SchünemannHJ , OxmanAD , VistGE , HigginsJPT , DeeksJJ , GlasziouP , et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011b</a>). According to the GRADE Working Group grades of evidence, a grading of high quality of evidence indicates that further research is unlikely to change the effect estimates substantially. For the remaining outcomes, the evidence was downgraded from high to moderate due to either imprecision (i.e. 95% CIs do not exclude clinically important differences (defined as 0.074 on the 0 to 1 EQ‐5D quality of life scale), or because the total number of events was small (for other outcomes). According to the GRADE Working Group grades of evidence, a grading of moderate quality of evidence indicates that further research may have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> <p>While the available data from eight trials that compared vertebroplasty with usual care generally favoured vertebroplasty for some, but not all outcomes, they were all rated as having a high risk of performance and detection bias for self‐reported outcomes due to lack of participant and personnel blinding. While recognising that blinding of participants and personnel is difficult to achieve in procedural trials, failure to blind studies of this nature is problematic as trials with unblinded assessment of subjective outcomes (such as pain and function) are estimated to exaggerate the treatment benefit by 22% on average (ratio of OR 0.78; 95% credible interval 0.65 to 0.92) (<a href="./references#CD006349-bbs2-0109" title="SavovićJ , JonesHE , AltmanDG , HarrisRJ , JüniP , PildalJ , et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Annals of Internal Medicine2012;157(6):429‐38. ">Savović 2012</a>). Correcting for these biases would likely drive the improvements seen with vertebroplasty over usual care, towards the null, in keeping with the findings from the placebo‐controlled trials. </p> </section> <section id="CD006349-sec-0098"> <h3 class="title" id="CD006349-sec-0098">Potential biases in the review process</h3> <p>We believe that we identified all relevant trials following a thorough search of all major databases with no language restrictions. </p> <p>Six review authors independently assessed the trials for inclusion in the review, extracted data and assessed the risk of bias, and a third review author adjudicated whenever there was any discrepancy. Two of the review authors (RB and DK) are authors of three of the trials included in this review (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>, and <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a> and <a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a>, respectively). To avoid any bias, these papers were assessed by an independent review author to assess whether they met the inclusion criteria for this review. Neither author was involved in the data extraction or 'Risk of bias' assessment of their own trials. </p> <p>In view of the potential for bias of open studies when the main outcomes are self‐reported, we chose vertebroplasty compared with placebo (sham) as our primary analysis. This decision was vindicated based upon the results of our sensitivity analyses that were performed to determine whether our primary results were robust to the inclusion of the open trials. </p> </section> <section id="CD006349-sec-0099"> <h3 class="title" id="CD006349-sec-0099">Agreements and disagreements with other studies or reviews</h3> <p>Numerous systematic reviews and/or meta‐analyses investigating the effects of vertebroplasty for osteoporotic spinal fractures have been published, e.g. <a href="./references#CD006349-bbs2-0055" title="AndersonPA , FroyshteterAB , TontzWLJr . Meta‐analysis of vertebral augmentation compared with conservative treatment for osteoporotic spinal fractures. Journal of Bone and Mineral Research2013;28(2):378‐32. ">Anderson 2013</a>; <a href="./references#CD006349-bbs2-0060" title="BliemelC , OberkircherL , BueckingB , TimmesfeldN , RuchholtzS , KruegerA . Higher incidence of new vertebral fractures following percutaneous vertebroplasty and kyphoplasty‐‐fact or fiction?. Acta Orthopaedica Belgica2012;78(2):220‐9. ">Bliemel 2012</a>; <a href="./references#CD006349-bbs2-0069" title="EckJC , NachtigallD , HumphreysSC , HodgesSD . Comparison of vertebroplasty and balloon kyphoplasty for treatment of vertebral compression fractures: a meta‐analysis of the literature. Spine Journal2008;8(3):488‐97. ">Eck 2008</a>; <a href="./references#CD006349-bbs2-0074" title="GillJB , KuperM , ChinPC , ZhangY , SchuttRJr . Comparing pain reduction following kyphoplasty and vertebroplasty for osteoporotic vertebral compression fractures. Pain Physician2007;10(4):583‐90. ">Gill 2007</a>; <a href="./references#CD006349-bbs2-0077" title="HanS , WanS , NingL , TongY , ZhangJ , FanS . Percutaneous vertebroplasty versus balloon kyphoplasty for treatment of osteoporotic vertebral compression fracture: a meta‐analysis of randomised and non‐randomised controlled trials. International Orthopaedics2011;35(9):1349‐58. ">Han 2011</a>; <a href="./references#CD006349-bbs2-0082" title="HochmuthK , ProschekD , SchwarzW , MackM , KurthAA , VoglTJ . Percutaneous vertebroplasty in the therapy of osteoporotic vertebral compression fractures: a critical review. European Radiology2006;16(5):998‐1004. [PUBMED: 16395532] ">Hochmuth 2006</a>; <a href="./references#CD006349-bbs2-0083" title="HulmePA , KrebsJ , FergusonSJ , BerlemannU . Vertebroplasty and kyphoplasty: a systematic review of 69 clinical studies. Spine2006;31(17):1983‐2001. ">Hulme 2006</a>; <a href="./references#CD006349-bbs2-0092" title="LeeMJ , DumonskiM , CahillP , StanleyT , ParkD , SinghK . Percutaneous treatment of vertebral compression fractures: a meta‐analysis of complications. Spine2009;34(11):1228‐32. ">Lee 2009</a>; <a href="./references#CD006349-bbs2-0095" title="LiuJ , LiX , TangD , CuiX , LiX , YaoM , et al. Comparing pain reduction following vertebroplasty and conservative treatment for osteoporotic vertebral compression fractures: a meta‐analysis of randomized controlled trials. Pain Physician2013;16(5):455‐64. ">Liu 2013</a>; <a href="./references#CD006349-bbs2-0096" title="MaXL , XingD , MaJX , XuWG , WangJ , ChenY . Balloon kyphoplasty versus percutaneous vertebroplasty in treating osteoporotic vertebral compression fracture: grading the evidence through a systematic review and meta‐analysis. European Spine Journal2012;21(9):1844‐59. ">Ma 2012</a>; <a href="./references#CD006349-bbs2-0099" title="McGirtMJ , ParkerSL , WolinskyJP , WithamTF , BydonA , GokaslanZL . Vertebroplasty and kyphoplasty for the treatment of vertebral compression fractures: an evidenced‐based review of the literature. Spine Journal2011;9(6):501‐8. [PUBMED: 19251485] ">McGirt 2009</a>; <a href="./references#CD006349-bbs2-0106" title="PapanastassiouID , PhillipsFM , VanMeirhaegheJ , BerensonJR , AnderssonGB , ChungG , et al. Comparing effects of kyphoplasty, vertebroplasty, and non‐surgical management in a systematic review of randomized and non‐randomized controlled studies. European Spine Journal2012;21(9):1826‐43. ">Papanastassiou 2012</a>; <a href="./references#CD006349-bbs2-0107" title="PloegWT , VeldhuizenAG , TheB , SietsmaMS . Percutaneous vertebroplasty as a treatment for osteoporotic vertebral compression fractures: a systematic review. European Spine Journal2006;15(12):1749‐58. ">Ploeg 2006</a>; <a href="./references#CD006349-bbs2-0108" title="RobinsonY , OlerudC . Vertebroplasty and kyphoplasty—a systematic review of cement augmentation techniques for osteoporotic vertebral compression fractures compared to standard medical therapy. Maturitas2012;72:42‐9. ">Robinson 2012</a>; <a href="./references#CD006349-bbs2-0113" title="ShiMM , CaiXZ , LinT , WangW , YanSG . Is there really no benefit of vertebroplasty for osteoporotic vertebral fractures? A meta‐analysis. Clinical Orthopaedics &amp; Related Research2012;470(10):2785‐99. ">Shi 2012</a>; <a href="./references#CD006349-bbs2-0116" title="StevensonM , GomersallT , Lloyd JonesM , RawdinA , HernandezM , DiasS , et al. Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for the treatment of osteoporotic vertebral fractures: a systematic review and cost‐effectiveness analysis. Health Technology Assessment (Winchester, England)2014;18(17):1‐290. ">Stevenson 2014</a>; <a href="./references#CD006349-bbs2-0120" title="TaylorRS , TaylorRJ , FritzellP . Balloon kyphoplasty and vertebroplasty for vertebral compression fractures: a comparative systematic review of efficacy and safety. Spine2006;31(23):2747‐55. ">Taylor 2006</a>; <a href="./references#CD006349-bbs2-0122" title="TroutAT , KallmesDF . Does vertebroplasty cause incident vertebral fractures? A review of available data. AJNR: American Journal of Neuroradiology2006;27(7):1397‐403. ">Trout 2006</a>; <a href="./references#CD006349-bbs2-0125" title="WangLJ , YangHL , ShiYX , JiangWM , ChenL . Pulmonary cement embolism associated with percutaneous vertebroplasty or kyphoplasty: a systematic review. Orthopaedic Audio‐Synopsis Continuing Medical Education2012;4(3):182‐9. ">Wang 2012</a>; <a href="./references#CD006349-bbs2-0128" title="ZhangYZ , KongLD , CaoJM , DingWY , ShenY . Incidence of subsequent vertebral body fractures after vertebroplasty. Journal of Clinical Neuroscience2014;21(8):1292‐7. ">Zhang 2013</a>; <a href="./references#CD006349-bbs2-0130" title="ZouJ , MeiX , ZhuX , ShiQ , YangH . The long‐term incidence of subsequent vertebral body fracture after vertebral augmentation therapy: a systemic review and meta‐analysis. Pain Physician2012;15(4):E515‐22. ">Zou 2012</a>). These have differed in terms of focus. </p> <p>Reviews that have synthesised the effectiveness of vertebroplasty have reported conflicting conclusions explainable on the basis of their inclusion criteria and/or methodological rigour (<a href="./references#CD006349-bbs2-0055" title="AndersonPA , FroyshteterAB , TontzWLJr . Meta‐analysis of vertebral augmentation compared with conservative treatment for osteoporotic spinal fractures. Journal of Bone and Mineral Research2013;28(2):378‐32. ">Anderson 2013</a>; <a href="./references#CD006349-bbs2-0082" title="HochmuthK , ProschekD , SchwarzW , MackM , KurthAA , VoglTJ . Percutaneous vertebroplasty in the therapy of osteoporotic vertebral compression fractures: a critical review. European Radiology2006;16(5):998‐1004. [PUBMED: 16395532] ">Hochmuth 2006</a>; <a href="./references#CD006349-bbs2-0083" title="HulmePA , KrebsJ , FergusonSJ , BerlemannU . Vertebroplasty and kyphoplasty: a systematic review of 69 clinical studies. Spine2006;31(17):1983‐2001. ">Hulme 2006</a>; <a href="./references#CD006349-bbs2-0095" title="LiuJ , LiX , TangD , CuiX , LiX , YaoM , et al. Comparing pain reduction following vertebroplasty and conservative treatment for osteoporotic vertebral compression fractures: a meta‐analysis of randomized controlled trials. Pain Physician2013;16(5):455‐64. ">Liu 2013</a>; <a href="./references#CD006349-bbs2-0099" title="McGirtMJ , ParkerSL , WolinskyJP , WithamTF , BydonA , GokaslanZL . Vertebroplasty and kyphoplasty for the treatment of vertebral compression fractures: an evidenced‐based review of the literature. Spine Journal2011;9(6):501‐8. [PUBMED: 19251485] ">McGirt 2009</a>; <a href="./references#CD006349-bbs2-0106" title="PapanastassiouID , PhillipsFM , VanMeirhaegheJ , BerensonJR , AnderssonGB , ChungG , et al. Comparing effects of kyphoplasty, vertebroplasty, and non‐surgical management in a systematic review of randomized and non‐randomized controlled studies. European Spine Journal2012;21(9):1826‐43. ">Papanastassiou 2012</a>; <a href="./references#CD006349-bbs2-0107" title="PloegWT , VeldhuizenAG , TheB , SietsmaMS . Percutaneous vertebroplasty as a treatment for osteoporotic vertebral compression fractures: a systematic review. European Spine Journal2006;15(12):1749‐58. ">Ploeg 2006</a>; <a href="./references#CD006349-bbs2-0108" title="RobinsonY , OlerudC . Vertebroplasty and kyphoplasty—a systematic review of cement augmentation techniques for osteoporotic vertebral compression fractures compared to standard medical therapy. Maturitas2012;72:42‐9. ">Robinson 2012</a>; <a href="./references#CD006349-bbs2-0113" title="ShiMM , CaiXZ , LinT , WangW , YanSG . Is there really no benefit of vertebroplasty for osteoporotic vertebral fractures? A meta‐analysis. Clinical Orthopaedics &amp; Related Research2012;470(10):2785‐99. ">Shi 2012</a>; <a href="./references#CD006349-bbs2-0116" title="StevensonM , GomersallT , Lloyd JonesM , RawdinA , HernandezM , DiasS , et al. Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for the treatment of osteoporotic vertebral fractures: a systematic review and cost‐effectiveness analysis. Health Technology Assessment (Winchester, England)2014;18(17):1‐290. ">Stevenson 2014</a>; <a href="./references#CD006349-bbs2-0120" title="TaylorRS , TaylorRJ , FritzellP . Balloon kyphoplasty and vertebroplasty for vertebral compression fractures: a comparative systematic review of efficacy and safety. Spine2006;31(23):2747‐55. ">Taylor 2006</a>). Our results are consistent with systematic reviews that only included RCTs and performed separate analyses according to comparator (e.g. <a href="./references#CD006349-bbs2-0095" title="LiuJ , LiX , TangD , CuiX , LiX , YaoM , et al. Comparing pain reduction following vertebroplasty and conservative treatment for osteoporotic vertebral compression fractures: a meta‐analysis of randomized controlled trials. Pain Physician2013;16(5):455‐64. ">Liu 2013</a>; <a href="./references#CD006349-bbs2-0108" title="RobinsonY , OlerudC . Vertebroplasty and kyphoplasty—a systematic review of cement augmentation techniques for osteoporotic vertebral compression fractures compared to standard medical therapy. Maturitas2012;72:42‐9. ">Robinson 2012</a>; <a href="./references#CD006349-bbs2-0113" title="ShiMM , CaiXZ , LinT , WangW , YanSG . Is there really no benefit of vertebroplasty for osteoporotic vertebral fractures? A meta‐analysis. Clinical Orthopaedics &amp; Related Research2012;470(10):2785‐99. ">Shi 2012</a>; <a href="./references#CD006349-bbs2-0116" title="StevensonM , GomersallT , Lloyd JonesM , RawdinA , HernandezM , DiasS , et al. Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for the treatment of osteoporotic vertebral fractures: a systematic review and cost‐effectiveness analysis. Health Technology Assessment (Winchester, England)2014;18(17):1‐290. ">Stevenson 2014</a>), while differing conclusions in other reviews are explainable on the basis that these reviews included pooled analyses combining placebo‐controlled and usual care comparators, included non‐randomised studies and/or combined vertebroplasty and kyphoplasty data (e.g. <a href="./references#CD006349-bbs2-0055" title="AndersonPA , FroyshteterAB , TontzWLJr . Meta‐analysis of vertebral augmentation compared with conservative treatment for osteoporotic spinal fractures. Journal of Bone and Mineral Research2013;28(2):378‐32. ">Anderson 2013</a>; <a href="./references#CD006349-bbs2-0106" title="PapanastassiouID , PhillipsFM , VanMeirhaegheJ , BerensonJR , AnderssonGB , ChungG , et al. Comparing effects of kyphoplasty, vertebroplasty, and non‐surgical management in a systematic review of randomized and non‐randomized controlled studies. European Spine Journal2012;21(9):1826‐43. ">Papanastassiou 2012</a>). </p> <p>Four previous reviews that have focused upon the available evidence with respect to incident vertebral fractures (<a href="./references#CD006349-bbs2-0060" title="BliemelC , OberkircherL , BueckingB , TimmesfeldN , RuchholtzS , KruegerA . Higher incidence of new vertebral fractures following percutaneous vertebroplasty and kyphoplasty‐‐fact or fiction?. Acta Orthopaedica Belgica2012;78(2):220‐9. ">Bliemel 2012</a>; <a href="./references#CD006349-bbs2-0122" title="TroutAT , KallmesDF . Does vertebroplasty cause incident vertebral fractures? A review of available data. AJNR: American Journal of Neuroradiology2006;27(7):1397‐403. ">Trout 2006</a>; <a href="./references#CD006349-bbs2-0128" title="ZhangYZ , KongLD , CaoJM , DingWY , ShenY . Incidence of subsequent vertebral body fractures after vertebroplasty. Journal of Clinical Neuroscience2014;21(8):1292‐7. ">Zhang 2013</a>; <a href="./references#CD006349-bbs2-0130" title="ZouJ , MeiX , ZhuX , ShiQ , YangH . The long‐term incidence of subsequent vertebral body fracture after vertebral augmentation therapy: a systemic review and meta‐analysis. Pain Physician2012;15(4):E515‐22. ">Zou 2012</a>), have reported conclusions broadly consistent with ours that it is not possible to definitely establish whether or not there is an increased risk of further vertebral fracture associated with vertebroplasty. <a href="./references#CD006349-bbs2-0123" title="TroutAT , KallmesDF , KaufmannTJ . New fractures after vertebroplasty: adjacent fractures occur significantly sooner. AJNR: American Journal of Neuroradiology2006;27:217‐223. ">Trout 2006a</a> has suggested that adjacent fractures may occur significantly sooner. </p> <p>In contrast to our review, previous reviews that have evaluated the comparative efficacy and safety of vertebroplasty compared with kyphoplasty have all combined data from observational and experimental studies (<a href="./references#CD006349-bbs2-0069" title="EckJC , NachtigallD , HumphreysSC , HodgesSD . Comparison of vertebroplasty and balloon kyphoplasty for treatment of vertebral compression fractures: a meta‐analysis of the literature. Spine Journal2008;8(3):488‐97. ">Eck 2008</a>; <a href="./references#CD006349-bbs2-0074" title="GillJB , KuperM , ChinPC , ZhangY , SchuttRJr . Comparing pain reduction following kyphoplasty and vertebroplasty for osteoporotic vertebral compression fractures. Pain Physician2007;10(4):583‐90. ">Gill 2007</a>; <a href="./references#CD006349-bbs2-0077" title="HanS , WanS , NingL , TongY , ZhangJ , FanS . Percutaneous vertebroplasty versus balloon kyphoplasty for treatment of osteoporotic vertebral compression fracture: a meta‐analysis of randomised and non‐randomised controlled trials. International Orthopaedics2011;35(9):1349‐58. ">Han 2011</a>; <a href="./references#CD006349-bbs2-0096" title="MaXL , XingD , MaJX , XuWG , WangJ , ChenY . Balloon kyphoplasty versus percutaneous vertebroplasty in treating osteoporotic vertebral compression fracture: grading the evidence through a systematic review and meta‐analysis. European Spine Journal2012;21(9):1844‐59. ">Ma 2012</a>), making comparison with our results problematic. More recent reviews (<a href="./references#CD006349-bbs2-0077" title="HanS , WanS , NingL , TongY , ZhangJ , FanS . Percutaneous vertebroplasty versus balloon kyphoplasty for treatment of osteoporotic vertebral compression fracture: a meta‐analysis of randomised and non‐randomised controlled trials. International Orthopaedics2011;35(9):1349‐58. ">Han 2011</a>; <a href="./references#CD006349-bbs2-0096" title="MaXL , XingD , MaJX , XuWG , WangJ , ChenY . Balloon kyphoplasty versus percutaneous vertebroplasty in treating osteoporotic vertebral compression fracture: grading the evidence through a systematic review and meta‐analysis. European Spine Journal2012;21(9):1844‐59. ">Ma 2012</a>), included one of the four RCTs in our review (<a href="./references#CD006349-bbs2-0013" title="LiuJT , LiCS , ChangCS , LiaoWJ . Long‐term follow‐up study of osteoporotic vertebral compression fracture treated using balloon kyphoplasty and vertebroplasty. Journal of Neurosurgery Spine2015;23(1):94‐8. LiuJT , LiaoWJ , TanWC , LeeJK , LiuCH . Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis International2010;21:359–64. ">Liu 2010</a>). In keeping with the findings of our review based upon only RCT data, previous reviews have generally concluded that the two treatments were of comparable longer‐term effectiveness and safety. </p> <p><a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a> considered average kyphosis correction as a secondary radiographic endpoint and reported no between‐group difference in kyphotic angulation correction post‐operatively or at three or 12 months. At 24 months, the authors reported a mean difference of 1.43 degrees (95% CI 0.10 to 2.74 degrees) favouring the kyphosis group although the clinical importance of this finding was not discussed. Some previous reviews have suggested that kyphoplasty may be superior with respect to improving kyphosis angle and vertebral height compared with vertebroplasty, but have acknowledged that this remains to be proven in rigorous RCTs (<a href="./references#CD006349-bbs2-0096" title="MaXL , XingD , MaJX , XuWG , WangJ , ChenY . Balloon kyphoplasty versus percutaneous vertebroplasty in treating osteoporotic vertebral compression fracture: grading the evidence through a systematic review and meta‐analysis. European Spine Journal2012;21(9):1844‐59. ">Ma 2012</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD006349-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD006349-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/full#CD006349-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006349-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/full#CD006349-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias summary': review authors' judgements about the risk of bias of the available evidence presented as percentages across all included studies." data-id="CD006349-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias summary': review authors' judgements about the risk of bias of the available evidence presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/full#CD006349-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Efficacy: Vertebroplasty versus placebo (sham), Outcome 1 Pain (0 to 10 point scale)." data-id="CD006349-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Efficacy: Vertebroplasty versus placebo (sham), Outcome 1 Pain (0 to 10 point scale). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Efficacy: Vertebroplasty versus placebo (sham), Outcome 2 Proportion of participants with pain improved by a clinically relevant amount (&gt;2.5 units or 30% on a 0 or 1 to 10 scale from baseline or less than 4 out of 10." data-id="CD006349-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Efficacy: Vertebroplasty versus placebo (sham), Outcome 2 Proportion of participants with pain improved by a clinically relevant amount (&gt;2.5 units or 30% on a 0 or 1 to 10 scale from baseline or less than 4 out of 10. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Efficacy: Vertebroplasty versus placebo (sham), Outcome 3 Disability (RMDQ)." data-id="CD006349-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Efficacy: Vertebroplasty versus placebo (sham), Outcome 3 Disability (RMDQ). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Efficacy: Vertebroplasty versus placebo (sham), Outcome 4 Quality of life (QUALEFFO) [0 to 100]." data-id="CD006349-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Efficacy: Vertebroplasty versus placebo (sham), Outcome 4 Quality of life (QUALEFFO) [0 to 100]. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Efficacy: Vertebroplasty versus placebo (sham), Outcome 5 Treatment success." data-id="CD006349-fig-0008" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Efficacy: Vertebroplasty versus placebo (sham), Outcome 5 Treatment success.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Efficacy: Vertebroplasty versus placebo (sham), Outcome 6 Quality of Life (EQ5D)." data-id="CD006349-fig-0009" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Efficacy: Vertebroplasty versus placebo (sham), Outcome 6 Quality of Life (EQ5D). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Efficacy: Vertebroplasty versus usual care (open label), Outcome 1 Pain (0 or 1 to 10 point scale)." data-id="CD006349-fig-0010" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Efficacy: Vertebroplasty versus usual care (open label), Outcome 1 Pain (0 or 1 to 10 point scale). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Efficacy: Vertebroplasty versus usual care (open label), Outcome 2 Disability (RMDQ [0 to 24] or ODI [0 to 100])." data-id="CD006349-fig-0011" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Efficacy: Vertebroplasty versus usual care (open label), Outcome 2 Disability (RMDQ [0 to 24] or ODI [0 to 100]). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Efficacy: Vertebroplasty versus usual care (open label), Outcome 3 Quality of Life (QUALEFFO)." data-id="CD006349-fig-0012" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Efficacy: Vertebroplasty versus usual care (open label), Outcome 3 Quality of Life (QUALEFFO). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Efficacy: Vertebroplasty versus usual care (open label), Outcome 4 Quality of life (EQ5D)." data-id="CD006349-fig-0013" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Efficacy: Vertebroplasty versus usual care (open label), Outcome 4 Quality of life (EQ5D). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Efficacy: Vertebroplasty versus usual care (open label), Outcome 5 Treatment success." data-id="CD006349-fig-0014" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Efficacy: Vertebroplasty versus usual care (open label), Outcome 5 Treatment success. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Efficacy: Vertebroplasty versus kyphoplasty (balloon), Outcome 1 Pain (0 to 10 point scale)." data-id="CD006349-fig-0015" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Efficacy: Vertebroplasty versus kyphoplasty (balloon), Outcome 1 Pain (0 to 10 point scale). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Efficacy: Vertebroplasty versus kyphoplasty (balloon), Outcome 2 Disability (ODI)." data-id="CD006349-fig-0016" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Efficacy: Vertebroplasty versus kyphoplasty (balloon), Outcome 2 Disability (ODI). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Efficacy: Vertebroplasty versus kyphoplasty (balloon), Outcome 3 Quality of Life (EQ5D)." data-id="CD006349-fig-0017" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Efficacy: Vertebroplasty versus kyphoplasty (balloon), Outcome 3 Quality of Life (EQ5D). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Efficacy: Vertebroplasty versus facet joint injection, Outcome 1 Pain (0 to 10 point scale)." data-id="CD006349-fig-0018" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Efficacy: Vertebroplasty versus facet joint injection, Outcome 1 Pain (0 to 10 point scale). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Efficacy: Vertebroplasty versus facet joint injection, Outcome 2 Disability (RMDQ)." data-id="CD006349-fig-0019" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Efficacy: Vertebroplasty versus facet joint injection, Outcome 2 Disability (RMDQ). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Efficacy: Vertebroplasty versus facet joint injection, Outcome 3 Quality of Life (SF‐36)." data-id="CD006349-fig-0020" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Efficacy: Vertebroplasty versus facet joint injection, Outcome 3 Quality of Life (SF‐36). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Safety: Vertebroplasty versus placebo (sham) or usual care, Outcome 1 New clinical vertebral fractures." data-id="CD006349-fig-0021" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Safety: Vertebroplasty versus placebo (sham) or usual care, Outcome 1 New clinical vertebral fractures. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Safety: Vertebroplasty versus placebo (sham) or usual care, Outcome 2 New radiographic vertebral fractures." data-id="CD006349-fig-0022" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Safety: Vertebroplasty versus placebo (sham) or usual care, Outcome 2 New radiographic vertebral fractures. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Safety: Vertebroplasty versus placebo (sham) or usual care, Outcome 3 Number of serious other adverse events." data-id="CD006349-fig-0023" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Safety: Vertebroplasty versus placebo (sham) or usual care, Outcome 3 Number of serious other adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Safety: Vertebroplasty versus kyphoplasty, Outcome 1 New clinical vertebral fractures." data-id="CD006349-fig-0024" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Safety: Vertebroplasty versus kyphoplasty, Outcome 1 New clinical vertebral fractures. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Safety: Vertebroplasty versus kyphoplasty, Outcome 2 New radiographic vertebral fractures." data-id="CD006349-fig-0025" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Safety: Vertebroplasty versus kyphoplasty, Outcome 2 New radiographic vertebral fractures. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Safety: Vertebroplasty versus kyphoplasty, Outcome 3 Number of serious other adverse events." data-id="CD006349-fig-0026" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Safety: Vertebroplasty versus kyphoplasty, Outcome 3 Number of serious other adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Safety: Vertebroplasty versus facet joint injection, Outcome 1 New radiographic vertebral fractures." data-id="CD006349-fig-0027" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Safety: Vertebroplasty versus facet joint injection, Outcome 1 New radiographic vertebral fractures. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Subgroup analysis: 'Acute' fractures versus 'subacute' fractures, Outcome 1 Pain at 1 to 2 weeks." data-id="CD006349-fig-0028" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Subgroup analysis: 'Acute' fractures versus 'subacute' fractures, Outcome 1 Pain at 1 to 2 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Subgroup analysis: 'Acute' fractures versus 'subacute' fractures, Outcome 2 Pain at 1 month." data-id="CD006349-fig-0029" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Subgroup analysis: 'Acute' fractures versus 'subacute' fractures, Outcome 2 Pain at 1 month. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Subgroup analysis: 'Acute' fractures versus 'subacute' fractures, Outcome 3 Disability at 1 to 2 weeks." data-id="CD006349-fig-0030" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 Subgroup analysis: 'Acute' fractures versus 'subacute' fractures, Outcome 3 Disability at 1 to 2 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-008-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-008-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Subgroup analysis: 'Acute' fractures versus 'subacute' fractures, Outcome 4 Disability at 1 month." data-id="CD006349-fig-0031" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-008-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8 Subgroup analysis: 'Acute' fractures versus 'subacute' fractures, Outcome 4 Disability at 1 month. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-008-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-008-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-008-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Subgroup analysis: 'Acute' fractures versus 'subacute' fractures, Outcome 5 Quality of life (EQ‐5D) at 1 month." data-id="CD006349-fig-0032" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-008-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.5</div> <div class="figure-caption"> <p>Comparison 8 Subgroup analysis: 'Acute' fractures versus 'subacute' fractures, Outcome 5 Quality of life (EQ‐5D) at 1 month. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-008-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Sensitivity analysis, Outcome 1 Pain at 1 to 2 weeks (0 or 1 to 10 point scale)." data-id="CD006349-fig-0033" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Sensitivity analysis, Outcome 1 Pain at 1 to 2 weeks (0 or 1 to 10 point scale). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-009-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-009-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Sensitivity analysis, Outcome 2 Pain at 1 month (0 or 1 to 10 point scale)." data-id="CD006349-fig-0034" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-009-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9 Sensitivity analysis, Outcome 2 Pain at 1 month (0 or 1 to 10 point scale).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-009-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-009-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-009-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Sensitivity analysis, Outcome 3 Pain at 3 months (0 or 1 to 10 point scale)." data-id="CD006349-fig-0035" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-009-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9 Sensitivity analysis, Outcome 3 Pain at 3 months (0 or 1 to 10 point scale). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-009-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-009-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-009-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Sensitivity analysis, Outcome 4 Disability at 1 to 2 weeks (RMDQ [0 to 24] or ODI [0 to 100]))." data-id="CD006349-fig-0036" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-009-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9 Sensitivity analysis, Outcome 4 Disability at 1 to 2 weeks (RMDQ [0 to 24] or ODI [0 to 100])). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-009-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-009-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-009-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Sensitivity analysis, Outcome 5 Disability at 1 month (RMDQ [0 to 24] or ODI [0 to 100])." data-id="CD006349-fig-0037" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-009-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.5</div> <div class="figure-caption"> <p>Comparison 9 Sensitivity analysis, Outcome 5 Disability at 1 month (RMDQ [0 to 24] or ODI [0 to 100]). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-009-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006349-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/urn:x-wiley:14651858:media:CD006349:CD006349-CMP-009-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_t/tCD006349-CMP-009-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Sensitivity analysis, Outcome 6 Disability at 3 months (RMDQ [0 to 24] or ODI [0 to 100])." data-id="CD006349-fig-0038" src="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-009-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.6</div> <div class="figure-caption"> <p>Comparison 9 Sensitivity analysis, Outcome 6 Disability at 3 months (RMDQ [0 to 24] or ODI [0 to 100]). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/media/CDSR/CD006349/image_n/nCD006349-CMP-009-06.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD006349-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Vertebroplasty for osteoporotic vertebral compression fracture</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Vertebroplasty for osteoporotic vertebral compression fracture</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with osteoporotic vertebral compression fracture<br/> <b>Settings:</b> hospital, various countries including Australia, USA, UK, Canada, several European countries, Iran, China, Taiwan<br/> <b>Intervention:</b> vertebroplasty versus placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo<sup>1</sup> </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Vertebroplasty</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain</b> <br/> Scale from: 0 to 10, 0 is no pain.<br/> Follow‐up: 1 month </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain in the control groups was<br/> <b>5 points</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain in the intervention groups was<br/> <b>0.7 points better</b><br/> (0.3 better to 1.2 better) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>535<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute change 7% better (3% better to 12% better); relative change 10% better (4% better to 17% better)<sup>3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Disability (Roland‐Morris Disability Questionnaire)</b><br/> Scale from: 0 to 23; 0 is no disability.<br/> Follow‐up: 1 month </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean disability in the control groups was<br/> <b>14.2 points</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean disability in the intervention groups was<br/> <b>1.5 points better</b><br/> (0.4 better to 2.6 better) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>472<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute change 7% better (2% better to 11% better); relative change 9% better (2% better to 15% better)<sup>3</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Disease‐specific quality of Life (QUALEFFO)</b> <br/> Scale from: 0 to 100; 0 is best.<br/> Follow‐up: 1 month </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life (QUALEFFO) in the control groups was<br/> <b>62 points</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean quality of life in the intervention groups was<br/> <b>2.33 points better</b><br/> (1.41 worse to 6.06 better) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>351<br/> (3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute change 2% better (1% worse to 6% better); relative change 4% better (2% worse to 10% better)<sup>3</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall quality of Life (EQ5D)</b> <br/> Scale from: 0 to 1; 1 is best.<br/> Follow‐up: 1 month </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life (EQ‐5D) in the control groups was<br/> <b>0.38 points</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean quality of life in the intervention groups was<br/> <b>0.05 points better</b><br/> (0.01 better to 0.09 better) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>285<br/> (3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute change 5% better (1% better to 9% better); relative change 18% improvement (4% better to 32% better)<sup>3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant global assessment of success</b> </p> <p>(People perceived their pain as better)</p> <p>Follow‐up: 1 month</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>225 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>315 per 1000</b><br/> (150 to 664) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.40</b> <br/> (0.67 to 2.95) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute difference 9% more reported success (11% fewer to 29% more); relative change 40% more reported success (33% fewer to 195% more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incident symptomatic vertebral fractures</b> </p> <p>Follow‐up: 12 ‐24 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>73 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>95 per 1000</b> </p> <p>(34 to 264)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.29</b> <br/> (0.46 to 3.62) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>840<br/> (6 studies)<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>4,6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Absolute difference 3% more fractures with vertebroplasty (8% fewer to 13% more); relative difference 29% more (54% fewer to 262% more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Other serious adverse events</b><br/> Follow‐up: 12‐24 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>56 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>34 per 1000</b><br/> (18 to 62) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.61</b><br/> (0.33 to 1.10) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>821<br/> (5 studies)<sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>4,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute difference 1% fewer events with vertebroplasty (6% fewer to 4% more); relative change 39% fewer (67% fewer to 10% more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>SMD:</b> Standardised mean difference; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> For incident vertebral fractures the comparison includes two placebo (sham)‐controlled trials and three trials that compared vertebroplasty versus usual care. </p> <p><sup>2</sup> The internal validity of the five placebo‐controlled trials that have full or some results available is high. Four trials have published their results in peer‐reviewed journals (<a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>; <a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a>; <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>; <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a>) while a fifth trial (<a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a>), completed in April 2014, was published as a thesis (http://www.forskningsdatabasen.dk/en/catalog/2371744560), and reported at a conference. Therefore we did not downgrade the evidence due to suspected publication bias although the results of one additional placebo‐controlled trial (<a href="./references#CD006349-bbs2-0052" title="NCT01963039 . A trial of vertebroplasty for painful chronic osteoporotic vertebral fractures (VERTOS V). clinicaltrials.gov/show/NCT01963039 First registered 28 August 2013. ">VERTOS V</a>) remain unpublished. This trial was previously reported as completed in June 2015, but its status has been changed to 'enrolling by invitation', at: https://clinicaltrials.gov/ct2/show/NCT01963039. While publication bias is possible, it is unlikely the conclusions will change when data from this trial become available. </p> <p><sup>3</sup> Relative changes calculated as absolute change (mean difference) divided by mean at baseline in the placebo group from <a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a> (values were: 7.1 points on 0 to 10 point VAS pain; 17.3 points on 0 to 23 point Roland‐Morris Disability questionnaire; 0.28 points on EQ‐5D quality of life scale; 59.6 points on the QUALEFFO scale). </p> <p><sup>4</sup> Downgraded due to imprecision: the 95% confidence intervals do not exclude a clinically important change (defined as 1.5 points on the 0 to 10 pain scale; 2 to 3 points on the 0 to 23 point RMDQ scale; 0.074 on the 0 to 1 EQ‐5D quality of life scale, and 10 points on the 0 to 100 QUALEFFO scale); or for dichotomous outcomes the total number of participants was small, or number of events was small (&lt;200); or data were from a single trial only </p> <p><sup>5</sup> Pooled both placebo and usual care comparisons in the safety analyses. </p> <p><sup>6</sup> Downgraded due to the possibility of detection bias in the studies with a usual care control group. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Vertebroplasty for osteoporotic vertebral compression fracture</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/full#CD006349-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006349-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Study characteristics of unpublished, ongoing and suspended or terminated trials</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Trial registration number</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Principle Investigator/s and Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparator/s</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Main selection criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Registration date</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Recruitment commenced</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Status 8 January 2018</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Planned sample size</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Final sample size</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NCT00749060</p> <p>‘OSTEO‐6’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Laredo JD</p> <p>France</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Kyphoplasty; Usual care with or without brace</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age ≥ 50 years</p> <p>Fracture &lt; 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 Sept 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dec 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Completed June 2012; results unpublished</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NCT00749086</p> <p>‘STIC2’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Laredo JD</p> <p>France</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Kyphoplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age ≥ 50 years</p> <p>Fracture &gt; 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 Sept 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dec 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Completed June 2012; results unpublished</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>97</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NCT00203554</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sorensen L</p> <p>Denmark</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fracture &lt; 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16/09/2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mar 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Completed Jan 2008; results unpublished</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ISRCTN14442024</p> <p>(Also</p> <p>N0213112414)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dolin, S</p> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fracture &gt; 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 Sep 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nov 28 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Completed (last updated 6 Feb 2014); results unpublished</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not provided</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not provided</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NCT01677806</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sun G</p> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age ≥ 50 years</p> <p>Fracture &lt; 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23 Aug 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oct 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recruitment status unknown (last updated 11 Sep 2014)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Registration details not found.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Longo UG</p> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 weeks bed rest, rigid hyperextension corset, followed by 2‐3 months in a Cheneau brace (called ‘double‐blind) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age ≥ 50 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Trial registration not found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unknown (protocol published)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NCT01963039</p> <p>‘VERTOS V’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Carli D</p> <p>the Netherlands</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sham</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age ≥ 50 years</p> <p>Fracture ≥ 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28 Aug 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>May 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Previously reported as completed (Nov 2015) then recruiting again (Feb 2017) (protocol published) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Record of trial registration not found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chen JP</p> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trial registration not found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Completed; study awaiting translation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Record of trial registration not found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Li DH</p> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kyphoplasty</p> <p>Bone filling mesh container</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trial registration not found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Completed; study awaiting translation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Record of trial registration not found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tan B</p> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kyphoplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trial registration not found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Completed; study awaiting translation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>106</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Record of trial registration not found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Zhou W</p> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kyphoplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trial registration not found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Completed; study awaiting translation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>* Abstract reported that analysis favoured vertebroplasty at 1 day and 1 week for pain, and disability measured by RMDQ and ODI (data not provided), but no evidence of important differences between groups at 1, 3, 6, 12 months for pain, RMDQ, ODI and SF‐36 function and SF‐36 physical and mental component scores. After 12 months follow‐up, there were 13 new fractures in the percutaneous vertebroplasty group and 11 new fractures in the facet joint block group. Abstract did not report method of randomisation, whether or not treatment allocation was concealed and whether or not participants and investigators were blinded to treatment allocation. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Study characteristics of unpublished, ongoing and suspended or terminated trials</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/full#CD006349-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006349-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Baseline demographic and clinical characteristics of the trial participants</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Treatment Groups</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean age, yrs</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean symptom duration</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean (SD) baseline pain (0‐10 scale<sup>$</sup>)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean (SD) baseline RMDQ<sup>+</sup> (0‐24 scale</b><sup>†</sup><b>)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean (SD) baseline QUALEFFO (0‐100 scale)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Procedures performed by</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean (range) volume cement injected (mL)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Follow‐up</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0001" title="BlascoJ , Martinez‐FerrerA , MachoJ , San RomanL , PomesJ , CarrascoJ , et al. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12‐month randomized follow‐up, controlled trial. Journal of Bone and Mineral Research2012;27(5):1159‐66. BlascoJ , Martinez‐FerrerA , San RomanJ , MachoA , Lopez RuedaD , CampodonicoC , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty. European Society of Radiology. 2014. PerisP , BlascoJ , CarrascoJL , Martinez‐FerrerA , MachoJ , San RomanL , et al. Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment. Calcified Tissue International2015;96(2):89‐96. ">Blasco 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Spain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>140.3 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.2 (0.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65.2 (2.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interventional radiologists</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 weeks, 2, 6, 12 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>143.1 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.3 (0.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59.2 (2.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Australia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9 weeks^</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.4 (2.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.3 (2.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56.9 (13.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interventional radiologists</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.8 (1.2 ‐ 5.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 week, 1, 3, 6, 12, 24 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.5 weeks^</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.1 (2.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.3 (2.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59.6 (17.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0004" title="BirdP , ClarkW , DiamondT , SchlaphoffG , SmerdelyP , GonskiP , et al. A placebo controlled trial of vertebral fill technique vertebroplasty for acute painful osteoporotic fracture (VAPOUR trial). Arthritis and Rheumatology. Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. 2016; Vol. 68:413‐4. ClarkW , BirdP , DiamondT , GonskiP . Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial. Trials2015;16:159. ClarkW , BirdP , GonskiP , DiamondT , SmerdelyP , McNeilH , et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double‐blind, placebo‐controlled trial. Lancet2016;388(10052):1408‐16. ">Clark 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Australia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.1 (1.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19.5 (3.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65.4 (11.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interventional radiologists</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.5 (4.7 ‐ 10.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 days, 14 days, 1, 3 and 6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.2 (1.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19.8 (3.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67.7 (11.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0003" title="ChenD , AnZQ , SongS , TangJF , QinH . Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures. Journal of Clinical Neuroscience2014;21:473‐7. ">Chen 2014a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.5 (0.9)<sup>&amp;</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.6 (1.8)<sup>#&amp;</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic surgeons</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.6 (3 ‐ 6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 day, 1 week, 1, 3, 6, 12 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care and brace</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29.5 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.4 (0.9)<sup>&amp;</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.7 (1.3)<sup>#&amp;</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0005" title="DohmM , BlackCM , DacreA , TillmanJB , FuerediG , KAVIAR investigators. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR: American Journal of Neuroradiology2014;35(12):2227‐36. ">Dohm 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA and Canada</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐¤</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>˜7.6<sup>µ</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interventional radiologists and neuroradiologists, orthopaedic surgeons, neuroradiologists</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.0 (3.0 to 6.0)<sup>¢</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7 days, 1, 3, 12 and 24 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Balloon kyphoplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐¤</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>˜7.6<sup>µ</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.6 (3.4 to 6.0)<sup>¢</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0006" title="EndresS , BaduraA . Shield kyphoplasty through a unipedicular approach compared to vertebroplasty and balloon kyphoplasty in osteoporotic thoracolumbar fracture: A prospective randomized study. Orthopaedics &amp; Traumatology: Surgery &amp; Research2012;98(3):334‐40. ">Endres 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Germany</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐<sup>§</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.8 (0.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic surgeon</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.1 (2 – 4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately, mean 5.8 months (range: 4 to 7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Balloon kyphoplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐<sup>§</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.0 (0.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic surgeon</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.9 (3 – 5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shield kyphoplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐<sup>§</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.8 (1.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic surgeon</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.6 (3 – 6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0007" title="EvansA , KipK , BrinjikjiW , LaytonK , JensenM , GaughenJ , et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. Journal of Neurointerventional Surgery2015;8(7):756‐63. ">Evans 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.9 (2.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.3 (7.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 days, 1, 6 and 12 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kyphoplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.4 (1.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.3 (6.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Iran</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.4 (1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neurosurgeons</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.5 (1 ‐ 5.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 week, 2, 6, 12, 24, 36 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.2 (1.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>the Netherlands</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29.2 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.7 (1.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18 (4.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68.4 (17.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interventional radiologists</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.11 (1 ‐ 11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 day, 1 week, 1, 3, 6, 12 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25.9 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.9 (1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.8 (4.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69.7 (17.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>US, UK, Australia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.9 (2.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.6 (3.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interventional radiologists</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.8 (1 ‐ 5.5)*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 days, 2 weeks, 1 month</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.2 (2.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.5 (4.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0011" title="KlazenCA , LohlePN , deVriesJ , JansenFH , TielbeekAV , BlonkMC , et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open‐label randomised trial. Lancet2010;376(9746):1085‐92. [PUBMED: 20701962] KlazenCA , VenmansA , deVriesJ , vanRooijWJ , JansenFH , BlonkMC , et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR: American Journal of Neuroradiology2010;31(8):1447‐50. KlazenCA , VerhaarHJ , LampmannLE , JuttmannJR , BlonkMC , JansenFH , et al. VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials2007;8:33. [PUBMED: 17973983] ">Klazen 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>the Netherlands, Belgium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29.3 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.8 (1.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.6 (3.6)<sup>#</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58.7 (13.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interventional radiologists</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.1 (1 ‐ 9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 day, 1 week, 1, 3, 6, 12 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26.8 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.5 (1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.2 (4.2)<sup>#</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.7 (14.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐<sup>§</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.8 (‐)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53.6 (‐)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 (‐)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 and 2 days, 6 weeks, 3 and 6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐<sup>§</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐<sup>§</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0013" title="LiuJT , LiCS , ChangCS , LiaoWJ . Long‐term follow‐up study of osteoporotic vertebral compression fracture treated using balloon kyphoplasty and vertebroplasty. Journal of Neurosurgery Spine2015;23(1):94‐8. LiuJT , LiaoWJ , TanWC , LeeJK , LiuCH . Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis International2010;21:359–64. ">Liu 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Taiwan</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.8 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.9 (0.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.9 (0.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 days, 6 months, 1, 3 and 5 years</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Balloon kyphoplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.0 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.0 (0.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.6 (0.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0014" title="RousingR , AndersenMO , JespersenSM , ThomsenK , LauritsenJ , RousingRikke , et al. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three‐months follow‐up in a clinical randomized study. Spine2009;34(13):1349‐54. RousingR , HansenKL , AndersenMO , JespersenSM , ThomsenK , LauritsenJM . Twelve‐months follow‐up in forty‐nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine2010;35(5):478‐82. [PUBMED: 20190623] ">Rousing 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Denmark</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.4 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.5 (2.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic surgeons</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care and brace</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.7 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.8 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0015" title="SunK , LiuY , PengH , TanJF , ZhangM , ZhengXN , et al. A comparative study of high‐viscosity cement percutaneous vertebroplasty vs. low‐viscosity cement percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures. Journal of Huazhong University of Science and Technology. Medical Sciences2016;36(3):389‐94. ">Sun 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.5 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70.6 (8.6)<sup>×</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.4 (0.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 days, 12 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kyphoplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.2 (0.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71.7(8.5)<sup>×</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.2 (0.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0016" title="VoglTJ , PflugmacherR , HierholzerJ , StenderG , GounisM , WakhlooA , et al. Cement directed kyphoplasty reduces cement leakage as compared with vertebroplasty: results of a controlled, randomized trial. Spine2013;38(20):1730‐6. ">Vogl 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Germany and USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐<sup>¥</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.5 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.0 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 day, 3 and 12 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shield kyphoplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐<sup>¥</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.3 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.8 (0.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0017" title="VoormolenMH , LohlePN , FransenH , JuttmannJR , deWaal MalefijtJ , LampmannLE . [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: first short term results]. Nederlands Tijdschrift Voor Geneeskunde2003;147(32):1549‐53. VoormolenMH , LohlePN , JuttmannJR , van derGraafY , FransenH , LampmannLE . The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. Journal of Vascular and Interventional Radiology2006;17(1):71‐6. VoormolenMH , LohlePN , LampmannLE , van denWildenbergW , JuttmannJR , DiekerhofCH , et al. Prospective clinical follow‐up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures. Journal of Vascular and Interventional Radiology2006;17(8):1313‐20. VoormolenMH , MaliWP , LohlePN , FransenH , LampmannLE , van derGraafY , et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short‐term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. American Journal of Neuroradiology2007;28(3):555‐60. VoormolenMH , vanRooijWJ , SluzewskiM , van derGraafY , LampmannLE , LohlePN , et al. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR: American Journal of Neuroradiology2006;27(7):1579‐85. VoormolenMH , vanRooijWJ , van derGraafY , LohlePN , LampmannLE , JuttmannJR , et al. Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome. AJNR: American Journal of Neuroradiology2006;27(5):983‐8. ">Voormolen 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>the Netherlands</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>85 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.1 (5 ‐ 9)<sup>+</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.7 (8‐24)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60.0 (37 to 86)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interventional radiologists</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.2 (1.0 ‐ 5.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.6 (5‐10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.8 (8‐22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60.7 (38 to 86)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Denmark</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐ª</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.47 ()</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic surgeons</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported<sup>˜</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 hours, weekly to 3 months, 12 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (lidocaine injected)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐ª</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.61 ()</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic surgeons</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69.43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.1 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71.22 (10.56)<sup>×</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.31 (0.77)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 day, 3 and 12 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Balloon kyphoplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68.63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.0 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71.30 (10.22)<sup>×</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.22 (1.29)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0020" title="HaoD , GuoH , WangB , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal; http://eposterlyon.eurospine.org/cm_data/eposter/P17.PDF. 2014; Vol. 23, Issue 5:Supplement, pp 527‐557. HaoD , WangB , GuoH , WangX . Treatment for acute or subacute osteoporosis vertebral compression fractures: Percutaneous vertebroplasty versus facets blocking (a clinical randomized study). European Spine Journal2014;23(1):S533. WangB , GuoH , YuanL , HuangD , ZhangH , HaoD . A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. European Spine Journal2016;25:3486‐94. [DOI: 10.1007/s00586‐016‐4425‐4] ">Wang 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐ª</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.65 (1.11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.3 (1.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Spine surgeon</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.5 (3.0 ‐ 9.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Facet joint injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐ª</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.76 (1.06)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.45 (0.98)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Spine surgeon</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertebroplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.5 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80.2 (9.9)<sup>×</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78.1 (8.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.5 (3‐6.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 week, 3, 6 and 12 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.7 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>81.5 (9.7)<sup>×</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77.5 (8.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> <tfoot> <tr> <td colspan="11"> <div class="table-footnote"> <p><sup>$</sup>1‐10 point scale used by <a href="./references#CD006349-bbs2-0008" title="FarrokhiMR , AlibaiE , MaghamiZ . Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. Journal of Neurosurgery. Spine2011;14(5):561‐9. ">Farrokhi 2011</a>, 0 to 100 scale used by <a href="./references#CD006349-bbs2-0018" title="HansenEJ . A double‐blind randomized clinical study comparing vertebroplasty with a SHAM procedure for acute osteoporotic vertebral compression fractures (VOPE). Thesis, University of Southern Denmark: Center for Spine Surgery and Research, Middelfart Hospital and Institute of Regional Health Research, University of Southern Denmark, Denmark2015. HansenEJ , SimonyA , RousingR , CarreonLY , TroppH , AndersenMO . Double blind placebo‐controlled trial of percutaneous vertebroplasty (VOPE). Global Spine Journal. 2017; Vol. 6 Issue 1_suppl:s‐0036‐1582763. [DOI: https://doi.org/10.1055/s‐0036‐1582763] NCT01537770 . Vertebroplasty versus periost infiltration with lidocaine as pain treatment in osteoporotic fractures in the thoracic and lumbar spine. clinicaltrials.gov/show/NCT01537770 Trial registered: EUCTR 2010‐024050‐10 (Also NCT01537770) completed as of 11 September 2015. ">VOPE 2015</a> and we report pain with forward bending for this trial as overall pain not reported and have converted SE to SD; <sup>+</sup>RMDQ: Roland‐Morris Disability Questionnaire; <sup>†</sup>modified RMDQ (0‐23 scale) used by <a href="./references#CD006349-bbs2-0002" title="BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtC , et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.[see comment]. New England Journal of Medicine2009;361(6):557‐68. BuchbinderR , OsborneRH , EbelingPR , WarkJD , MitchellP , WriedtCJ , et al. Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskeletal Disorders2008;9:156. KroonF , StaplesMP , EbelingP , WarkJ , OsborneR , MitchellP , et al. Vertebroplasty for osteoporotic vertebral fractures: Two‐year results from a randomized controlled trial. Journal of Bone and Mineral Research2014;29(6):1346‐55. StaplesMP , HoweBM , RinglerM , MitchellP , WriedtC , WarkJ , et al. Vertebroplasty for osteoporotic vertebral fractures: radiological outcomes from a 2 year randomized controlled trial. Archives of Osteoporosis2015;10(1):229. ">Buchbinder 2009</a>, <a href="./references#CD006349-bbs2-0010" title="BrinjikjiW , ComstockBA , HeagertyPJ , JarvikJG , KallmesDF . Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy. Radiology2010;257(1):219‐25. ComstockBA , SitlaniCM , JarvikJG , HeagertyPJ , TurnerJA , KallmesDF . Investigational vertebroplasty safety and efficacy trial (INVEST): patient‐reported outcomes through 1 year. Radiology2013;269:224‐31. GrayLA , JarvikJG , HeagertyPJ , HollingworthW , StoutL , ComstockBA , et al. INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelet Disorders2007;8:126. KallmesDF , ComstockBA , GrayLA , HeagertyPJ , HollingworthW , TurnerJA , et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR: American Journal of Neuroradiology2009;30(6):1203‐5. KallmesDF , ComstockBA , HeagertyPJ , TurnerJA , WilsonDJ , DiamondTH , et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.[see comment]. New England Journal of Medicine2009;361(6):569‐79. StaplesMP , KallmesDF , ComstockBA , JarvikJG , OsborneRH , HeagartyPJ , et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta‐analysis. BMJ2011;342:d3952. ">Kallmes 2009</a> and <a href="./references#CD006349-bbs2-0009" title="FiranescuC , LohlePN , deVriesJ , KlazenCA , JuttmannJR , ClarkW , et al. VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Trials2011;12(93):http://www.trialsjournal.com/content/12/1/93. [DOI: 10.1186/1745‐6215‐12‐93] FiranescuC , deVriesJ , LodderP , SchoemakerMC , SmeetsAJ , VemansA , et al. VERTOS IV study group. American Society Spine Radiology (ASSR) 2017 Annual Symposium. San Diego, 2017. FiranescuCE , deVriesJ , LodderP , VenmansA , ShoemakerMC , SmeetAJ , DongaE , JuttmannJR , KlazenCAH , ElgersmaOEH , JansenFH , TielbeekAV , BoukrabI , SchonenbergK , vanRooijWJJ , HirschJA , LohlePNM . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 20182018;360:k1551. [DOI: 10.1136/bmj.k1551] ">Firanescu 2018</a>; <sup>×</sup>Oswestry Disability Index (0 to 100) used by <a href="./references#CD006349-bbs2-0012" title="LealiPT , SollaF , MaestrettiG , BalsanoM , DoriaC . Safety and efficacy of vertebroplasty in the treatment of osteoporotic vertebral compression fractures: A prospective multicenter international randomized controlled study. Clinical Cases in Mineral and Bone Metabolism2016;13(3):234‐6. ">Leali 2016</a>, <a href="./references#CD006349-bbs2-0019" title="WangC , MaJ , ZhangC , NieL . Comparison of high‐viscosity cement vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Pain Physician2015;18(2):187‐94. ">Wang 2015</a>, <a href="./references#CD006349-bbs2-0021" title="YangEZ , XuJG , HuangGZ , XiaoWZ , LiuXK , ZengBF , et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures. Spine2016;41(8):653‐60. ">Yang 2016</a>; ^ median duration of symptoms; <sup>¤</sup>Not reported but symptom duration 6 months or less; <sup>µ</sup>Mean symptom duration reported graphically only; <sup>¢</sup>Median and interquartile range;<sup>§</sup>Not reported but symptom duration 6 weeks or less; ªNot reported but symptom duration 8 weeks or less; <sup>&amp;</sup>Data only included for the 42/46 in VP group and 43/50 in the usual care group who completed 12‐month follow‐up in groups assigned to at baseline; <sup>#</sup>Disability significantly higher in the vertebroplasty group; *from n = 20 treated at Mayo (personal communication); <sup>¥</sup>Not reported but at least 6 weeks of conservative treatment; <sup>+</sup>Only range provided; <sup>˜</sup>up to 2 mL. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Baseline demographic and clinical characteristics of the trial participants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/full#CD006349-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006349-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Efficacy: Vertebroplasty versus placebo (sham)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Pain (0 to 10 point scale) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 1 to 2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>539</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐0.82, 0.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>535</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.73 [‐1.18, ‐0.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.48 [‐1.01, 0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.59 [‐1.18, 0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>265</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.42 [‐1.02, 0.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.1 [‐2.68, 0.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Proportion of participants with pain improved by a clinically relevant amount (&gt;2.5 units or 30% on a 0 or 1 to 10 scale from baseline or less than 4 out of 10 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 1 to 2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.43 [0.78, 2.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.53 [0.99, 2.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.60 [1.12, 2.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [1.02, 1.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>230</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [1.06, 1.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.43 [0.84, 2.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Disability (RMDQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 1 to 2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>475</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [‐1.23, 1.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>472</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.50 [‐2.61, ‐0.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>333</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.81 [‐3.15, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.82 [‐4.12, 0.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [‐1.56, 1.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐3.67, 3.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Quality of life (QUALEFFO) [0 to 100] <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 1 to 2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>352</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.10 [‐6.96, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.33 [‐6.06, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>244</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.42 [‐4.23, 3.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>330</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.88 [‐6.66, 2.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.5 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.32 [‐5.41, 2.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.6 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [‐5.48, 8.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Treatment success <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 1 week</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.6 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Quality of Life (EQ5D) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 1 to 2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>164</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.03, 0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>285</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [0.01, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.00, 0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [0.01, 0.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.17, 0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.24, 0.24]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Efficacy: Vertebroplasty versus placebo (sham)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006349-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Efficacy: Vertebroplasty versus usual care (open label)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Pain (0 or 1 to 10 point scale) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 1 to 2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.33 [‐2.26, ‐0.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>384</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.06 [‐3.35, ‐0.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 2 to 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.18 [‐1.95, ‐0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>573</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.05 [‐1.82, ‐0.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>612</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.02 [‐1.74, ‐0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.45 [‐0.90, 0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Disability (RMDQ [0 to 24] or ODI [0 to 100]) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 1 to 2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>494</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.06 [‐3.28, ‐0.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>378</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.52 [‐3.00, ‐0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>460</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.76 [‐4.65, ‐0.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>461</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.84 [‐3.37, ‐0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>455</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.59 [‐2.79, ‐0.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.65 [‐6.67, ‐4.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Quality of Life (QUALEFFO) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 1 to 2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>448</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.67 [‐11.65, 0.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>289</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.18 [‐21.49, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 2 to 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>415</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.83 [‐15.41, 3.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>415</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.14 [‐15.02, 4.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>415</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.40 [‐9.90, 3.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Quality of life (EQ5D) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 1 to 2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [0.00, 0.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 0.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>215</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [0.00, 0.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.02, 0.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.5 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>215</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.00, 0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Treatment success <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Efficacy: Vertebroplasty versus usual care (open label)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006349-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Efficacy: Vertebroplasty versus kyphoplasty (balloon)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Pain (0 to 10 point scale) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 1 to 2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>462</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐0.37, 0.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>441</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.59, 0.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>419</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [‐0.11, 0.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>230</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.31, 0.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>558</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [‐0.07, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>320</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐0.56, 0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Disability (ODI) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1758</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.12, 0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 1 to 2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.38, 0.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>425</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.11 [‐0.30, 0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>399</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.16, 0.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐0.46, 0.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>542</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.16, 0.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.35, 0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Quality of Life (EQ5D) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1346</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.04, 0.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>422</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.09, 0.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>292</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.23, 0.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.39, 0.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>342</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.15, 0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>202</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.18, 0.37]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Efficacy: Vertebroplasty versus kyphoplasty (balloon)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006349-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Efficacy: Vertebroplasty versus facet joint injection</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Pain (0 to 10 point scale) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 1 to 2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Disability (RMDQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 1 to 2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Quality of Life (SF‐36) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Efficacy: Vertebroplasty versus facet joint injection</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006349-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Safety: Vertebroplasty versus placebo (sham) or usual care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 New clinical vertebral fractures <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>840</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.46, 3.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 New radiographic vertebral fractures <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>804</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.71, 1.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Number of serious other adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>821</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.33, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Safety: Vertebroplasty versus placebo (sham) or usual care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006349-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Safety: Vertebroplasty versus kyphoplasty</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 New clinical vertebral fractures <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 New radiographic vertebral fractures <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>593</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.97, 1.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>372</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.21, 3.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>221</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.92, 1.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Number of serious other adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 4.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>221</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.42, 1.97]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Safety: Vertebroplasty versus kyphoplasty</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006349-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Safety: Vertebroplasty versus facet joint injection</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 New radiographic vertebral fractures <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Safety: Vertebroplasty versus facet joint injection</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006349-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Subgroup analysis: 'Acute' fractures versus 'subacute' fractures</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Pain at 1 to 2 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 'Acute' fractures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>378</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.12 [‐0.38, 0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 'Subacute' fractures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.30, 0.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pain at 1 month <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>535</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.27 [‐0.44, ‐0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 'Acute' fractures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>378</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.26 [‐0.46, ‐0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 'Subacute' fractures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.29 [‐0.61, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Disability at 1 to 2 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>467</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.16, 0.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 'Acute' fractures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.29, 0.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 'Subacute' fractures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [‐0.20, 0.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Disability at 1 month <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 'Acute' fractures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐0.47, ‐0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 'Subacute' fractures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.47, 0.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Quality of life (EQ‐5D) at 1 month <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [0.01, 0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 'Acute' fractures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [0.01, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 'Subacute' fractures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.02, 0.10]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Subgroup analysis: 'Acute' fractures versus 'subacute' fractures</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006349-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Sensitivity analysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Pain at 1 to 2 weeks (0 or 1 to 10 point scale) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1166</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.76 [‐1.30, ‐0.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Sham (placebo) control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>539</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.30, 0.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Usual care (open label) control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.33 [‐2.26, ‐0.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pain at 1 month (0 or 1 to 10 point scale) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>919</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.94 [‐1.55, ‐0.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Sham (placebo) control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>535</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.27 [‐0.44, ‐0.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Usual care (open label) control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>384</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.06 [‐3.35, ‐0.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain at 3 months (0 or 1 to 10 point scale) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1021</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.78 [‐1.28, ‐0.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Sham (placebo) control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐0.40, ‐0.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Usual care (open label) control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.18 [‐1.95, ‐0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Disability at 1 to 2 weeks (RMDQ [0 to 24] or ODI [0 to 100])) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>793</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.25 [‐2.06, ‐0.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Sham (placebo) control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>299</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.34, 0.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Usual care (open label) control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>494</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.06 [‐3.28, ‐0.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Disability at 1 month (RMDQ [0 to 24] or ODI [0 to 100]) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>674</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.88 [‐1.60, ‐0.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Sham (placebo) control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>296</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.27 [‐0.50, ‐0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Usual care (open label) control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>378</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.52 [‐3.00, ‐0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Disability at 3 months (RMDQ [0 to 24] or ODI [0 to 100]) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>622</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.85 [‐3.08, ‐0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Sham (placebo) control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.11 [‐0.78, 0.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Usual care (open label) control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>460</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.76 [‐4.65, ‐0.87]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Sensitivity analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006349.pub4/references#CD006349-tbl-0012">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006349.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD006349-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD006349-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006349-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD006349-note-0013">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD006349-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD006349-note-0002">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006349\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006349\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006349\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006349\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006349\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006349\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006349\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006349\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006349\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006349\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006349\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006349\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006349\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006349\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006349\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006349\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006349\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006349\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Xx9QLps0&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006349.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006349.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006349.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006349.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006349.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740715396985"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006349.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740715396988"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006349.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d8614ccc79374',t:'MTc0MDcxNTM5Ny4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 